altogether better  
  Member Login


Forgot Password ?

      
Member's Spotlight
  Member Spotlight     
Department of Science, Information Technology, Innovation and the Arts - Thursday, 26 July 2012

Type of Organisation
State Government

Services Offered
Access to Science Capability and Investment
Industry Development Strategies
Policies and Programs

Life Sciences Sub-sector
Agricultural Biotechnology
Animal Health
Environmental Biotechnology
Human Healthcare
Industrial Biotechnology
Marine Biotechnology

Organisation Description
The Queensland Government recognises the importance of the State’s life sciences sector in developing a diversified and knowledge-based economy.
Over the past decade more than $4.9 billion has been invested in research, skills and innovation.
Queensland has an international reputation for research excellence in human health, agricultural and industrial biotechnology.
Queensland has new state-of-the-art facilities which promote collaborative research across disciplines, advance international linkages and house many of our science leaders. These include:
the Ecosciences Precinct (
www.science.qld.gov.au)
the Health and Food Sciences Precinct (
www.science.qld.gov.au)
the Smart State Medical Research Centre (Queensland Institute of Medical Research -
http://www.qimr.edu.au/)
Translational Research Institute (TRI) -
http://www.tri.edu.au/
The Department of Science, Information Technology, Innovation and the Arts supports universities and research organisations, and links with businesses, peak bodies and other state and federal government agencies to foster the development of a sustainable life sciences sector in Queensland.
The Department is pleased to be an LSQ Foundation Supporter, working together with this peak body to promote and create real opportunities for the Queensland life sciences industry now, and into the future.

 

Davies Collison Cave - Thursday, 26 July 2012

Type of Organisation
Intellectual Property Legal Practise

Services Offered
Intellectual property due dilligence
Patent advice and services include: preparation, design, filing, proscecuting, novelty searches and assesment, infringement and validity, conducting opposition and enforcement of patent and design rights
Trade Mark advice and services include: selection, creation, searching, registration, infringement, defence and anti-counter fitting. 
     
Life Sciences Sub-sector
Agricultural Biotechnology
Animal Health
Environmental Biotechnology
Human Healthcare
Industrial Biotechnology
Marine Biotechnology

Organisation Description
Davies Collison Cave (DCC) is Australia’s leading intellectual property (IP) legal practice. We provide expert services in the areas of patents, trade marks, trade secrets, copyright and design protection, licensing, litigation and related legal and commercial matters. Davies Collison Cave is Australia’s largest filer of both patent and trade mark applications.
Our firm is distinguished by its considerable commitment to teaching and professional organisations. These involvements mean that members of the firm have a deep understanding and intimate involvement with shaping IP law and policy in Australia and internationally.  There is no doubt that our clients benefit as a result of the high level and detailed knowledge of the legal policy and framework that members of our firm possess. 
As our professionals are drawn from a broad range of science and technology backgrounds, many with PhD’s in their field of specialisation, you can be sure Davies Collison Cave will bring the greatest legal and technical skills to bear on all matters entrusted to us.
Davies Collison Cave has over 240 employees who are led by 37 Partners throughout our four offices, located in Brisbane, Melbourne, Sydney and Newcastle. We provide services in both regional and metropolitan areas.  We have almost 80 professionals consisting of patent attorneys, trade mark attorneys and lawyers.  

For more information on the firm and our people please visit our website:  www.davies.com.au


 

Cooper Grace Ward Lawyers - Monday, 23 July 2012

Type of Organisation
• Lawyers - Legal Services  
   
Services Offered
• Commercial
• Construction and Infrastructure
• Employment and Workplace Relations
• Energy and Resources
• Family Law
• Insurance
• IP/IT
• Litigation and Dispute Resolution
• Property Planning and Environment
• Transport 

Life Sciences Sub-sector
• Agricultural Biotechnology
• Environmental Biotechnology
• Human Healthcare
• Industrial Biotechnology
• Marine Biotechnology

Organisation Description
Cooper Grace Ward is a Queensland-based law firm with local, national and international clients. Since our origins in 1980, we have established a first class reputation, with the people, experience and resources to achieve excellent outcomes for our clients.
We promise you a commercial approach along with tailored and high quality advice at all times. Our focus on client service includes working with you to understand your personal and business requirements in our time, not at your expense.
We are committed to our clients’ success, the development of our valued team and our continuing role as our clients’ business partner.

 

Coridon Pty Limited - Monday, 23 July 2012

Type of Organisation
• Vaccine Developer 
     
Life Sciences Sub-sector
• Human Healthcare

Organisation Description
Coridon was founded in 2000 by the founder inventor Prof Ian Frazer as a private unlisted company, to develop and commercialise patented technology for improving immune responses to DNA vaccines licensed by UniQuest Pty Ltd and developed at the University of Queensland.  The company has laboratories within the research facility at the Princess Alexandra Hospital in Brisbane, working in collaboration with the University of Queensland Diamantina Institute.  The company’s overall objective is to utilise its unique optimisation technology to produce prophylactic and/or therapeutic DNA vaccines for a range of infectious diseases and cancers in humans. Product development is currently focused on herpes virus vaccines.

Our research has shown that using the technologies in combination can provide protection in a number of infectious diseases and tumour challenge animal models.
Coridon has 6 granted US patents protecting its codon optimisation DNA technology, which enhances protein expression in the cell or tissue targeted and results in an improved humoral response.  The second component of the technology, also patent protected, is to use DNA encoding ubiquitin to enhance the degradation of the same protein, which results in an increased cell mediated response. 

 

 

Clinical Network Services (CNS) Pty Ltd - Tuesday, 3 July 2012

Type of Organisation
Clinical Research Organisation
Clinical Trial Management
Contract Research Organisation
Medical Writing Consultancy
Product Development Consultancy

Services Offered
BioDesk
Clinical Trial Management
Fast2First
Independent Medical Advice
International Regulatory Consultancy
Medical Writing
Preclinical Consultancy
Product Development Planning
Quality Consultancy & Auditing

Life Sciences Sub-sector
Human Healthcare

Organisation Description
Clinical Network Services (CNS) Pty Ltd is a Brisbane-based Clinical Research Organisation (CRO) specialising in the planning and implementation of Phase I & II clinical trials in Australia and New Zealand. With over 13 years experience in early stage clinical trial management in more than 141 projects, CNS is one of the most experienced providers within the Australian market and a partner of choice for biotech companies from home and abroad. CNS has been a leader in the planning, management and implementation of early stage clinical trials in Australia and New Zealand for biotechnology companies from around the world. As an established, niche CRO serving the needs of SME biotech companies, we have a deep understanding of the commercial and scientific challenges that our clients face. CNS provides its biotech clients with the full range of Phase I and Phase II clinical trial services under the “Fast2First” brand and now offers “BioDesk”, a bespoke product development and regulatory planning service which helps our clients efficiently enter the clinic with their lead candidate for the first time and realise commercial goals earlier.

 

ClinSolutions Pty Ltd - Tuesday, 3 July 2012

Type of Organisation
Clinical Research Service Provider
Clinical Research Software Provider

Services Offered
Data management
Drug management
Drug safety systems
Electronic patient diary
Emergency unblinding
Randomisation
Trial payment systems

Life Sciences Sub-sector
Human Healthcare

Organisation Description
ClinSolutions is an independent Australian provider of IT systems and services to the clinical research industry.  Our systems can be used for Phase I-IV trials across one or more countries in multiple languages. 
We supply IVRS and IWRS services for subject screening, randomisation, emergency un-blinding, drug supply management and patient diaries.  We also supply web-based systems for data management, drug safety and clinical trial payments.  

 

Brisbane South Clinical Research Centre - Thursday, 28 June 2012

Type of Organisation
Private Dedicated Clinical Trials Centre

Services Offered
Clinical Research
Patient Recruitment
Patient Screening
Treatment of Subjects (Context of Phase I/II Trials)
Treatment of Subjects (Context of Phase III/IV Trials)
    
Life Sciences Sub-sector
Human Healthcare

Organisation Description
BSCRC is a small dedicated private clinical research centre conducting Phase II to Phase IV clinical trials for the pharmaceutical  industry. We have been established 14 years with a good track record of meeting and exceeding recruitment targets. We have had a number of sponsor audits with excellent reports. 

 

Brisbane Marketing - Investment Attraction - Thursday, 28 June 2012

Type of Organisation
Investment Agency (inward and outward)

Services Offered
Business consultancy services
Investment consultancy services    

Organisation Description
Brisbane Marketing’s Investment Attraction division is the city’s experienced and world-class inward investment agency. Established by the Lord Mayor of Brisbane more than 20 years ago, we have a strong track record in bringing new business to Brisbane and connecting local partners with international networks. We focus our efforts to attract Foreign Direct Investment (FDI) in six key sectors for which Brisbane has a national or international competitive advantage:

  • Clean Technologies and Renewable Energy
  • Digital Industries (including ICT, mining technology and services, and electronic games)
  • Food and Beverage R&D and Manufacturing
  • Life Sciences
  • Logistics and Distribution
  • Infrastructure
  • Innovative Manufacturing
  • Our dedicated and experienced team works with investors to determine how Brisbane fits with their future growth strategy for the Asia Pacific region. We provide critical introductions to extensive networks in the private sector, all levels of government and academia, talent and labour analysis, property solutions and advice regarding grants and incentives.

Supporting our work in FDI, we play an influential role in shaping the business environment – ensuring Brisbane remains a competitive destination for business investment.

 

 

Biostate - Thursday, 21 June 2012

Type of Organisation
• Business Consultancy
     
Services Offered
• Business Consultancy Services

Life Sciences Sub-sector
• Human Healthcare

Organisation Description
biostate provides advocacy and strategic business consulting services to individuals and entities who require assistance to identify and realise the potential of their endeavors.  As active participants in the life sciences sector - and in particular human health, we can provide:
• Introductions to industry contacts
• independant advice in identifying and realising the commercial potential of ideas
• assistance with marketing and business plan development (and execution)
• representation at appropriate forums
• identification and selection of suitable strategic partners
• support in negotiation of agreements
• advocacy services

 

BioPharmaceuticals Australia (BPA) - Thursday, 21 June 2012

Type of Organisation
• Biopharmaceutical industry development
• Contract Manufacturing Organisation
• Government Liaison and Advocacy
• State Government

Services Offered
• Advocacy
• Bioprocessing/Fermentation
• Contract Manufacturing/Scale-up
• Process Development

Life Sciences Sub-sector
• Human Healthcare

Organisation Description
BPA has been established with the support of the Queensland Government to achieve two broad objectives:
• to design, fund and implement construction of a biotherapeutic manufacturing facility to be operated in alliance with an experienced international partner;
• to support and grow existing local Australian biotherapeutic manufacturing organisations, and to facilitate synergies between complementary providers of clinical development services.

The new facility will provide a service solution for companies with biological drug candidates who seek to outsource their process development and manufacturing. It will provide cutting-edge technical and economical methods for generating biopharmaceutical compounds expressed in mammalian cells.

The facility will enable early stage research to be converted into robust, production-ready processes, which can be tested at pilot scale before moving into the highly controlled GMP manufacturing environment required for human medicinal products. The BPA facility will not only cater for pre-clinical development projects, but also for clients manufacturing for clinical trials and the marketplace.
The new facility will be operated by DSM Biologics and is due to be opened in early 2013. The facility upstream suites will cater for mammalian cell culture up to 2000 litres, with the ability to accommodate future expansion.

 

BDO - Thursday, 14 June 2012

Type of Organisation
Audit Tax Advisory

Services Offered
Audit
Business Recovery & Insolvency
Corporate Finance
Corporate & International Tax
Forensic Services
Performance Improvement
Private & Entrepreneurial Clients
Private Wealth
Risk Advisory

Organisation Description
In Australia, BDO offers the expertise of more than 150 partners, supported by over 1300 staff. The longevity we have in the Queensland marketplace has been invaluable in cementing our approach to client relationships and customer service.
We provide our services to a diverse range of clients, from large corporate organisations to private businesses, entrepreneurs and individuals across a broad array of industry sectors.
We enjoy outstanding relationships with our clients by focusing on what is important to them, adopting a partnership-style approach, being responsible and reliable, keeping our promises and maintaining open and frank communication.
Our approach to relationships allows us to partner with our clients and really get to know them and their organisation. Using this insight, we look for innovative ways to help our clients maximise growth opportunities, improve processes and avoid pitfalls. The end result is that we meet – or exceed – our clients’ expectations.
We treat our clients’ businesses as if they were our own: we get the job done; solve problems; open doors; and come up with new ideas to ensure potential is maximized.

 

BioAssayLINK Pty Ltd - Thursday, 14 June 2012

Type of Organisation
Online matching service
Specialised online marketplace 
     
Services Offered
List specialised consultant in database
List biomedical researcher capabilities in database
List service provider (CRO) capabilities in database
Match industry with biomedical researchers
Match industry with specialised consultants
Match industry with specialised service providers (CROs)

Life Sciences Sub-sector
Agricultural Biotechnology
Animal Health
Human Healthcare
Industrial Biotechnology
Marine Biotechnology

Organisation Description
BioAssayLINK (www.bioassaylink.com) is the first online linking service for discovery and preclinical research services. It can be described as the 'expedia' or 'wotif' of new therapeutic research and development. Our online matching tool enables industry seekers' to locate their outsourcing and collaborative partners that meet their specific needs. Our online matching focuses on early stage R&D such as drug and small molecule discovery, biomedical research, preclinical and non-clinical. Our unique online linking tool provides a rapid, cost effective and customer-specific way for seekers to connect with specialized providers. This information allows seekers to arrive at better decisions more quickly to advance their R&D programs, improving effectiveness and efficiency. BioAssayLINK is a privately owned company headquartered in Brisbane, Australia with distribution networks and affiliates in the United States of America and the United Kingdom and constantly expanding.

 

Australian Prostate Cancer Research Centre - Queensland (APCRC-Q) - Thursday, 7 June 2012

Type of Organisation
Biomarker Discovery
Clinical Trials Unit
Not-for-profit Institution/Organisation
Preclinical Facility 
Research Organisation

Services Offered
Bioassays
Bioinformatics
Biomarker Services
Genomics Research Services
Nutraceutical Development Services
Pharmacogenomics
Patient Recruitment
Preclinical Research Models and Therapeutic Testing
Tissue Banking
Translational Medicine

Life Sciences Sub-sector
Human Healthcare

Organisation Description
The Australian Prostate Cancer Research Centre - Queensland is a transdisciplinary research centre, focused on the development of prostate cancer therapeutics and prognostic biomarkers.  Initially funded by the Australian Government, we collaborate with a variety of institutions and industry organisations.  Our activities span from  high throughput discovery, molecular pathology, functional characterisation of potential targets, preclinical therapeutic development and evaluation, to clinical trials.
APCRC-Q leads the Multidisciplinary Team Clinic (MDT) for advanced prostate cancer at the Princess Alexandra Hospital, for Phase I/II and III trials.  The APCRC-Q is also the headquarters of the Australian-Canadian Prostate Cancer Research Alliance, an initiative established with funding from the Queensland Government.  This international Alliance links all the major prostate cancer research groups and relevant clinical societies across Australia and Canada.  It partners nearly 300 scientists and clinicians to facilitate access to unique resources, leading edge infrastructure, and clinical trials networks.  The APCRC-Q is highly interested in working collaboratively or contracting with Biotech, Pharma, and other industries in the development of new therapeutics, imaging and biomarkers. The APCRC-Q also operates the Australian only circulating tumour cell facility and provides service to academics and industry for clinical research.
The APCRC-Q will move into the Translational Research Institute in late 2012.

 

Banksia Scientific - Thursday, 7 June 2012

Type of Organisation
Medical and Scientific Supplier

Services Offered
Balances Cells and Culture Media
Chemicals
Diagnostic Products
Food Diagnostics
Forensic and Drug Detection
Human Proteins  
Human Stem Cells
Pathology
Research Products 
Used Lab Equipment

Life Sciences Sub-sector
Agricultural Biotechnology
Animal Health
Human Healthcare
Industrial Biotechnology

Organisation Description
Queensland owned and offering a level of service not shown by other suppliers. We have a wide range of products from general laboratory requirements through to research and development products from a number of quality maunfacturers from around the world. So from chemicals through to cells and media we can help you in your endeavours and ensure a timely supply of product.

 

Australian Institute for Bioengineering and Nanotechnology (AIBN) - Thursday, 24 May 2012

Type of Organisation
Research Institute

Services Offered
Education
Commercialisation
Industry Partnership
Research
  
Life Sciences Sub-sector
Agricultural Biotechnology
Environmental Biotechnology
Human Healthcare
Industrial Biotechnology

Organisation Description
The University of Queensland's Australian Institute for Bioengineering and Nanotechnology (AIBN) is an integrated multi-disciplinary research institute bringing together the skills of world-class researchers in the areas of bioengineering and nanotechnology.  The Institute is home to 19 research groups working at the interface of the biological, chemical and physical science to alleviate current problems in human health and environmental issues.
Three key areas collectively distinguish it from other institutes in the country, namely AIBN's:
research excellence;
industry focus;
dynamic research environment
These characteristics focus AIBN research efforts on the development of new products, processes and devices for improving human health and quality of life. In this way the institute goes beyond basic research to promote and develop the growth of innovative industries, which will benefit the Queensland and Australian economies.

 

 

Australian Institute of Marine Science (AIMS) - Thursday, 24 May 2012

Type of Organisation
Commonwealth statutory authority 

Services Offered
Environmental responses to coastal development and associated activities Advice for scientists in universities and other research organisations wishing to work in marine ecosystems.
Information on the Institute's research program and its scientific capabilities
Marine application of new technologies
Provision of scientific data relating to marine and coastal ecosystems 
Scientific input to policy development related to marine research and technology
     
Life Sciences Sub-sector
Animal Health
Environmental Biotechnology
Marine Biotechnology

Organisation Description
The Australian Institute of Marine Science (AIMS) is a leader in tropical marine science, internationally renowned for its unique capacity to investigate marine life from microbes to whole-of-ecosystems, and develop enabling molecular tools and ocean technologies.  Our research improves understanding of tropical marine ecosystems, enables forecasting effects of global climate change and guidance to sustainable development of tropical marine-based industries. 
AIMS' headquarters is located on a coastal site 50km from Townsville and houses modern research laboratories, state-of-the-art analytical facilities, major collections like the Australian Coral Core Archive and a bioresource library of extracts, an aquaculture centre, numerous seawater aquaria, controlled environment rooms, and engineering workshops for instrument development. Our location also provides a fast transition from the sea to the laboratory, a key advantage in marine science.  Two smaller offices, in Perth, Western Australia, and Darwin, Northern Territory, provide direct links for research partners and clients in these regions.  We also have two research vessels, the RV Solander and the RV Cape Ferguson, and several smaller boats that enable access to tropical marine ecosystems across the Great Barrier Reef, throughout the Arafura and Timor Seas and along the West Australian coast from the North-West Shelf to Ningaloo Reef.

 

Alchemia - Thursday, 17 May 2012

Type of Organisation
Drug Discovery
Oncology

Life Sciences Sub-sector
Human Healthcare

Organisation Description
Alchemia has a marketed product, generic fondaparinux that was launched in the US mid 2011 by Alchemia’s marketing partner Dr Reddy’s and will be filed for approval in the EU and other markets in 2012. Fondaparinux is a high value generic, due to the complexity of its synthesis, which will limit future competition.

Alchemia Oncology is developing improved chemotherapeutics using its proprietary HyACT technology platform. HyACT targets drugs to tumors thereby enhancing the effectiveness of the drug. This occurs through a well documented receptor-based mechanism (CD44). The lead program, HA-Irinotecan is currently in a pivotal Phase III study in metastatic colorectal cancer (mCRC) which should report its primary endpoint mid 2013. HA-Irinotecan is also being evaluated in Small Cell Lung Cancer (SCLC) in a Phase II study which will also investigate the impact of the treatment on cancer stem cells. The HyACT platform is extremely versatile and is able to increase the effectiveness of a broad range of important cancer drugs.

 

Australian Genome Research Facility (AGRF) - Thursday, 17 May 2012

Type of Organisation
Agriculture    
Bioinformatics
Genomics
Service Provider

Services Offered
Epigenomics Bioinformatics
Gene Expression
Genotyping
Next-Generation Sequencing
Nucleic Acid Extraction
Sequencing
     
Life Sciences Sub-sector
Agricultural Biotechnology
Animal Health
Environmental Biotechnology
Human Healthcare
Industrial Biotechnology
Marine Biotechnology

Organisation Description
Australian Genome Research Facility Ltd (AGRF), a not for profit company, is Australia's largest provider of genomics services and solutions. AGRF has laboratories in Brisbane, Sydney, Melbourne, Adelaide and Perth, each providing a gateway to a national network of state-of-the-art facilities, technology and expertise. From microbes to plants, animals and humans, AGRF provides a full range of services across the entire biological spectrum. We provide services to academia and industry with clients from bioscience, environmental science, biomedicine and agricultural biotechnology.
Our range of services is unique in Australia and recognised internationally. AGRF is accredited by NATA to the ISO/IEC17025:2005 Quality Standard.

 

Institute of Health and Biomedical Innovation (IHBI), Queensland University of Technology - Thursday, 10 May 2012

Organisation Name 
Institute of Health and Biomedical Innovation (IHBI), Queensland University of Technology

Organisation Category
Research Organisation
List of Services
Clinical Research
Medical Research

Organisation Description
The Institute of Health and Biomedical Innovation(IHBI) is a collaborative institute based at QUT, devoted to improving the health of individuals through research innovation. We combine high quality health research with a commitment to social justice. This means that we do more than develop innovative solutions to health issues. We also apply our solutions to real world experiences to make sure that they are effective. Through our work, we seek to improve the health of individuals and of communities.

IHBI’s researchers focus on three broad health areas - prevention; mind and body health; and recovery. IHBI’s researchers are clustered into five flexible research domains that emphasise multidisciplinary collaboration:

Cells & Tissue
Human Health & Wellbeing
Injury Prevention & Rehabilitation
Medical Device
Vision Improvement.

 

IPG Print - Thursday, 10 May 2012

Organisation Name
IPG Print

Organisation Category
Print Solutions Company

Organisation Description
IPG Print is one of the leading providers of print solutions in Queensland. IPG was the first company in Queensland to embrace a true print management business model with online ordering and professional inventory management systems. We offer a broad range of in house printing equipment that includes traditional printing presses, state of the art digital presses and full colour envelope machines.

The IPG Print plant is located at Brendale in Brisbane, approximately 16km north of the Brisbane GPO and convenient to all main arterial roads and the Brisbane airport. Employing 75 staff, IPG comprehensively covers all aspects of the commercial offset and digital printing field. Our qualified
tradesmen operate a wide range of presses from single colour to 6 colour offset as well as the digital INDIGO presses. IPG Print have the technology, expertise and above all enthusiasm to deliver to our customers a product with the quality an organization such as yours deserves and we look forward to the opportunity to work with you.

 

James Cook University - Thursday, 3 May 2012

Organisation Name
James Cook University

Organisation Category
Clinical Research Organisation
Medical School
Research Institution
Research Organisation
Teaching Hospital
University

Organisation Description
James Cook University (JCU) is a comprehensive and multicampus university based in tropical North Queensland, ranked in the top 5% of the world’s tertiary institutions. It is Australia’s leading tropical research university and is amongst the top five tropical universities of the world for research in its major research fields. In clinically-relevant areas, JCU produces graduates and undertakes research and research training in medicine, dentistry, allied health and rehabilitation (including physiotherapy, occupational therapy, speech pathology, and sports science) public health, nursing, midwifery, nutrition, veterinary science, psychology, and in the biomedical and biomolecular sciences. In the biomedical area, it has particular research strengths in immunology, genomics, cardiovascular biology and vascular disease, neuroscience, infectious diseases, parasitology, tropical medicine, tropical public health and epidemiology, colo-rectal and skin cancers, and in clinical program delivery to underserved populations. In most of these areas, JCU researchers are involved in both basic biological research and strongly clinical projects, including clinical trials.

 

Institute for Glycomics - Thursday, 3 May 2012

Organisation Name
Institute for Glycomics

Organisation Category
Research Institution

Organisation Description
Griffith’s Institute for Glycomics is a global leader in carbohydrate focused research into clinically significant diseases. The Institute is the only one of its kind in Australia and only one of six in the world. Research at the Institute for Glycomics involves the study of the glycan and glycan-binding proteins in various biological systems, and the design of novel drugs and vaccines. This approach presents an exciting therapeutic platform for the control of a wide-range of medical conditions such as infectious diseases (including Influenza, Malaria, Dengue fever and Rotavirus), cancer, diabetes, inflammation and immune disorders.

The Institute takes a multi-disciplinary approach to research bringing together researchers from medicinal chemistry, computational chemistry, structural biology, microbiology, immunology, virology, biochemistry and molecular and cell biology. It collaborates with leading scientists around the world to build a critical mass around carbohydrate-based research. Global collaboration together with a mutil-disciplinary approach to research, are essential to achieving our vision to bring forward novel medicines and vaccines to the community.

 

Haematology & Oncology Clinics of Australia Research Centre - Tuesday, 24 April 2012

Organisation Name
Haematology & Oncology Clinics of Australia Research Centre

Organisation Category
Dedicated Clinical Trials Centre (as part of a public or private hospital)
Not-for-profit Institution/Organisation
Research Organisation

Organisation Description
The Haematology & Oncology Clinics of Australia Research Centre is a not for profit organization established in 1993. It operates from the following locations two of which are leading tertiary healthcare facilities:

The Mater Private Centre for Haematology & Oncology
The Wesley Clinic for Haematology & Oncology
North Brisbane Cancer Centre at the Chermside Medical Centre
HOCA Gold Coast Cancer Centre

The Research Centre is staffed by experienced clinical research professionals who work along side leading Haematologists and Oncologists providing treatment options to over 70% of privately treated patients in Brisbane.

HOCA Research Centre has established a strong tradition of providing excellence in trial conduct to both local and international partners in the pharmaceutical and biotechnology sector. HOCA Research Centre also works closely with collaborative groups working together to develop new and innovative drugs for Australian patients.

The Mission of the HOCA Research Centre is Caring for People with Cancer.

 

 

Logan Hospital - Tuesday, 24 April 2012

Organisation Name 
Logan Hospital

Organisation Category
Government – State Government
Medical Clinic/Ward (public hospital)
Public Hospital

List of Services
Clinical Research
Ethics Review Services (HREC)
Medical Research
Quality Assurance
Training and Educational Services


Organisation Description
Logan/Beaudesert Hospitals provide secondary medical, surgical, obstetric and gynaecology, mental health, paediatric, palliative care, renal dialysis, specialist outpatient and allied health services. Patients also flow into the PA Hospital for tertiary services and via the Mater Children’s, Adults’ and Women’s Hospitals. Logan/Beaudesert Hospitals also provide mental health services with 40 Acute Adult Inpatient Beds, 10 Acute Adolescent Inpatient Beds, Adult community-based mental health services, with multiple teams working from a range of community facilities.

The District also provides a significant volume and variety of primary health services from a large number of community facilities, including oral health, mental health, child health, school health, aged care, rehabilitation, palliative care, chronic disease management, general primary medical care and alcohol, tobacco and other drug services. Outreach clinical services are also provided in non-Queensland Health facilities e.g. high school and primary school nursing, oral health services, antenatal, child health and sexual health services.

Logan Hospital:
Located on the corner of Loganlea and Armstrong Roads at Meadowbrook in the centre of Logan City, the Logan Hospital has 291 beds and provides a wide range of secondary inpatient services to the surrounding community. These include general surgery, oral surgery, orthopaedic general and trauma surgery, ear nose and throat surgery (adults only), internal and emergency medicine, respiratory and cardiac medicine, gastroenterology, intensive and coronary care, anaesthetics, palliative care, general paediatric, a special care nursery, obstetrics and gynaecology, and acute mental health care for both adults and adolescents.

This is complemented by a range of outpatient, day only, and support services, including a 24 hour emergency department, a day surgery unit, allied health services, specialist multi-disciplinary outpatient services (including a private practice clinic), a public dental clinic, a renal dialysis unit, and a supportive care unit (for step-down oncology patients from the PAH).  Demand for the Emergency Department, which has recently been expanded, is such that it is now the third busiest in the state, behind that of the Royal Brisbane and Women’s Hospital and the Gold Coast Hospital.

The Logan Hospital is currently the subject of a significant Master Planning exercise and has been allocated funding following the recent state elections which will see the redevelopment of the Emergency Department at Logan Hospital and an expansion in  various services.
Beaudesert Hospital:
Located 45 to 60 minutes drive south-west of Logan Hospital in the rural town of Beaudesert, the 22 bed Beaudesert Hospital is the main provider of first line hospital care to the rural communities of Canungra, Beaudesert, Rathdowney and Kooralbyn in the far southern reaches of the District.
Services provided include general medicine, general surgery, Indigenous Health Services, mental health services, specialist outpatient clinics, antenatal and post-natal care, allied health services, drug and alcohol service, public dental clinic, child health clinic, school based youth health service, child health clinic, and HACC funded home care services. Also provides day surgery and ante-natal care.

All of these services are closely linked to Logan Hospital, where more complex care is organized and provided as required. For example the birthing service provided to the residents of Beaudesert is fully integrated with the Logan Hospital service, with all antenatal and post-natal care (including specialist outpatient clinics) provided on site at Beaudesert Hospital with patients attending Logan Hospital for the birth of their children.

 

Ground Zero Pharmaceuticals - Thursday, 19 April 2012

Organisation Name 
Ground Zero Pharmaceuticals

Organisation Category
Biotech Consultancy Organisation
GMP/Quality Management Consultancy
PK/PD Modelling Consultant
Regulatory Consultancy

Organisation Description
Ground Zero Pharmaceuticals (GZP) provides regulatory affairs, FDA representation, and product development consulting to firms developing drugs, biologics, vaccines, medical devices and combinations in areas such as strategic global planning, toxicology, pharmacology, PK/PD, manufacturing compliance, project management, medical writing, and clinical trials management. 

We provide objective, practical, targeted and quality services and believe that our first responsibility is to our clients. Our experience enables us to provide value-added strategic consulting with continuing innovation and consideration for the legal and regulatory framework of medical product development. Our services have proved beneficial to our clients from late discovery through marketing submission and post-submission activities and we are currently involved with more than 25 IND programs.

 

 

Mater Medical Research Institute - Thursday, 19 April 2012

Organisation Name
Mater Medical Research Institute

Organisation Category
Biomarker Discovery
Medical Research Institute
Not-for-profit Organisation
Research Institution
Research Organisation

Organisation Description
Based on a commitment to academic medicine, we are building a world-class medical research institute to discover, develop, translate, and commercialise medical research that integrates with relevant areas of excellence with Mater Health Services.

 

Griffith University, School of Pharmacy - Thursday, 12 April 2012

Organisation Name
Griffith University, School of Pharmacy

Organisation Category
Research Institution
School of Pharmacy

Organisation Description
Griffith’s Pharmacy School research spans a continuum from pharmacological and pharmaceutical sciences through to clinical and community care. The School has a strong tradition of research excellence, especially in inter-disciplinary and translational research. Staff comprises of clinical
pharmacists, pharmacologists and pharmaceutical scientists with a multifaceted expertise in areas such as complementary medicines, nutraceuticals, clinical pharmacy (esp. pain, osteoporosis, infectious diseases, cancer and geriatric medicine), pharmacology, bioassays and drug delivery. The
School has established research links with various institutions nationally and internationally, as well as with pharmacies and hospitals on the Gold and Sunshine Coast and in Brisbane.

 

Mater Pathology Services - Thursday, 12 April 2012

Organisation Name
Mater Pathology Services

Organisation Category
Analytical/Pathology Laboratory
Biomarker Discovery
Medical Department (clinic/ward part of a public hospital)

Organisation Description
Mater Pathology Services provides a comprehensive diagnostic service to the general practice and specialist medical community, and to the seven hospitals comprising the Mater network. Mater Pathology’s expertise ranges from prenatal medicine to the full spectrum of diseases of adulthood.
There is a major interest in materno-foetal medicine, oncology, metabolic diseases and diabetes, as well as many other disorders. Mater Pathology is leading the way in the development of the latest genomic and proteomic-bases pathology testing.
 

 

Griffith Health Institute - Tuesday, 3 April 2012

Organisation Name 
Griffith Health Institute

Organisation Category
Analytical/Pathology Laboratory
Biomarker Discovery
Clinical Research Organisation
Clinical Trials Unit
Clinical Trials Centre
Laboratory
Medical Research Institute
Research Institution
Research Organisation

Organisation Description
The Griffith Health Institute (GHI) is a large multidisciplinary research institute with a focus on chronic disease prevention - specifically cancer, cardiovascular disease, infectious disease and mental health and an approach that encompasses behavioural, molecular, clinical and population components of research. The GHI conducts research to address health priorities of disease prevention and healthcare innovation utilising expertise in biomedical science, immunology, molecular and microbial genomics, developmental and clinical psychology, dietetics, nursing, dentistry and oral health, epidemiology, cardiovascular science, neuroscience, public health, economics and health policy.

Incorporated within GHI is the Genomics Research Centre which investigates the genetic basis of disease and has a NATA accredited DNA testing laboratory to undertake testing tor neurogenetic and stroke related disorders for Australia. The GRC also undertakes clinical trials primarily in neurological and cardiovascular areas, including migraine CVD and MS clinical trials, but also nutriceutical trials for various conditions. The GRC along with the Molecular Basis of Disease program, the Infectious Disease sub-program and the Schools of Medicine, Dentistry and Pharmacy conduct clinical trials addressing a number of chronic health conditions. Experts within the Behavioural Basis of Health program specialise in the delivery and evaluation of behavioural treatments and psychological interventions in various clinical groups including but not limited to brain injury and drug abuse. Researchers within the Clinical and Community Practice Innovation and Population Health programs have conducted clinical trials within areas of expertise in acute and critical care, pain, ageing, disability and rehabilitation, women and families, weight loss, nutrition and dietetics.

 

McCullough Robertson - Tuesday, 3 April 2012

Organisation Name
McCullough Robertson

Organisation Category
Legal & Patent Attorneys

Organisation Description
McCullough Robertson provides specialist legal services to all participants in the clinical trial industry. We are one of the largest groups of specialist life sciences lawyers of any Australian legal firm. With a significant depth of experience, several lawyers have science qualifications, relevant training in good clinical practice and experience in phase I, II and III single and multi-site clinical trials.

Our lawyers act for listed and unlisted life science companies, local and international sponsors, CROs, investigators, together with a wide range of start-up companies, universities and research institutes. We advise on all aspects of bio-business, including intellectual property protection and commercialisation, venture capital, capital raising, contract negotiation and regulatory issues.

 

Medical Technology Association of Australia - Tuesday, 27 March 2012

Organisation Name
Medical Technology Association of Australia

Organisation Category
Industry Association
Not-for-profit Institution/Organisation

Organisation Description
The Medical Technology Association of Australia (MTAA) is the national association representing companies in the medical technology industry. MTAA aims to ensure the benefits of modern, innovative and reliable medical technology are delivered effectively to provide better health outcomes to the Australian community.

MTAA represents manufacturers and suppliers of medical technology used in the diagnosis, prevention, treatment and management of disease and disability. The range of medical technology is diverse with products ranging from familiar items such as syringes and wound dressings, through to high-technology implanted devices such as pacemakers, defibrillators, hip and other orthopaedic implants. Products also include hospital equipment, diagnostic imaging equipment such as ultrasounds and magnetic resonance imaging machines, as well as diagnostic tests that detect disease.

MTAA Members distribute approximately 70% of the non-pharmaceutical products used in the diagnosis and treatment of disease and disability in Australia. Our Member companies also play a vital role in providing healthcare professionals with essential education and training to ensure safe and effective use of medical technology. 
 

 

Griffith Hack - Tuesday, 27 March 2012

Organisation Name 
Griffith Hack

Organisation Category
Legal and Patent Attorneys

Organisation Description
Griffith Hack is Australia’s largest IP firm for Australian applicants, comprising patent and trade marks attorneys, IP lawyers, information services, and IP portfolio management consultants. We provide a full range of comprehensive IP services to many of Australia’s leading companies.
 
Griffith Hack Patent and Trade Marks Attorneys deal in all aspects of patents, trade marks and registered designs, from registration through to prosecution and enforcement.
 
The Griffith Hack  IP Law Group works closely with our patent and trade mark attorney colleagues across a range of technological areas including: Engineering, Life Sciences and Chemical and Electrical, IT and Physics.   This team approach gives Griffith Hack a competitive advantage particularly in the conduct of patent litigation involving complex technology. The specialist Trade Mark attorney group is also on hand to provide specialist assistance as necessary in Trade Mark litigation cases.
 
Griffith Hack’s IP Law Group sits within the firm’s integrated IP practice and is a fundamental component of Griffith Hack’s range of IP services.  We are rated by peer reviewed guides as a first tier IP litigation firm and we have strength and experience across all of the IP disciplines.  We are a particular force in respect of complex patent and trade secret litigation and copyright and registered design enforcement.

With 31 Principals and 260 staff Australia-wide, including 95 professionals and 165 support staff across our Melbourne, Sydney, Perth and Brisbane offices, Griffith Hack is a major IP force in Australia.


 

 

Griffith Enterprise - Thursday, 22 March 2012

Organisation Name
Griffith Enterprise

Organisation Category
Bioanalytical Facility
Bio-banking (Compund Library)
Bio-banking (Tissue Bank)
Biotech Consultancy Organisation
Business Consultancy Organisation
Clinical Research Organisations
Clinical Trials Unit
Clinical Trials Centre
Commercialisation Company
Consultancy
Contract Research Organisation
Genomics Service Provider
Medical Research Institute
Medical School
Not-for-profit Institution/Organisation
Regulatory Consultancy Organisation
Research Insititute
Research Organisation
Tertiary Teaching Hospital
University

Organisation Description
Griffith Enterprise is the commercialisation and technology transfer office of Griffith University. We support the University’s research and turn intellectual assets into marketable products and services. We are also an enterprise creator converting technologies, intellectual property and ideas into thriving businesses within the University.

Griffith University is an innovative, multidisciplinary, research intensive university. Griffith Enterprise is committed to creating sustainable collaborative relationships with local, national and international businesses and government partners. Griffith is a  leading Australian research university exhibiting national and world leading excellence in areas of strategic importance including water science, criminology, health and chronic disease, drug discovery, quantum physics, climate change adaption, music, sustainable tourism and political science.

Fast facts: Five campuses in the Brisbane to Gold Coast corridor, Queensland, Australia. 230
partnership agreements around the world, 1,400 academic staff and 1,300 research students across
38 research centres, 3,500 staff.

 

Mental Health Service, Metro South Health Service District - Thursday, 22 March 2012

Organisation Name
Mental Health Service, Metro South Health Service District

Organisation Category
Community and Primary Health Division
Government – State
Mental Health
List of Services
Drug Delivery
Clinical Data Management
Clinical Research
Literature Reviews
Patient Screening
Mental Health inpatient and community services

Organisation Description
Metro South Mental Health Services provide mental health care to the largest culturally and linguistically diverse population in the state, and regions that have some of the highest population growth.

Metro South Mental Health Services provides inpatient, hospital-based and community mental health services for all age groups across the range of mental health care.

Metro South Mental Health services embrace a forward looking, progressive approach and works collaboratively with all stakeholders in order to achieve expected outcomes. A clear and strong consumer and carer focus is promoted.

 

Gold Coast Health Services District - Cardiology Research Department - Thursday, 15 March 2012

Organisation Name
Gold Coast Health Services District - Cardiology Research Department

Organisation Category
Clinical Trials Unit
Dedicated Clinical Trials Centre (as part of a public or private hospital)
Government – State
Medical Department (clinic/ward part of a public hospital)
Research Institution
Tissue Bank

Organisation Description
The Cardiology Department of the Gold Coast District Health Service is currently part of a two campus hospital service, which also incorporates satellite clinics in a community setting – such as Cardiac Rehabilitation and Heart Failure Clinics.

As part of our growing commitment to continuing education and research the department has established itself as a research hub participating in clinical and non clinical trials that are specific to Cardiology. The department is also fortunate to have a Director who has affiliation with both Bond and
Griffith Universities, and so the emphasis of the department is one of education through research and participation.

In 2012 the Gold Coast Hospital will become the ‘University Teaching Hospital’ when services are relocated to the new multi-million dollar facility at Parklands-Griffith University Campus. It is anticipated that by this time the Cardiology Department of the hospital will have established itself as a nationally recognised research centre.

 

Metro South Oral Health Service - Thursday, 15 March 2012

Organisation Name
Metro South Oral Health Service

Organisation Category
Government - State

Organisation Description
The Metro South Oral Health Service is the largest oral health service in the State. The Service provides hospital/community based (adult) and school based (child/adolescent) primary oral health care services and a range of secondary and specialist care services at more than 80 different facilities
across the Health Service District.

The Oral Health Service also provides, and or manages, services provided at oral health locations external to the Metro South District and at a range of other external locations including correctional centres, prison farms and various hospitals.

While a limited number of oral health services are provided under general anaesthetic within a hospital, the majority of services are delivered by multi-disciplinary teams in a range of ambulatory settings. A range of occupational groups are employed as follows:

clinicians: dentists, dental specialists, oral health therapists, dental therapists, dental prosthetists
clinical support staff: dental assistants, nurses
non-clinical support staff: dental technicians, operational officers, administrative officers.

 

Microsoft - Thursday, 8 March 2012

Organisation Name 
Microsoft

Organisation Category
Information and Technology
Clinical Research Software Company

Organisation Description
Microsoft is committed to improving health around the world through software innovation. Over the past 13 years, Microsoft has steadily increased its investments in health, with a focus on addressing the challenges of health providers, health and social services organizations, payers, consumers and life sciences companies worldwide. Microsoft closely collaborates with a broad ecosystem of partners and develops its own powerful health solutions, such as Amalga and HealthVault. Together, Microsoft and its industry partners are working to deliver health solutions for the way people aspire to work and live.

 

The Genomics Research Centre - Thursday, 8 March 2012

Organisation Name
The Genomics Research Centre

Organisation Category
Analytical/Pathology Laboratory
Clinical Research Organisation
Dedicated Clinical Trials Centre (as part of a public or private hospital)
Research Organisation
Tissue Bank

Organisation Description
The Genomics Research Centre investigates the genetic basis of disease. Research is focused on common chronic human disorders that have a significant genetic component such as migraine, CVD and high blood pressure, various types of cancer, multiple sclerosis and osteoporosis. Scientists within the Centre have expertise in gene mapping and the characterisation of gene dysfunction and have the ability to translate this information to both diagnostic and therapeutic outcomes. In addition, the Centre is aware of the important ethical and psychological issues associated with genetics and consequently is actively engaged in training Genetic Counsellors and Clinical Geneticists.

The Centre has a NATA accredited DNA testing laboratory and undertakes testing for 6 neurogenetic and stroke related disorders for Australia. The Centre also undertakes clinical trials, recently completing a sponsored Phase 2 trial on migraine and another testing a potential new MS therapeutic. New trials for 2009 include a Phase II migraine trial, an immune based Phase III nutraceutical trial and trials of new medical devices. The Centre has good industry links and has been involved in many industry funded R&D projects with for example GSK, Gemini Genomics, Sequenom, Corbett Research, CBio Ltd, Emerillon Ltd and Janssens. 
 

 

Gallipoli Medical Research Foundation - Thursday, 1 March 2012

Organisation Name
Gallipoli Medical Research Foundation

Organisation Category
Clinical Trials Unit
Dedicated Clinical Trials Centre (as part of a public or private hospital)

Organisation Description
The Gallipoli Medical Research Centre Clinical Trials Unit was established in 2007. It is located on the campus at Greenslopes Private Hospital, Australia’s largest private teaching hospital. Both investigator initiated and pharmaceutical company sponsored trials are conducted in the Unit. The Unit aims to promote and increase research activities on the Hospital campus and profits from clinical trials are channelled back into medical research in the Gallipoli Medical Research Centre.

 

 

Model Answers - Thursday, 1 March 2012

Organisation Name
Model Answers

Organisation Category
Biotech Consultancy Organisation
Contract Research Organisation
Pharmacokinetic and Pharmacodynamic Modelling Consultant

Organisation Description
Model Answers assists the pharmaceutical and biotechnology industry by quantifying the pharmacokinetics and/or pharmacodymics of potential new chemical entities. Model Answers develops sophisticated mathematical models that can be used to describe observations as well as predict future trial outcomes. The methods used by Model Answers are highly advocated by the FDA, expediting the drug development process and providing much needed knowledge about a new chemical entities PK and PD properties.

Model Answer’s consultants are highly experienced in both the pharmaceutical industry and regulatory authority providing individualized results tailored to a client’s personal needs. Services include development of pharmacokinetic and pharmacodynamic models for the population and typical individual together with deterministic and full stochastic (monte-carlo) simulation studies (i.e. extrapolation to various patient populations, proof of concept, trial outcome), mechanistic modelling of bio-systems and optimal trial design.

The techniques Model Answers uses can be applied to all phases of drug development from in-vitro systems, animal studies and first in human studies through to phase III confirmatory trials.
 

 

Fusidium Pty Ltd - Thursday, 23 February 2012

Organisation Name
Fusidium Pty Ltd

Organisation Category
Biotech Consultancy Organisation
Business Consultancy Organisation
Commercialisation Company

Organisation Description
Fusidium Pty Ltd is an independent consulting company servicing the Life Sciences industry in Australia. The company offers a range of services including:

  • Business Development
  • Strategic Planning Support
  • Commercialisation Services
  • Interim Management Services
  • Market Research
  • Grant Preparation
  • Surveys
  • Source Distributors in Asia Pacific

We can help with the development of your strategic plan with a focus on your Strategic Partners. We can work with you to develop your business through building contacts with potential partners, customers or licensees.

We can provide support in governance at the level of Advisory or Corporate Board. We can assist business growth through the provision of management services. Fusidium has the experience and international contacts that may be necessary to the growth and development of your business.

 

Nambour Hospital - Thursday, 23 February 2012

Organisation Name
Nambour Hospital

Organisation Category
Dedicated Clinical Trials Centre (as part of a public or private hospital)
Medical Department (clinic/ward part of a public hospital)

Organisation Description
The Nambour Hospital services a population of more than 400,000 people, and has busy clinical services and active research programs in all major health disciplines with experienced research investigators and clinical trial coordinators. The Hospital attracts local, national and international research projects and participates in pharmaceutical initiated studies, and has demonstrated high rates of recruitment. Many of the Departments have participated in multiple clinical trials.

 

Fraunhofer Institute for Toxicology and Experimental Medicine - Thursday, 16 February 2012

Organisation Name
Fraunhofer Institute for Toxicology and Experimental Medicine

Organisation Category
Analytical/Pathology Laboratory
Bioanalytical Facility
Clinical Research Organisation
Clinical Trials Unit
Contract Research Organisation
GMP/Quality Management Consultancy
Government
Medical Research Institute
Not-for-profit Institution/Organisation
Preclinical Facility
Research Institution

Organisation Description
At the Fraunhofer ITEM, expertise in various disciplines such as toxicology, human and veterinary medicine, biology, chemistry and physics forms the basis for comprehensive contract research work and services. With regard to inflammatory and allergic diseases of the respiratory tract, the Institute offers research and development services from the molecular level, up to clinical trials. 

Main areas of work

  • Human health is the focus of research at the Fraunhofer ITEM. In the area of preventative medicine all relevant topics are covered. Research into cause and effect processes and development of methods and concepts for disease diagnosis and therapy play an important role. In in-vitro and in-vivo models, we study primarily substances that are taken up via the airways. Methods of biochemistry, molecular biology, immunotoxicology and histopathology are used to elucidate mechanisms of action.
  • GXP – top-level quality
  • The acronym GXP collectively refers to quality assurance systems that are legally required and implemented at the Institute: GLP (Good Laboratory Practice), GCP (Good Clinical Practice) and GMP (Good Manufacturing Practice).
  • Clinical studies for the indication airway diseases
  • For the registration of pharmaceuticals for the indications allergy, asthma and COPD, the Fraunhofer ITEM conducts clinical studies phases I-II.
 

Neuromathix (NeuroTech Research Pty Ltd) - Thursday, 16 February 2012

Organisation Name 
Neuromathix (NeuroTech Research Pty Ltd)

Organisation Category
Clinical Research Software Company
Consultancy
Medical Device Company
Pharmacokinetic and Pharmacodynamic Modelling Consultant
PK/PD Modelling Consultant
Research Organisation
Information Technology

Organisation Description
Running on high-performance computers, the Neuromathix software uses proprietary algorithms to estimate patient-specific biological parameters governing drug uptake, transport and metabolism, reconstructed mathematically from a suitable fragment of time-series data, under conditions where conventional statistical methods fail. It also employs sophisticated control algorithms to manipulate this data, to create medication programs suitable for a confined therapeutic window. This can improve drug effectiveness and confidence, reducing cost and waste across the entire drug lifecycle.

The purpose of the software is:

  • To enhance and personalise medication for sufferers of chronic diseases, where PK values have become highly idiosyncratic, or illnesses where the drug therapeutic window is narrow, making medication programs difficult to calculate. Our flagship application is “artificial pancreas” software to improve personalised insulin medication for type-1 diabetes;
  • To “value-add” on gold-standard drugs that have become generic, providing an additional value proposition;
  • To break the chokepoint of Phase II trials, where essentially valid drug candidates are currently being rejected due to lack of a suitable dosage regime;
  • To provide a new quantitative tool to enhance drug discovery and deliver a competitive edge.
  • A web-based service is in development, enabling global access to the software.
 

Eskitis Institute for Cell and Molecular Therapies - Thursday, 9 February 2012

Organisation Name 
Eskitis Institute for Cell and Molecular Therapies

Organisation Category
Compound Library
Research Institution
Tissue Bank
University

Organisation Description
The Eskitis Institute for Cell and Molecular Therapies investigates novel therapies for human diseases in the thematic areas of cancer, neglected and infectious disease, neurodegenerative diseases and stem cell biology. Eskitis offers a range of unique opportunities.

Eskitis is home to Nature Bank, a unique library of optimized, prefractionated natural product extracts, available for screening on our fully-equipped high-throughput screening centre. Eskitis can provide fully characterised lead compounds active against a drug target. Current commercial partners include Pfizer, Actelion and Innate Pharma.

Eskitis incorporates the Queensland Compound Library, Australia’s only compound management and logistics facility. This facility acts as a nexus between the supply of small molecules and screening.  It is the best way for Australian biomedical researchers to access novel compounds, large commercial libraries and natural products like Nature Bank for their assays.

The Institute houses the Federally-funded National Centre for Adult Stem Cell Research. The Centre is developing cell transplant therapies for patients with Parkinson’s disease and other disorders.  These use the patient’s own olfactory neural stem cells accessible via the nose.  The Centre also possesses a globally unique collection of  olfactory-derived adult stem cells that are available for research collaborations with commercial and academic partnerships.

 

Newro Foundation (formerly BrizBrain and Spine Research Foundation) - Thursday, 9 February 2012

Organisation Name 
Newro Foundation (formerly BrizBrain and Spine Research Foundation) 

Organisation Category
Medical Research Institute
Not-for-profit Institution/Organisation
Research Organisation

Organisation Description
The Newro Foundation is a not-for-profit organisation and registered charity dedicated to advancing the treatment of brain conditions. The Newro Foundation seeks to find new ideas, new research and new hope.

The foundation is constantly seeking to push the boundaries of research within the fields of spinal surgery and neurosurgery and it is only with the support of the community that they are able to continue their work.

Through research, the goal is to improve the treatment and post-operative care of patients so they can return to normal life as quickly as possible.

To do this we need to evaluate our current treatment methods scientifically and methodically. This often raises new questions about what we can do better, and these new methods must be trialled in a precise and scientific manner. We need to discover and initiate new ideas, techniques and approaches, which requires research and development in our speciality area.

Our mission is to monitor effectiveness of current neurosurgical treatment, develop and assess new treatments for brain and spinal conditions, provide advance training in neurosurgical research and surgery and provide a private source for research and training in neurosurgery.

 

Ernst & Young - Thursday, 2 February 2012

Organisation Name
Ernst & Young

Organisation Category
Accounting
Professional Services

Organisation Description
Ernst & Young is a global leader in Assurance, Tax, Transactions and Advisory services. We aim to have a positive impact on businesses and markets, as well as on society as a whole.

Our 141,000 people are the foundation of our success. We assemble the right multi-disciplinary team for your business, drawing on our global talent pool, to help you achieve your potential. We work closely with you, gaining a clear understanding of your organization and striving to identify issues before they become problems. We make sure you get fast access to the people you need, wherever in the world you need them. And with our global focus on 14 Global Industry Sectors you benefit from a market-leading global response to your specific needs.

We attract talented people from diverse backgrounds. Our emphasis on inclusiveness matters more than ever today. As business challenges become more complex, we need to call upon the widest spectrum of views and opinions to address them.
Making a difference in a changing world
Business, government and NGOs are increasingly pulling together to promote business, social and environmental progress. Ernst & Young contributes to this effort through skill-based volunteering that’s coordinated globally while taking account of local conditions and culture. We channel our efforts into three key areas that are aligned with our business strategy and critical to improving and expanding market economies: entrepreneurship, education and environmental sustainability.

 

Office of Health and Medical Research (OHMR), Queensland Health - Thursday, 2 February 2012

Organisation Name 
Office of Health and Medical Research (OHMR), Queensland Health

Organisation Category
Government – State Government

Organisation Description
The Office of Health and Medical Research (OHMR), within the Centre for Healthcare Improvement, Queensland Health, was established as part of the Queensland Government’s $25.65 million Research for a healthier future: 2020 Health and Medical Research and Development Strategy.  The OHMR provides direction and support for Queensland’s health and medical research development, with the ultimate goal of improving the health and wealth of Queenslanders, through three key initiatives. These initatives are: support our people – recruit, develop and retain a skilled health research workforce; promote the transfer of knowledge in to improved health and wealth; and provide clear leadership and promote collaboration.

The OHMR fosters the health and medical research sector by providing the right environment and support for research and development through the following programs:

$20.55 million Health Research Fellowship Program - increasing the amount of research undertaken in Queensland Health facilities.
‘Bridging the Gap’ series - providing multiple opportunities for research collaboration including but not limited to Queensland Health facilities, universities, institutes, industry and research foundations.
Queensland Health intellectual property guidance and education - reducing the gap between discovery and clinical practice.
Streamlining of administrative and regulatory processes for research ethics and governance in Queensland Health facilities - making the ethics process quicker and easier, to reduce the impact on health and medical research, while maintaining quality and safety for patients.

 

ERA Consulting (Australia) Pty Ltd - Thursday, 19 January 2012

Organisation Name 
ERA Consulting (Australia) Pty Ltd

Organisation Category
Biotech Consultancy Organisation
Consultancy
Regulatory Consultancy

Organisation Description
From its foundations in 1987, the ERA Consulting Group is now one of the longest established and most experienced global scientific/regulatory consulting groups for human medicines. Over the past 24 years ERA has consulted on over 450 drug and biotech/biological therapeutic products. With offices in Washington DC, London, Germany and Australia, our internationally experienced team can offer:

  • Advice covering Australian, US and European regulatory expectations for drugs and biologics
  • Advice on product development for high-tech biotech/biological and gene/cell therapy products
  • Review of quality (manufacturing and control), non-clinical and clinical documentation for regulatory compliance
  • Guidance and interaction with regulatory agencies worldwide
  • Writing of clinical trial applications (IND, CTX and CTA), expert reports and registration dossiers for Australia Europe and the USA
  • The benefits of EMEA SME status to small non-EU companies
  • Biomarker validation and qualification with the FDA and EMEA

ERA’s mission is to add value to a client’s project and identify the most expeditious developmental and regulatory pathways.

We achieve this in a variety of ways. Our contribution may be in minimising the time to marketing authorisation of a product through adding resources to the client’s team and bringing creative ideas to the project. In other cases ERA’s input is to identifiy potential opportunities in the preclinical development phase whilset ensuring that potential problems are avoided and costly delays are prevented.

 

Pharmaceutical Solutions Pty Ltd - Thursday, 19 January 2012

Organisation Name
Pharmaceutical Solutions Pty Ltd

Organisation Category
Contract Research Organisation

Organisation Description
Pharmaceutical Solutions Limited (PSL) is a Contract Research Organisation providing personalised clinical research management and regulatory services in Australasia.

Pharmaceutical Solutions is proud to promote the quality of clinical research in the Asia Pacific region and of the part we play to improving people’s health and well being.
Pharmaceutical Solutions provides a wide range of clinical trial services within Australasia. We offer the full suite of clinical trial management services, from early feasibility through to trial closure. In addition, we can provide study design, protocol development, and general data management services.

Our clients include some of the leading global pharmaceutical companies, as well as established and early stage biotechnology and medical device companies.

We have a strong set of core values that are actively lived in the company. We are preferred partners with many of our clients. This is a direct result of our flexibility and responsiveness to client needs. Our superior staff competence is reflected in the consistent provision of quality data on time and within budget.

We manage clinical trials from Phase I to IV in a wide variety of therapeutic areas, with key expertise in Cardiovascular, Oncology, Endocrinology, Respiratory and Neurology.

 

Emphron Informatics Pty Ltd - Thursday, 12 January 2012

Organisation Name
Emphron Informatics Pty Ltd

Organisation Category
Contract Research Organisation
Information and Technology

Organisation Description

Clinical Trial Statistics
Emphron Informatics provide high-level statistical consultancy to ensure that trial protocols satisfy the complex set of clinical, regulatory and commercial objectives which you face.  We understand your business problems, and we deliver effective solutions.

We also provide full service biostatistics analysis and clinical SAS programming for clinical trials, covered by a comprehensive and established set of standard operating procedures.

We have experience across the spectrum of clinical research, from investigator-led clinical studies through to phase III trials, and across many therapeutic areas.
Diagnostics
We have solid experience in the discovery and development of diagnostics. We operate across the spectrum from discovery using modern genomic and proteomic platforms, through assay optimisation to the design and analysis of diagnostic clinical trials. We have experience negotiating the design of diagnostic trials with the FDA.
Genomics and Proteomics
We have substantial experience across the range of genomic platforms including: Illumina, Combimatrix, Affymetrix and RTPCR based platforms. We cover the spectrum of activities through study design, data management, quality assurance, differential expression, ontology analysis and study reporting. We use state-of-the-art tools and techniques.

We also have experience in a range of proteomic technologies including mass spectroscopy, 2D electrophoresis gels,  FACS and antibody arrays.
Web Services
We have experience in developing and deploying GMP-compliant on-line diagnostic and analysis tools.
 

 

Princess Alexandra Hospital Centres for Health Research - Thursday, 12 January 2012

Organisation Name
Princess Alexandra Hospital Centres for Health Research

Organisation Category
Biomarker Discovery
Government – State
Medical Clinic/Ward (public Hospital)
Not-for-profit Institution/Organisation
Public Hospital
Tertiary Teaching Hospital (public sector) Research

Organisation Description
The Princess Alexandra Hospital is a pre-eminent research and teaching hospital and is a major contributor to national and international clinical research.   A strong research culture with active programs prevails in basic science, clinical, and health services research.  The theme of all research is translational, utilising research based understanding of disease processes and developing new treatments and therapies to improve the health of the community.  Clinician researchers undertake an extensive range of investigator-initiated and collaborative research programs including Phase I / IV sponsored clinical trials. 

 

Q-Pharm Pty Limited - Thursday, 22 December 2011

Organisation Name 
Q-Pharm Pty Limited


Organisation Category
Clinical Research Organisation
Clinical Trials Unit
Clinical Trials Centre
Contract Research Organisation

Organisation Description
Q-Pharm is a specialist clinical trials centre located on the campus of the Royal Brisbane and Women’s Hospital in the capital city of Queensland.  We have extensive experience in the conduct of a broad range of early phase and vaccine studies (conducted >300 studies) and the data we collect is accepted by regulators worldwide (TGA, FDA, EMEA, ANVISA)

The benefits of conducting clinical trials at Q-Pharm are:


Save TIME

  • ­Fast clinical trial start-up under the clinical trial notification scheme (CTN)  (~4-6 weeks from ethics submission to commencement of the clinical trial)
  • Multiple dates available for ethics submission (option for submission to local ethics committee OR commercial ethics committee = 40 meetings per year total)
  • Local committee: Set timelines (e.g. 2 days from IRB meeting to receipt of approval then CTN lodgement); Efficient ethics review (in round/live review); ~10 meetings/yr
  • Commercial HREC: 3 submission dates each month (~30 meetings per year) 

Save COSTS

  • Time is money!
  • Low average cost (very cost competitive compared to U.S. and Western Europe)
  • Clinical trials completed on time and within budget


COMFORT in working with an established provider

  • Excellent working relationship with local ethics committee (submitted, managed and conducted > 300 studies; expedited approvals possible locally)
  • USA (FDA), Europe (AFSSAPS and AEMPS), and South America (ANVISA) inspected
  • Data accepted worldwide by regulators
  • Safe location (high level of IP protection, low-risk stable destination)
 

DLA Piper Australia - Thursday, 22 December 2011

Organisation Name 
DLA Piper Australia 

Organisation Category
Legal and Patent Attorneys
Professional Services

Organisation Description
DLA Piper Australia delivers:

Strategic legal support - our strength lies in our ability to add value at each stage of the technology development cycle, by providing strategic advice on research and development, venture capital, intellectual property protection, joint ventures, manufacturing and supply.

Unique expertise and insights - many of our lawyers have scientific and technical training in molecular biology, pharmacology, chemistry and medicine, enabling us to better understand the technology and developments within the industry.

Broad geographic capability - we offer global insights and service provision through our exclusive alliance with DLA Piper.  Our clients have direct access to the advice of legal practitioners from around the world, with DLA Piper having represented a large number of leading pharmaceutical and biotechnology companies.  For example, our alliance partner, DLA Piper, acts as a single point of contact for a global clinical trials program, and provides a virtual mailbox for legal and contractual queries from CROs in more than 40 countries to deliver rapid answers and ensure a consistent approach across the client’s program.

Our clients - We have experience acting for government, research institutes, universities, spin offs, biotechnology and pharmaceutical companies, and major corporate in respect of the commercialisation of health care and therapeutic products.

 

Quality Matters Safety Matters Pty Ltd - Thursday, 22 December 2011

Organisation Name 
Quality Matters Safety Matters Pty Ltd 

Organisation Category
Bioscience Development Organisation
Biotech Consultancy Organisation
Business Consultancy Organisation
Commercialisation Company
Complementary/Nutraceutical Company
Consultancy 
GMP/Quality Management Consultancy
Regulatory Consultancy 

Organisation Description
Results Orientated, Professional, Product, Quality & Safety Consulting Service for the complementary and natural medicines industry, specialising in new products and regulatory compliance. With over 20 years experience, we have a strong ethical, quality and safety focus. All enquiries are welcome and treated with confidence. Expertise includes natural medicines and medical devices.

Contact us for friendly, helpful advice on complementary medicines, dietary supplements, liquid formulations or excipient formulation development; Class I devices, PIC/S GMP, ISO 13485, ISO 14971, ISO 10993 etc, confidential trouble-shooting and more. We provide our clients with complete, fully documented results including a comprehensive product “Listing” service.

 

DSM Biologics - Thursday, 22 December 2011

DSM Biologics

Organisation Category
Contract Manufacturing Organisation
 
List of Services
Contract Manufacturing/Scale-up
Process Development
Process Technology Licensing
Production and Sterile Manufacture
 
Organisation Description
Service supplier of cGMP mammalian custom manufacturing (CMO) to clients in clinical-stage product development and for product in commercial phase.
 

Department of Employment, Economic Development and Innovation (DEEDI) - Thursday, 15 December 2011

Organisation Name 
Department of Employment, Economic Development and Innovation (DEEDI)

Organisation Category
Government – State Government

Organisation Description
The Queensland Government is committed to the development of the State’s life sciences sector. Life sciences are integral to the Government’s Toward Q2: Tomorrow’s Queensland strategy for a strong, green, smart, healthy and fair State. Under this strategy the government has invested more than $3.4 billion over ten years on research, skills and innovation.

The Department of Employment, Economic Development and Innovation (DEEDI), works in partnership with business, universities, research organisations, peak bodies and other state and federal government agencies to foster the development of a sustainable life sciences sector in Queensland.

DEEDI supports the sector by:

  • working with local companies and the commercialisation units of Queensland universities to increase the commercial opportunites from existing life science research and product development.
  • working with local universities to help develop world-class science and research that address issues relevant to Queensland, increase future commercial opportunities and build Queensland’s international reputation as a hub of science and research excellence.
  • helping identify new opportunities by raising the State’s profile at national and international exhibitions and conferences including the AusBiotech National Conference, BIO USA and other international events.
  • working closely with Queensland Health to link it with world class clinical practice and research, and enhance, where appropriate, the integration of Queensland life science research and products into Queensland Health’s purchasing, testing and trialling processes.

DEEDI is also helping to build a critical mass of activity by supporting the establishment of a new industry association for the sector in Queensland – Life Sciences Queensland.

DEEDI is pleased to be working with the Queensland Clinical Trials Network Inc. to promote and create real opportunities for the Queensland life sciences industry now, and into the future.

 

Queen Elizabeth II Jubilee Hospital - Thursday, 15 December 2011

Organisation Name
Queen Elizabeth II Jubilee Hospital

Organisation Category
Government – State
Public Hospital which undertakes some research and engages in some clinical trials

Organisation Description
The Queen Elizabeth II (QEII) Jubilee Hospital is a Level 3-4 acute hospital and is part of the Metro South Health Service District. QEII Hospital is the general hospital for its immediate geographic area. It has approximately 140 beds and provides specialist services in general surgery, orthopaedics, urology, gynaecology, ophthalmology, general medicine, intensive care, geriatric, rehabilitation medicine and emergency services. Emergency Department presentations are approximately 35,000 per year.
 

 

Davies Collison Cave - Thursday, 8 December 2011

Organisation Name 
Davies Collison Cave

Organisation Category
Legal and Patent Attorneys

Organisation Description
Davies Collison Cave combines Australia’s leading patent and trade mark attorney firm with an associated intellectual property legal practice, Davies Collison Cave Law.  Davies Collison Cave is recognised locally and internationally as Australia’s largest Intellectual Property firm, providing strategically focused advice on patents, trade marks, trade secrets, copyright and design protection, licensing, litigation and related legal and commercial matters.

To ensure that we provide and maintain the highest level of service to our clients, many of our personnel hold doctoral degrees and have the ability to approach matters from both a technical and legal perspective. Our policy is to engage personnel who have superior standards of academic excellence and commercial acumen.  Please visit our website for more information on our staff www.davies.com.au

Our staff of more than 80 lawyers, trade marks attorneys and patent attorneys are engaged solely in intellectual property matters and are led by 36 partners throughout our five Australian offices, which are located in Melbourne, Sydney, Brisbane, Canberra and Newcastle.  We provide services in both metropolitan and regional areas.

Davies Collison Cave continues to be Australia’s largest filer of Patents and Trade Marks and in 2010 has been voted No.1 patent and trade mark attorney firm in Australia by the following:

Australian Prosecution Firm of the Year 2010 by Managing Intellectual Property
AsiaIP Law Awards – Patents 2010 by AsiaIP
Business Review Weekly Client Choice Awards, Best Patent and Trade Mark Attorney Firm 2010
IP Specialist Firm of the Year 2010 by Australasian Legal Business Magazine.

 

Queensland Brain Institute - Thursday, 8 December 2011

Organisation Name
Queensland Brain Institute

Organisation Category
Research Institution

Organisation Description
The Queensland Brain Institute’s fundamental research in neuroscience plays a vital role in the ongoing development of improved treatments for a diverse range of diseases and conditions. QBI’s main therapeutic areas of research include spinal cord injury, motor neuron disease, brain tumour, dementia, developmental disorders, schizophrenia and multiple sclerosis. QBI scientists collaborate with treating physicians in each of these therapeutic areas.

To support their research, QBI scientists have access to world-class technology, including a neuroscience dedicated Flow Cytometry Facility, 16.4T MRI for animal imaging and 4.0T fMRI human brain scanner and Zeiss microscopy suite.
 

 

Cullens Patent and Trade Mark Attorneys - Thursday, 1 December 2011

Organisation Name 
Cullens Patent and Trade Mark Attorneys

Organisation Category
Legal and patent attorneys
Professional services
Scientific and patent literature searching services

Organisation Description
Cullens is one of Australia’s most experienced firms of patent and trade mark attorneys with a proven record of meeting clients’ intellectual property needs. We advise and guide our clients in all aspects of protecting and managing their intellectual property.

By creating a framework of legal protection for our clients’ intellectual property assets and providing strategic counselling on their opportunities worldwide, we assist them in securing a market advantage.

Our multi-skilled team of patent and trade mark attorneys have expertise in a wide range of technologies, including mechanical, electrical, ICT, chemical, civil and mining engineering, biotechnology, pharmaceuticals, chemistry, physics, electronics, biology, agriculture, nanotechnology and environmental science, as well as expertise in design, trade mark and domain name matters. 

Cullens attorneys are Members of, or affiliated with, a broad range of professional organisations in the field of intellectual property and are also affiliated with a broad range of industry, government and educational groups.

 

Queensland Centre for Gyncocological Cancer Research (QCGC Research) - Thursday, 1 December 2011

Organisation Name 
Queensland Centre for Gyncocological Cancer Research (QCGC Research)

Organisation Category
Clinical Research Organisation
Clinical Trials Unit
Clinical Trials Centre
Research Institution
Research Organisation

Organisation Description
We research and develop the best standard of care for women experiencing gynaecological cancer.

 

CORE Research Group Pty Ltd - Thursday, 17 November 2011

Organisation Name 
CORE Research Group Pty Ltd

Organisation Category
Clinical Research Organisation
Clinical Trials Centre
Clinical Trials Unit
Study Management Services

Organisation Description
We began as an independent clinical site and grew to become a site management organisation.
Our strength lies in our extensive network of partner sites which include general practitioners, dieticians, complementary medicine practitioners, and medical specialists.
 

  1. Site Management
    Unparalleled patient reach with our extensive network of experienced investigators and active prescribers in primary and specialist care.
  2. Clinical Research Site
    A preferred site for many international pharmaceutical companies and other organisations.
  3. Research Services
    From protocol design to implementation with researchers with over 30 years combined experience
  4. Monitoring
    Provide monitoring expertise for University of Queensland and Southern Cross University.

Core Research Group is the ideal answer for all aspects of research and research related functions. We specialise in rapid recruitment with high retention.

 

 

Queensland Clinical Trials & Biostatistics Centre - Thursday, 17 November 2011

Organisation Name
Queensland Clinical Trials & Biostatistics Centre

Organisation Category
Clinical Trials Unit
Research Institution

Organisation Description
The Queensland Clinical Trials & Biostatistics Centre (QCTBC) was established by The University of Queensland in recognition of the need for a specialised centre to promote clinical trials and biostatistical research and services. QCTBC provides expertise and infrastructure to design, conduct,
and facilitate high quality clinical studies and biostatistical research with academic and industry collaborators to improve human health outcomes. Services and expertise include clinical trials, clinical studies, biostatistical research, and biostatistical consulting. The Centre has a depth of experience in many therapeutic areas, and welcomes collaborations with academic and industry researchers in any area of clinical trials research.
 

 

Cooper Grace Ward Lawyers - Thursday, 10 November 2011

Organisation Name 
Cooper Grace Ward Lawyers

Organisation Category
Legal and Patent Attorneys
Professional Services

Organisation Description
Cooper Grace Ward is a Queensland-based law firm with local, national and international clients. Since our origins in 1980, we have established a first class reputation, with the people, experience and resources to achieve excellent outcomes for our clients.

We deliver a commercial approach along with tailored and high quality advice at all times. Our focus on client service includes working with clients to understand their personal and business requirements in our time, not at their expense.

We are committed to our clients’ success, the development of our valued team and our continuing role as our clients’ business partner.

 

Queensland Emergency Medicine Research Foundation (QEMRF) - Thursday, 10 November 2011

Organisation Name 
Queensland Emergency Medicine Research Foundation (QEMRF)

Organisation Category
Not for profit institute/organisation
Research funding body

Organisation Description
The Queensland Emergency Medicine Research Foundation (QEMRF) is a Not for Profit Trust that is registered as a charity. The Foundation receives an annual investment of $2 million under a funding agreement with Queensland Health.

QEMRF Vision: QEMRF will be regarded as a key facilitator in emergency medicine research, positioning Queensland as the location of choice for the brightest minds in emergency medicine.

The Queensland Emergency Medicine Research Foundation awards Grants and Fellowships to support research relating to the practice of Emergency Medicine in Queensland.  Our purpose is to support high quality research directed at improving the care of patients in Emergency Departments and to develop Emergency Medicine research capacity in Queensland.

We aim to:

  • Fund high quality, robust, ethical Emergency Medicine research.
  • Advance the field of Emergency Medicine through research for the benefit of patients.
  • Promote the development of a research culture in Queensland Public Hospital Emergency Departments.
  • Raise public awareness of Emergency Medicine research.
  • Attract national and international interest in Queensland Emergency Medicine.
  • Facilitate and provide education and training in Emergency Medicine research.
  • Raise funds to support Emergency Medicine research.

 

 

Community and Primary Health Services, Metro South Health Service District - Thursday, 3 November 2011

Organisation Name 
Community and Primary Health Services, Metro South Health Service District

Organisation Category
Community and Primary Health Division
Government - State

Organisation Description
The Community and Primary Health Care Services is a division within the Metro South Health Service District.

The Division delivers a wide variety of clinical and community based services to a population of over 1,000,000 with a diverse demographic profile inclusive of urban and rural components, significant size communities of Indigenous Australians, migrants and refugees and large pockets of both relative wealth and significant socio-economic disadvantage. According to the 2006 Census the District is the most cultural and linguistically diverse in Queensland, with the second highest Aboriginal and Torres Strait Islander population in Queensland behind Cairns.

The division has established strong partnerships with Griffith University, Queensland University and Queensland University of Technology in research activities.

Services provided include:
Aged Care Assessment                                    
Alcohol and Drug Services
Breast screen
Centre for Excellence in Indigenous Primary Health Care
Child Health     
Chronic Disease Services  
Community Hospital interface Programs  
Community Rehabilitation
Dementia Care   
Indigenous Health
Hospital in the Home Program     
Hospital in the Nursing Home Program             
Home and Community Care 
Multicultural Services
Paediatric Development Services
Palliative Care            
Post Acute Care                   
Respite Care
Transition Care
Sexual Health    
Young Disabled Program                                  
Youth Health                             

 

Queensland Eye Institute and Prevent Blindness Foundation - Thursday, 3 November 2011

Organisation Name 
Queensland Eye Institute and Prevent Blindness Foundation

Organisation Category
Clinical Research Organisation
Clinical Trials Unit
Laboratory
Central Laboratory
Medical Clinic/Ward (private hospital)
Medical Research Institute
Not-for-profit Institution/Organisation
Research Funding Body
Research Institution
Research Organisation

Organisation Description
The mission of the Prevent Blindness Foundation is to provide clinical eye care, educate all levels of eye health care providers, conduct research and find new ways to save sight and stimulate awareness of eye health in the community. One of the major achievements of The Prevent Blindness Foundation is the establishment and ongoing funding of the Queensland Eye Institute.

 

 

ClinSolutions Pty Ltd - Thursday, 27 October 2011

Organisation Name 
ClinSolutions Pty Ltd

Organisation Category
Clinical Research Software Company
Information and Technology

Organisation Description
ClinSolutions provides targeted, customizable and fit-for-purpose IT applications and services for patient enrolment, data management, trial management and statistics needs in the drug and device fields of clinical research. 

Our staff has wide operational experience in all of these fields as well as first class IT skills and experience. 

ClinSolutions is an Australian company based in Queensland with offices in NSW.  We operate with low overheads, always striving to ensure that our products and services align closely with the requirements of our clients. 

Because we specialise in the application of information technology to the field of clinical research, our clients don’t have to incorporate expensive IT resources in their infrastructure and headcount, meaning more of their budget is directed to their core specialties. 

ClinSolutions’ products conform to the US FDA’s 21 CFR part 11 protocols and our data  is compliant with CDISC SDTM and ODM standards.

 

 

Queensland Facility for Advanced Bioinformatics (QFAB) - Thursday, 27 October 2011

Organisation Name 
Queensland Facility for Advanced Bioinformatics (QFAB)

Organisation Category
Contract Research Organisation
Research Organisation
Bioinformatics Services

Organisation Description
QFAB provides the opportunity for researchers from a range of disciplines to capture the value in the overwhelming amounts of data being generated in the biotechnology and healthcare domains.  Working with the researchers QFAB can help uncover the information in that data and ultimately derive greater knowledge about the system of interest.

Underpinning the discovery process, bioinformatics is the catalyst for interdisciplinary knowledge management.  With the blending of fundamental DNA sequence data, expression profiling, through to protein folding prediction, metabolomic modelling and statistical inference, innovation is accelerated through the application of the skills of the bioinformatician.

QFAB offers a range of workflow solutions, customised web services and over 400 bioinformatic tools through a unique collaborative interface which allows dispersed research groups to work seamlessly together.  It supports the bioinformatics requirements of research-intensive companies, institutions and universities including secure access to very large databases, specialist software, high-performance computing, terabyte storage, data integration technologies and expert services beyond the capability of any single institution or company in Australia.

With its dedicated group of bioinformatics professionals QFAB helps deliver enhanced outcomes to health related research projects.

 

Clinical Network Services (CNS) - Thursday, 6 October 2011

Organisation Name
Clinical Network Services (CNS) Pty Ltd

Organisation Category
Clinical Research Organisation
Contract Research Organisation
Research Organisation

Organisation Description
CNS is an Australian Contract Research Organisation (CRO), focused on providing full service clinical management to the international healthcare community particularly during the early phase (Phase I and Phase II) clinical development of their products. Since 1998, CNS has established itself as Australia’s leading early phase Australian CRO working both nationally with dedicated Phase I units and hospital
groups as well as internationally with its strategic partners, in New Zealand, Europe, USA and Canada.

In addition to its early phase expertise, CNS also supports its partners by acting as their Australasian partner where their clients require Australasia to support global phase III & IV studies. Based in Brisbane, CNS has worked on over 100 projects for over 70 different clients, mainly from the US but increasingly in Europe and Australia. Also over this period CNS has expanded from providing study management and national clinical monitoring to a full range of services from protocol/IB development, through study start up, selection of sites with capacity to run early phase (0 – IIa) studies, monitoring and overall study management concluding with full Data Management/Biostatistics
and Clinical Study Report writing. Furthermore, CNS now provides QA services and continues to support ACRP training and Accreditation.

 

Queensland Institute of Medical Research (QIMR) - Thursday, 6 October 2011

Organisation Name
Queensland Institute of Medical Research (QIMR)

Organisation Category
Biomarker Discovery
Contract Research Organisation
Medical Research Institute
Not-for-profit Institution/Organisation
Research Institution
Research Organisation

Organisation Description
QIMR is a fully integrated biomedical research and development centre and one of the largest medical research institutes in Australia. QIMR has the capability to translate fundamental basic research from the discovery and development phase, through manufacture to Phase I and II clinical trials.
The Institute incorporates Q-Gen Pty Ltd, a Therapeutic Goods Administration (TGA) approved, certified good manufacture process (cGMP) manufacturing facility and Q-Pharm Pty Ltd, a company specialising in Phase I and II clinical trials and bioequivalence studies.

QIMR has a long and prestigious history that spans nearly 60 years in medical research. Areas of research include the immunology and molecular basis of infectious diseases, cancers and immune disorders. The Institute is at the forefront in the discovery of genes, candidate vaccines and cancer
therapeutics and the testing of vaccines and novel therapies at the cellular, animal model and clinical level.

QIMR has specialised facilities for genomics research, microarray and mass array analysis, transgenic and gene knockout mice, mouse models of tumour growth and infectious diseases, confocal and laser dissection microscopy, FACS and cell sorting facilities, PC2 animal facilities and Good Laboratory Practice (GLP) capabilities.

QIMR is the home of the Australian Centre for Vaccine Development and also houses a number of specialist laboratories including the drug discovery group and the protein discovery centre.
 

 

Centre for Nutraceutical and Medical Research (CNMR) - Thursday, 29 September 2011

Organisation Name
Centre for Nutraceutical and Medical Research

Organisation Category
Clinical Research Organisation
Clinical Trials Unit
Complementary/Nutraceutical Company
Contract Research Organisation
Medical Cooperative Group
Medical Research Institute
Regulatory Consultancy
Research Institution
Research Organisation

Organisation Description
The Centre for Nutraceutical & Medical Research (CNMR) is the point of contact for any company looking to conduct medical research on a nutraceutical product. CNMR is a collaboration of highly regarded specialist nutraceutical and medical researchers. The team comprises university researchers, physicians, specialists, contract research organisations, and regulatory consultants.

The strength of the centre is the ability to combine medical specialists with research at the forefront of Nutraceutical innovation. We recognise the value of nutraceuticals working in combination with pharmaceuticals to treat and prevent disease.

 

Queensland Paediatric Infectious Diseases Laboratory (QPID) - Thursday, 29 September 2011

Organisation Name
Queensland Paediatric Infectious Diseases Laboratory

Organisation Category
Clinical Research Organisation
Clinical Trials Unit
Dedicated Clinical Trials Centre (as part of a public or private hospital)
Government – State
Medical Department (clinic/ward part of a public hospital)

Organisation Description
The Queensland Paediatric Infectious Diseases (Qpid) Laboratory Clinical Trials Group has been conducting research and clinical trials since 2004. We conduct research in a number of areas: infectious diseases, epidemiology and laboratory diagnostics and methods; vaccines and other preventative agents; antibiotics and other therapeutic agents; and other hospital based research unrelated to infectious diseases. Our studies have been hospital based and community based. We currently employ eight (FTE 7.2) nurse study coordinators, one dedicated study nurse, two laboratory technicians (FTE 1.0), three medical officers and the head of our group is an infectious diseases paediatrician and microbiologist.

 

Cairns Base Hospital - Thursday, 22 September 2011

Organisation Name
Cairns Base Hospital

Organisation Category
Clinical Trials Unit
Dedicated Clinical Trials Centre (as part of a public or private hospital)

Organisation Description
Cairns Base Hospital is situated in the tropical climate of far north Queensland. The hospital has 285 beds and 12 Intensive Care beds. The hospital services the Cape York area including the Torres Strait. The Infectious Diseases Department has consistently had the highest enrolment in Australia for antinfective drug trials. The respiratory studies conducted at our centre have always met or exceeded recruitment targets.

 

Queensland Tropical Health Alliance (QTHA) - Thursday, 22 September 2011

Organisation Name 
Queensland Tropical Health Alliance

Organisation Category
Research Institution

Organisation Description
The Queensland Tropical Health Alliance (QTHA) is a unique collaboration between Queensland universities and research institutes, creating a wealth of tropical health and medical research expertise in the tropics. QTHA brings together, within one network, world-class researchers focused on the common goal of reducing the burden of tropical diseases in tropical regions. Research is conducted within three broad programs –

drugs, diagnostics and vaccines - targeted or rational drug development, development of novel therapeutics directed towards pathogen-derived toxins and development of vaccines targeted at parasitic infections; investigation of pathogen detection platforms and development of diagnostic assays for detection of parasitic infections;
Indigenous health - assisting Indigenous and underserved populations to improve health and well-being; endemic diseases affecting rural, remote and Indigenous communities;
disease surveillance and control - development of novel pathogens to shorten the lifespan of the disease vectors and develop methods and kits to control disease.
 

 

Brisbane South Clinical Research Centre - Thursday, 15 September 2011

Organisation Name
Brisbane South Clinical Research Centre

Organisation Category
Private Dedicated Clinical Trials Centre

Organisation Description
BSCRC is a small dedicated private clinical research centre conducting Phase II to Phase IV clinical trials for the pharmaceutical industry. We have been established 11 years with a good track record of meeting and exceeding recruitment targets. We have had a number of sponsor audits with excellent reports.

 read more ...

RBS Morgans - Thursday, 15 September 2011

Organisation Name
RBS Morgans

Organisation Category
Stockbroking

Organisation Description
RBS Morgans is a full service stockbroking business. One of the specialty services it provides is research and funding for ASX listed companies operating in the life science sector. Over the last decade RBS Morgans has raised in excess on A$1bn for Australian listed life science companies.

Recent capital raisings include ImpediMed (IPD), Sunshine Heart (SHC), Alchemia (ACL), QRX Pharma (QRX) and ChemGenex (CXS).

 read more ...

Brisbane Marketing - Investment Attraction - Thursday, 8 September 2011

Organisation Name
Brisbane Marketing - Investment Attraction

Organisation Category
Investment Agency (inward and outward)

Organisation Description
Brisbane Marketing’s Investment Attraction division is the city’s experienced and world-class inward investment agency. Established by the Lord Mayor of Brisbane more than 20 years ago, we have a strong track record in bringing new business to Brisbane and connecting local partners with international networks. We focus our efforts to attract Foreign Direct Investment (FDI) in six key sectors for which Brisbane has a national or international competitive advantage:

  • Clean Technologies and Renewable Energy
  • Digital Industries (including ICT, mining technology and services, and electronic games)
  • Food and Beverage R&D and Manufacturing
  • Life Sciences
  • Logistics and Distribution
  • Infrastructure
  • Innovative Manufacturing

Our dedicated and experienced team works with investors to determine how Brisbane fits with their future growth strategy for the Asia Pacific region. We provide critical introductions to extensive networks in the private sector, all levels of government and academia, talent and labour analysis, property solutions and advice regarding grants and incentives.

Supporting our work in FDI, we play an influential role in shaping the business environment – ensuring Brisbane remains a competitive destination for business investment.

 

Redland Hospital - Thursday, 8 September 2011

Organisation Name
Redland Hospital

Organisation Category
Government - State
Public Hospital

Organisation Description
General acute outer metropolitan hospital with a busy emergency department, obstetric service, paediatrics, medicine, cardiology, surgery and mental health departments. The Redland Hospital is co-llocated with a private hospital as well as a residential nursing facility.

 

Brisbane Convention & Exhibition Centre - Wednesday, 31 August 2011

Organisation Name 
Brisbane Convention & Exhibition Centre

Organisation Category
Convention Centre

Organisation Description
Brisbane Convention & Exhibition Centre is ideally located in a unique riverside urban arts and lifestyle precinct, home to Australia’s newest and largest Gallery of Modern Art, opera companies, symphony orchestras, performing arts and more than 30 sidewalk cafes and restaurants and a wide selection of
stylish shops.

The Centre is Australia’s most awarded convention centre and is officially ranked among the top three convention centres world-wide by the Association Internationale des Palais de Congres (AIPC).

A world-class venue, the Centre provides superb flexibility and versatility and offers a comprehensive
range of fully integrated in-house services all under the one roof and delivered by our team of experienced professionals whose commitment to excellence extends across all events.

An impressive portfolio of meeting rooms and event spaces meets the challenge of all events of any
complexity or size, accommodating plenary needs of 400 or 4,000, with the capacity to extend to 8,000.
Testimonials
“The staff Members at the Convention Bureau and the Convention Centre are by far the most professional and enthusiastic that I have ever dealt with. The city as a whole understands and appreciates the convention business…I have no hesitation in running a meeting in Brisbane”.
Gwynn Dominguez, IADR Director of Meetings, USA – International Association of Dental Research,3000 delegates.

 

RBWH Endocrinology Clinical Trials Unit - Wednesday, 31 August 2011

Organisation Name
RBWH Endocrinology Clinical Trials Unit

Organisation Category
Dedicated Clinical Trials Centre (as part of a public or private hospital)

Organisation Description
The Endocrinology Clinical Trials Unit is based in one of the largest public hospitals of Australia and has been participating in clinical trials since 1986. It has a long history of successful recruitment into clinical trials due to the large patient population that it draws on. Its principal investigator, Dr Michael
d’Emden has been on the management committee of several major international trials such as ASPEN, FIELD and TNT. It delivers high quality data and has received high commendations after many major audits. Its major clinical focus is any endocrine study, especially in diabetes and cardiovascular disease prevention trials.
 

 

BMDIF (Biotechnology and Medical Devices Industry Forum) - Thursday, 25 August 2011

Organisation Name
BMDIF (Biotechnology and Medical Devices Industry Forum)

Organisation Category
Industry Forum
Not-for-profit Institution/Organisation

Organisation Description
The Biotechnology and Medical Devices Industry Forum (BMDIF) is an exciting opportunity for you to
have a genuine role in the growth and success of the sector in Queensland.

For the first time we have key representatives from across the industry participating in an executive group that will help shape the strategic direction of the industry:

Medical Technology Association of Australia (MTAA)
AusBiotech QLD
AusMedtech QLD
Queensland Clinical Trials Network (QCTN)
Queensland Health
Industry representatives

A key goal of the BMDIF is to develop industry-led solutions to the following impediments to industry growth (as identified from industry surveys and analysis):

Industry Financing
Skills and Expertise
Regulatory Compliance
Product Development and Manufacturing
Market Entry

BMDIF supports the Commercialisation Matrix: gateway to a wealth of resources for commercial success. The matrix is a tool to connect you to a wealth of government (state and federal), private sector, and tertiary sector resources to assist you with your commercialisation journey.
But we can’t do it without you! You are the champions that can drive the strategic development of your industry.

 

St Andrew’s Medical Institute - Thursday, 25 August 2011

Organisation Name
St Andrew’s Medical Institute

Organisation Category
Clinical Trials Centre
Medical Research Institute
Not-for-profit Institution/Organisation

Organisation Description
St Andrew’s Medical Institute (SAMI) supports clinical trial activities undertaken by the leading medical specialists based at St Andrew’s War Memorial Hospital in Brisbane. These specialists treat a procedural and medical casemix which is among the most acute in Australia, with substantial volume in specific therapeutic areas. SAMI’s collaborative arrangements with St Andrew’s Hospital enable direct access to the technology and facility infrastructure to support these activities.

 

biostate - Thursday, 18 August 2011

Organisation Name 
biostate

Organisation Category
Business Consultancy Organisation
Consultancy

Organisation Description
biostate provides consulting services to those individuals, institutions and commercial entities who require assistance to identify and realise the commercial potential of their research. With significant experience in the health sector, and as active participants in the biotech and pharmaceutical forums, we can provide:

  • advice in identifying the commercial potential of an idea or technology
  • assistance in the development of business and marketing plans
  • representation for our clients in relevant meetings, conferences or other forums
  • guidance in the identification and selection of strategic partners
  • support in negotiation of commercial and licensing agreements
  • introductions to industry contacts.
  •  
 

The Spinal Cord Injury Network - Thursday, 18 August 2011

Organisation Name 
The Spinal Cord Injury Network

Organisation Category
Not-for-profit Institution/Organisation

Organisation Description
The Spinal Cord Injury Network is a young and vibrant not-for-profit organisation. We are a bi-national network spanning Australia and New Zealand. Our aim is to coordinate efforts to promote recovery, minimise disability and maximise quality of life for people with spinal cord injury. As an alliance of leading researchers, frontline clinicians and people with spinal cord injury we are working together to develop research, facilitate clinical trials and improve translation of basic and clinical research into more effective treatments for spinal cord injury.

 

 

BioPharmaceuticals Australia (BPA) - Thursday, 11 August 2011

Organisation Name 
BioPharmaceuticals Australia (BPA) 

Organisation Category
Contract Manufacturing Organisation
Government - State

Organisation Description
BPA has been established with the support of the Queensland Government to achieve two broad objectives:

  • to design, fund and implement construction of a biotherapeutic manufacturing facility to be operated in alliance with an experienced international partner;
  • to support and grow existing local Australian biotherapeutic manufacturing organisations, and to facilitate synergies between complementary providers of clinical development services.
  • The new facility will provide a service solution for companies with biological drug candidates who seek to outsource their process development and manufacturing. It will provide cutting-edge technical and economical methods for generating biopharmaceutical compounds expressed in mammalian cells.

The facility will enable early stage research to be converted into robust, production-ready processes, which can be tested at pilot scale before moving into the highly controlled GMP manufacturing environment required for human medicinal products. BPA will not only cater for pre-clinical development projects, but also for clients manufacturing for clinical trials and the marketplace.

The new facility will be operated by DSM Biologics and is due to be opened in early 2013. The facility upstream suites will cater for mammalian cell culture up to 2000 litres, with the ability to accommodate future expansion.

 

Sullivan Nicolaides Pathology - Thursday, 11 August 2011

Organisation Name 
Sullivan Nicolaides Pathology

Organisation Category
Analytical/Pathology Laboratory
Central Laboratory

Organisation Description
Sullivan Nicolaides Pathlolgy has considerable experience in the provision of clinical trial services to the pharmaceutical industry and university research departments.

SNP provides services 24 hours a day, 7 days a week.  All samples are processed immediately on arrival with most reports being returned to the investigator site/sponsor within 24 hours by transmission medium of your choice.

SNP Clinical Trials maintains its own -70 degree freezer for either short or long term storage of specimens.

Trials Management:  SNP has a dedicated trials team who are able to tailor our service to meet your trial’s specific requirements.  We are able to provie trial and visit specific collection kits or provide a bulk supply of collection material. Comprehensive, easy to use laboratory manuals are provided for each investigator site, as well as trial specific training at Site Initiation Visits, to ensure good site compliance.
Logistics: Whilst utilising the extensive coverage of our own courier network, Sullivan Nicolaides Pathology also works in close co-operation with major courier companies to supply investigator sites with supplies, and rapid pick-up and return of samples for testing.  We have also gained certification in the transport of biological and dangerous goods, in accordance with regulatory requirements.

Quality Assurance:  Sullivan Nicolaides Pathology Clinical Trials has a dedicated Quality Manager, who maintains an internal audit program to ensure compliance with Good Clinical Practice (GCP), NCSI ISO 9001:2008 and NATA.

 

BioAssayLINK Pty Ltd - Thursday, 4 August 2011

Organisation Name 
BioAssayLINK Pty Ltd

Organisation Category
On-line Matching Service

Organisation Description
BioAssayLINK (
www.bioassaylink.com) is the first online linking service for discovery and preclinical research services. It can be described as the ‘expedia’ or ‘wotif’ of new therapeutic research and development. Our online matching tool enables industry seekers’ to locate their outsourcing and collaborative partners that meet their specific needs. Our online matching focuses on early stage R&D such as drug and small molecule discovery, biomedical research, preclinical and non-clinical. Our unique online linking tool provides a rapid, cost effective and customer-specific way for seekers to connect with specialized providers. This information allows seekers to arrive at better decisions more quickly to advance their R&D programs, improving effectiveness and efficiency. BioAssayLINK is a privately owned company headquartered in Brisbane, Australia with distribution networks and affiliates in the United States of America and the United Kingdom and constantly expanding.
BioAssayLINK’s Vision
To be the global online leader linking the services and expertise of specialized laboratories with those individuals, teams and organizations involved in discovery, development and delivery of new healthcare products.

 

TetraQ - Thursday, 4 August 2011

Organisation Name 
TetraQ

Organisation Category
Analytical/Pathology Laboratory
Bioanalytical Facility
Biotech Consultancy Organisation
Central Laboratory
Consultancy
Contract Research Organisation
Laboratory
PK/PD Modelling Consultant
Preclinical Facility

Organisation Description
TetraQ is a full-service preclinical Contract Research Organisation that provides preclinical research services on a commercial basis to the life sciences industry. Our services focus on assessing Toxicity, Efficacy (using in vitro and in vivo disease models), ADME (Absorption, Distribution, Metabolism, Excretion) and Pharmaceutics.

TetraQ has world-class facilities backed by a highly skilled scientific team with a wealth of experience in all four core disciplines of preclinical development. TetraQ has NATA ISO 17025 (R&D) accreditation and GLP recognition which allows bioanalytical and toxicology work to be accepted internationally for regulatory review and provides a high degree of assurance for TetraQ clients.
TetraQ works with companies developing new drugs, seeking assistance with selecting a drug
candidate or requiring preclinical drug characterisation. TetraQ develops preclinical programs to ensure careful selection of studies which is critical to save on time and expenditure.

An area of special expertise at TetraQ is developing bioanalytical methods of investigational compounds in a range of biological matrices using a variety of methods. TetraQ has a large library of fully validated bioanalytical methods on file. The bio-analytical facilities support both preclinical and clinical studies.

Pain drug development is another area of special expertise. TetraQ has many testing models for investigating the efficacy of new drugs/biologics in different types of pain. TetraQ also has a wealth of experience in conducting studies in the following disease models: Obesity, Multiple Sclerosis, Diabetes, Alzheimer’s Disease, Arthritis, Respiratory Depression, Allergic Rhinitis and Constipation.

TetraQ currently provide services to clients based in the USA, Japan, Europe, UK, SE Asia and New Zealand.

 

BDO - Wednesday, 27 July 2011

Organisation Name
BDO (QLD)

Organisation Category
Accounting
Business Consultancy Organisation
Consultancy
Corporate Advisory
Financial Planning
IP Tax Consultancy
Professional Services
R&D Consultancy
Tax Consultancy

Organisation Description
BDO is one of Australia’s leading full-service audit, tax and advisory firms.  With offices in Adelaide, Brisbane, Cairns, Darwin, Hobart, Melbourne, Perth and Sydney, the firm has the national reach to service clients in any location.  Combine this with the firm’s strong global presence as a Member of the international BDO Network and there is no task too big or too small for BDO. 

Through the firm’s commitment to building and maintaining strong client relationships, its dedicated team of more than 1,200 professionals develop solutions tailored to the individual needs of their clients.

BDO is the fifth largest full-service audit, tax and advisory firm in the world. We have more than 47,000 people across 1,082 offices in over 110 countries.

BDO’s growth in recent years, particularly in Queensland, highlights the strength of the firm’s service offering and its ability to meet the needs of its clients, both in Australia and abroad, regardless of the economic conditions.  BDO Partners take an active role in all aspects of the firm, not only providing insightful guidance for clients, but helping develop the next generation of leaders.

 

Trialfacts - Wednesday, 27 July 2011

Organisation Name 
Trialfacts

Organisation Category
Patient Recruitment Organisation
List of Services
Marketing and Communications Services
Patient Recruiting
Patient Screening
Print Design Production and Management
Surveys and Market Research

Organisation Description
Trialfacts increases the competitiveness of local industry by partnering with research organisations to ensure trials are completed on or ahead of schedule, and rescue trials which have suffered delays. Trialfacts does this by combining our extensive marketing and advertising expertise with our in-depth clinical trial experience to create effective marketing solutions that adhere to GCP and HREC requirements.

Trialfacts provides a full range of marketing services as well as predefined solutions tailored to individual investigator sites or smaller studies. For CROs and sponsors Trialfacts provides an end to end recruitment solution with a continual focus on ROI to drive down cost per randomisation, which can include the following services:

Marketing strategy and campaign development
Advertisement creative and promotional material, including study specific websites
Online advertising
Database marketing
Traditional media buying (newspaper, other publications, radio, TV etc) agency
PR and media relations
Social media strategies
Online automated and offline call centre screening
Retention campaigns and study communications via email, SMS, phone, post and online questionnaires

A prime focus of Trialfacts’ since 2006 has been to build a database of qualified patients across Australia and New Zealand that would like to take part in clinical research. This database now exceeds 25,000 patients.

 

AusTrials Pty Ltd - Thursday, 21 July 2011

Organisation Name 
AusTrials Pty Ltd   

Organisation Category
Analytical/Pathology Laboratory
Central Laboratory
Clinical Research Organisation
Clinical Trials Centre
Laboratory
Research Organisation
Study Management Services

Organisation Description
AusTrials is a leading operator of private clinical trial facilities with four (4) centres in South East Queensland.  Each of these community based centres is operated by an experienced team of medical officers and study coordinators.  Clinical and organizational oversight is provided by a medical director with 16 years of clinical trial involvement as a principal investigator in public and private community and hospital environments. 

AusTrials has single points of contact for study feasibility assessment and HREC submissions for all of its sites. We have strong relationships with networks of general practitioners and specialists. This provides access to large clinical databases that facilitate recruitment in many different therapeutic areas. We have a dedicated liaison manager / recruitment specialist and collaborative arrangements with associated pathology and radiology providers. This has ensured that access to suitable volunteers for many clinical indications is, at the very least, equal to the best available in Australia.  AusTrials is noted for its extensive healthy volunteer database and has successfully conducted many large scale vaccine trials enrolling in excess of 500 participants per site.

It is our mission is to conduct clinical research of the highest quality while attaining or exceeding recruitment targets within study timeframes.

 

Trialworks Clinical Research Pty Ltd - Thursday, 21 July 2011

Organisation Name
Trialworks Clinical Research Pty Ltd

Organisation Category
Clinical Research Organisation
Clinical Trials Unit
List of Services
Clinical Research
Clinical Research Network
Contract Research Services
Medical Research
Treatment of Subjects (Context of Phase I/II Trials)
Treatment of Subjects (Context of Phase III/IV Trials)

Organisation Description
Trialworks is a community based clinical trials centre with access to a large GP network and healthy volunteers. The PI has had 15 years experience in phase II-IV clinical trials and outcomes-based studies across a wide range of indications in both public and private settings. Trials have been conducted for all the major pharmaceutical companies, CROs and University-based research centres. The centre is staffed by highly experienced research nurses / trial coordinators who have been working with the PI for more than nine years. Trialworks works closely with both public and private institutions to ensure the successful conduct and completion of its contracted trials.
 

 

Australian Prostate Cancer Research Centre - Queensland - Thursday, 14 July 2011

Organisation Name 
Australian Prostate Cancer Research Centre - Queensland

Organisation Category
Biomarker Discovery
Clinical Research Organisation
Clinical Trials Unit
Medical Research Institute
Not-for-profit Institution/Organisation
Preclinical Facility
Research Institution
Research Organisation

Organisation Description
The Australian Prostate Cancer Research Centre - Queensland is a transdisciplinary research centre, focused on the development of prostate cancer therapeutics and prognostic biomarkers. Initially funded by the Australian Government, we collaborate with a variety of institutions and industry organisations. Our activities span from high throughput discovery, molecular pathology, functional characterisation of potential targets, preclinical therapetuic development and evaluation, to clinical trials.

We recently launched the Multidisciplinary Team Clinic (MDT) for advanced prostate cancer at the Princess Alexandra Hospital, for Phase I/II and III trials. The APCRC - Q is also the headquarters of the Australian-Canadian Prostate Cancer Research Alliance, an initiative established with funding from the Queensland Government. This international Alliance links all the major prostate cancer research groups and relevant clinical societies across Australia and Canada. It partners nearly 300 scientists and clinicians to facilitate access to unique resources, leading edge infrastructure, and clinical trials networks. The APCRC - Q is highly interested in working collaboratively or contracting with Biotech, Pharma, and other industries in the development of new therapeutics, imaging and biomarkers.

 

TropLinks Inc - Thursday, 14 July 2011

Organisation Name 
TropLinks Inc

Organisation Category
Commercialisation Company
Consultancy
Matching Services
Not-for-profit Institution/Organisation
Professional Services

Organisation Description
TropLinks is a membership-based organisation comprised of companies, industry groups, economic development organisations and research bodies across Northern Australia.  TropLinks promotes Tropical Expertise and represents businesses who have developed innovative techniques for working in tropical environments.  Our Members are particularly experienced in managing the typical challenges of the tropics including the climate, remote and isolated locations and cultural differences.

Within the network, Members maintain their own corporate identity and benefit from working collaboratively.  TropLinks assists with business matching and identifying international business opportunities.  In particular, we promote partnerships between our Northern Australia Members and local companies in off-shore markets.  TropLinks offers expertise suitable to international clients in government, non-government and the private sector.

 

The Australian Lung Foundation - Thursday, 7 July 2011

Organisation Name
The Australian Lung Foundation

Organisation Category
Medical Cooperative Group
Not for Profit Public Benevolent Institution

Organisation Description
The Australian Lung Foundation’s Multi-Centre Clinical Trials Network (ALF MCTN) is an established service available to clinical trial sponsors and Clinical Research Organisations (CROs). It provides access to a large-scale investigator and patient database. The MCT Network is supported by an
efficient ethics submission process as well as an established network and recruitment management system.

The Network has been formed to support both local and international studies. It does not compete with the institutions that currently undertake clinical trials, but will enhance the recruitment base so that collectively, recruitment targets and tight study timelines can be met. The ALF MCTN business returns any surplus earned to the ALF assisting the foundation to fulfil their vision as a key agent of change in Australia, bringing about the understanding, management and relief of lung disease

 

Queensland Centre for Gyncocological Cancer Research (QCGC Research) - Thursday, 7 July 2011

Organisation Name 
Queensland Centre for Gyncocological Cancer Research (QCGC Research)

Organisation Category
Clinical Research Organisation
Clinical Trials Unit
Clinical Trials Centre
Research Institution
Research Organisation

Organisation Description
We research and develop the best standard of care for women experiencing gynaecological cancer.
 

 

Australian Institute for Commercialisation (AIC) - Thursday, 30 June 2011

Organisation Name 
Australian Institute for Commercialisation (AIC)

Organisation Category
Commercialisation Company
Not-for-profit organisation/institution

Organisation Description
The Australian Institute for Commercialisation (AIC) provides innovation and collaboration services that help organisations grow. Nationally, we work with entrepreneurs, businesses, research organisations and governments to identify opportunities to convert ideas or intellectual property into successful business outcomes. Using our networks and experience, we deliver services to achieve this by establishing partnerships, improving skills, and providing commercialisation advice. The AIC is an advocate for commercialisation, and assists government with policy initiatives and thought leadership in the innovation space.

Our innovation and commercialisation services that may assist companies include:

Market research and opportunity analysis. This is particularly important for Nano-enabled technologies for identifying market opportunities as well as barriers to market entry.
Facilitation of collaboration along the value chain, for instance between research organisations and SMEs, or governments and industry.
Commercialisation project management services to achieve and manage technology transfer or brokerage of intellectual property. The AIC has experience working with nanotechnology companies for the commercialisation of new products.
Strategic advice around IP management  and  commercialisation
Professional development programs to increase commercialisation skills and successes.

 

University of Queensland Centre for Clinical Research - Thursday, 30 June 2011

Organisation Name 
University of Queensland Centre for Clinical Research

Organisation Category
Biomarker Discovery
Clinical Trials Unit
Contract Research Organisation
Medical Research Institute
Not-for-profit Institution/Organisation
Preclinical Facility
University

Organisation Description
The University of Queensland’s Centre for Clinical Research (UQCCR) is a new $66M facility designed to bridge the gap between exponentially-expanding biomedical science and the increasing complexity of modern patient care.  Our joint ‘bench to bedside’ and ‘bedside to bench’ focus addresses a critical area of unmet need in the early 21st century.  UQCCR offers a unique and exciting opportunity for new and established investigations to pursue cutting-edge, clinically-relevant research in a world-class facility. 

UQCCR is pivotally located alongside Australia’s largest 1,000 bed tertiary Royal Brisbane & Women’s Hospital (RBWH).  UQCCR’s 8,000m2 building boasts state-of-the-art equipment, 1 clinical research floor with outpatient facility for up to 500 patients/day, and 5 wet laboratory floors.  Our goals are to foster innovation in clinical research; translate basic and applied research into more effective outcomes for patients; and train tomorrow’s generation of translational researchers and MD PhD Clinical Scientists.

 

 

Australian Institute for Bioengineering and Nanotechnology - Wednesday, 22 June 2011

Organisation Name 
Australian Institute for Bioengineering and Nanotechnology

Organisation Category
Research Institution

Organisation Description
The AIBN brings together the skills of research groups working on biological, chemical and physical solutions to alleviate problems in human health and environmental issues.

Companies interact with AIBN’s internationally acknowledged research leaders and use the institute’s facilities and capabilities to support their business growth and development. These companies are finding a host of avenues available to them, with AIBN offering consultation, partnerships, contract research, use of the latest equipment and an industry affiliates program. AIBN’s infrastructure and world-class facilities include a comprehensive suite of instrumentation for materials characterisation, bioreactors and microbioreactors, flow cytometry facilities, thermogravimetric analyser and spectrometers.

AIBN leads the field in: Materials design and characterisation at the nanometre scale; Micro/nanofabrication and prototyping; Advanced microscopy, electron microscopy and microanalysis; Protein expression, purification and characterisation and high-throughput screening; Simulating and visualising molecular systems; Analysis in mass spectrometry, HPLC and calorimetry.

AIBN works with industry, undertakes research and develops flexible arrangements to meet the needs of partners. Successful arrangements have included the use of metabolic engineering to produce new bioproducts from cells; combining stem cell biology with novel scaffolds for regenerative medicine; developing nanomaterials for biomedical applications; and enzyme encapsulation.

 

VenturePro - Wednesday, 22 June 2011

Organisation Name
VenturePro

Organisation Category
Biotech Consultancy Organisation
Business Consultancy Organisation

Organisation Description
VenturePro is a professional services firm that specialises in developing and assessing business plans and grant applications for public and private organisations. We have expertise in co-ordinating the development of research project plans, writing business cases for major R&D funding and preparing business plans. Since 2005, VenturePro clients have been awarded over $280 million in government and private funding for R&D projects. The success rate across all of our clients is 82% with the median grant being $2.0m, and the average being $6.4m. We contribute to science and innovation policy through the development of major life sciences industry analyses including the 2007 and 2009 Queensland Life Sciences Industry Reports. Our clients include universities across Australia including 7 of the G8 Universities, the ATN universities and many others. Some of our health sector clients in Queensland include the Royal Brisbane and Women’s Hospital, Greenslopes Private Hospital, St Andrew’s Medical Research Institute, the Hear and Say Centre, Queensland Brain Institute, TetraQ, Queensland Health Forensic and Scientific Services, BioPharmaceuticals Australia, QUT Institute of Health and Biomedical Innovation, Queensland Institute of Medical Research, Queensland Tropical Health Alliance, Australian Institute for Bioengineering and Nanotechnology and several biotechnology and medical device companies.

 

Vicibio - Thursday, 16 June 2011

Organisation Name
Vicibio

Organisation Category
Business Consultancy Organisation

Organisation Description
The Principal and Founder of Vicibio, Dr Peter Riddles, has broad experience in science and innovation having contributed to both government and private sector activities in the life sciences industries in Australia and elsewhere. Vicibio facilitates strategic planning in organisations where science, technology and innovation are vital to the business activities.

Key clients include governments, public sector research agencies and private sector new ventures. During the facilitation, Vicibio will consider innovation, governance, policy and strategy. If required, Vicibio will assist the organisation in attracting boards and financing. Vicibio provides the following core capabilities and experiences:

Knowledge of innovation policy and strategy;
Experienced Entrepreneur and Director of new ventures;
Experienced Chairman of government and private sector organisations including complex multistakeholder ventures;
The ability to conceptualise and develop scoping studies with complex technical and market opportunities;
Experienced at reviewing and evaluating programs in both government and private sector;
Expertise in science and technology and its commercialisation.
The principal of Vicibio, Dr Peter Riddles, may be retained in the longer term as a Chairman/Director or as a strategic advisor, or engaged on a project basis.
 

 

Australian Genome Research Facility Ltd - Thursday, 16 June 2011

Organisation Name
Australian Genome Research Facility Ltd

Organisation Category
Contract Research Organisation
Genomics Service Provider to Academic and Industrial Markets
Not-for-profit Institution/Organisation

Organisation Description
Australian Genome Research Facility Ltd (AGRF) was established in 1997 with the mission of providing high quality genomic services to the academic and industrial markets spanning biomedicine, plant and animal science, microbiology, evolutionary biology and biodiversity.

With facilities in Brisbane, Melbourne, Adelaide and Sydney, AGRF Ltd is Australia’s largest genomics service provider. We place a high value on quality and maintain accreditation to the internationally recognised ISO 17025:2005 quality standard as well as other regulatory licences. The AGRF Brisbane
Node houses AGRF’s Sanger and Next-Generation sequencing services as well as the Sequenom SNP Genotyping platforms. AGRF’s services range from pharmacogenomics, small to large-scale DNA sequencing using Sanger and Next-Generation technologies, genotyping / SNP analysis, gene
expression studies and small to large scale nucleic acid extractions. Our services are underpinned by the provision of customised bioinformatics solutions.

 

Australasian Kidney Trials Network - Tuesday, 31 May 2011

Organisation Name
Australasian Kidney Trials Network

Organisation Category
Clinical Research Organisation
Dedicated Clinical Trials Centre (as part of a public or private hospital)
Research Organisation

Organisation Description
Australasian Kidney Trial Network facilitates clinical trials in kidney disease in Australia and New Zealand, and publish the impact that this may have on improving the treatment of kidney disease. The network aims to design, conduct and support high quality clinical trials in kidney disease, focused on
improving appropriate patient-centre outcomes. The need for a clinical trials network in the area of kidney disease was recognized by both the Australian and New Zealand Society of Nephrology (ANZSN) Council and Kidney Health Australia (KHA).

In October 2003, ANZSN and KHA asked for expressions of interest to run such a network. Three groups were chosen to submit full proposals, and in August 2004 the proposal for the network with a Brisbane-based Operations Secretariat was endorsed by ANZSN and KHA. Since then a group of
national leaders in nephrology, representing geographically diverse locations and special interests have cooperated in forming the network.

 

The Wesley Research Institute Ltd - Tuesday, 31 May 2011

Organisation Name 
The Wesley Research Institute Ltd

Organisation Category
Clinical Research Organisation
Clinical Trials Unit
Clinical Trials Centre
Medical Research Institute
Research Institution
Study Management Services
Tissue Banking

Organisation Description
The Wesley Research Institute (WRI), established in 1994, is an independent not-for-profit medical research facility that provides support for laboratory, clinical and translational research that works towards its shared value of ‘making a difference today’. The Institute incorporates Queensland’s largest Tissue Bank, an innovative Health and Medical Research Centre and the Clinical Trials Centre. WRI has strong affiliations with world class, research-focused universities and other medical research institutes.
 
The Clinical Trials Centre has an established base of specialist investigators, access to a general practitioner referral network and private hospital services, which provides our clients with wide-ranging clinical expertise, and a comprehensive, high quality service which includes:

Conduct of clinical trials from Phase I to IV (including device and surgical) over a diverse range of therapeutic specialities
Single point of contact to coordinate single and multi-centre trials
Timely and cost-effective submission of protocols to the on-site Human Research Ethics Committee
Efficient financial and contract administration processes
Biological specimen processing and storage
Investigational Product storage and dispensing, including access to on-site facilities and equipment
Database and clinical registry establishment, management and reporting
Support framework for Investigator-Initiated Research

 

Athlomics Pty Ltd - Thursday, 26 May 2011

Organisation Name 
Athlomics Pty Ltd

Organisation Category
Biomarker Discovery
Biotech Company
Medical Device Company
Commercialisation Company

Organisation Description
Athlomics is commercializing molecular diagnostic (MDx) and molecular monitoring tests (MMx) for the personalized management of sepsis patients and those at risk (e.g. post-surgical and burns patients). Two product lines, SeptiCyte Lab and SeptiCyte Monitor are being clinically validated, and are based on multiplex qRT-PCR platforms for both hospital laboratory and Point of Care applications.

The products are specifically designed for use in hospitals - in Intensive Care Units (ICUs) and Emergency Departments (ED). These products are based on the host immune response, and not pathogen detection, utilising multiple genomic biomarkers. Athlomics products out-perform pathogen-based tests in both turnaround time and sensitivity and specificity, and SeptiCyte Monitor can also be used to determine immune status (see Hotchkiss quote below) and for earlier detection of sepsis in patients at risk.

The company has been successful with national and international grants. It expects to have product in the Australian and European markets over the next 3 years (2011-2013). Athlomics has offices in Brisbane and Seattle (subsidiary US company, ImmuneXpress Inc.).

 

World Courier (Aust) Pty Ltd - Thursday, 26 May 2011

Organisation Name 
World Courier (Aust) Pty Ltd

Organisation Category
Logistics Company

List of Services
Dangerous Goods Certification Training Course
Drug Delivery
Clinical Trial Management and Logistics
Logistics

 

IMBcom Pty Ltd - Thursday, 19 May 2011

Organisation Name 
IMBcom Pty Ltd

Organisation Category
Bioscience Development Organisation
Commercialisation Company

Organisation Description
IMBcom Pty Ltd is the University of Queensland’s private company dedicated to the commercialisation of research from one of the leading biotechnology research organisations in Australia, The Institute for Molecular Bioscience (IMB). IMBcom works closely with researchers to protect the IMB’s intellectual property portfolio, and creates pathways for commercial success. Services are provided to the IMB via an expert, experienced team comprising IP professionals and staff with pharma and biotechnology experience in areas such as:

  • In-house management and protection of intellectual property;
  • Strategic business development projects for novel technologies;
  • Capital raising, particularly pre-seed;
  • Sourcing and negotiation of commercial contracts and grants;
  • Start-up company generation and administration;
  • Commercialisation education programs.
  • As a result of IMBcom’s commercialisation activities, inventions for health, pharmaceutical and other molecular technology-based products with potential future social and economic benefits are being developed.


 

 

Applied Science and Nutrition Pty Ltd (ASN) - Thursday, 19 May 2011

Organisation Name
Applied Science and Nutrition Pty Ltd (ASN)

Organisation Category
Clinical Research Organisation
Complementary/Nutraceutical Company
Contract Research Organisation
Regulatory Consultancy
Research Organisation
Members

Organisation Description
Applied Science and Nutrition Pty Ltd (ASN) is an independent Contract Research Organisation specialising in complementary medicine and nutraceutical product research. We partner closely with our clients to help them develop their “ideas” into successful globally-marketed complementary
medicines. Our primary focus is the design and management of all stages of clinical trials.

ASN comprises a team of regarded specialist complementary medicine researchers that are driven to advance the valid evidence-base for complementary medicines within the broader healthcare context.

In collaboration with general practitioners, clinicians, and leading service providers, we are uniquely positioned to provide quality complementary medicine research. Our extensive regulatory knowledge and understanding of the challenges unique to complementary medicine research ensures we are able to design and manage trials that support clients’ product-realisation efforts.

 

Haematology & Oncology Clinics of Australia Research Centre - Thursday, 12 May 2011

Organisation Name
Haematology & Oncology Clinics of Australia Research Centre

Organisation Category
Dedicated Clinical Trials Centre (as part of a public or private hospital)
Not-for-profit Institution/Organisation
Research Organisation

Organisation Description
The Haematology & Oncology Clinics of Australia Research Centre is a not for profit organization established in 1993. It operates from the following locations two of which are leading tertiary healthcare facilities:

  • The Mater Private Centre for Haematology & Oncology
  • The Wesley Clinic for Haematology & Oncology
  • North Brisbane Cancer Centre at the Chermside Medical Centre
  • HOCA Gold Coast Cancer Centre

The Research Centre is staffed by experienced clinical research professionals who work along side leading Haematologists and Oncologists providing treatment options to over 70% of privately treated patients in Brisbane.

HOCA Research Centre has established a strong tradition of providing excellence in trial conduct to both local and international partners in the pharmaceutical and biotechnology sector. HOCA Research Centre also works closely with collaborative groups working together to develop new and innovative drugs for Australian patients.

The Mission of the HOCA Research Centre is Caring for People with Cancer.

 

Institute for Glycomics - Thursday, 12 May 2011

Organisation Name
Institute for Glycomics

Organisation Category
Research Institution

Organisation Description
Griffith’s Institute for Glycomics is a global leader in carbohydrate focused research into clinically significant diseases. The Institute is the only one of its kind in Australia and only one of six in the world. Research at the Institute for Glycomics involves the study of the glycan and glycan-binding proteins in various biological systems, and the design of novel drugs and vaccines. This approach presents an exciting therapeutic platform for the control of a wide-range of medical conditions such as infectious diseases (including Influenza, Malaria, Dengue fever and Rotavirus), cancer, diabetes, inflammation and immune disorders.

The Institute takes a multi-disciplinary approach to research bringing together researchers from medicinal chemistry, computational chemistry, structural biology, microbiology, immunology, virology, biochemistry and molecular and cell biology. It collaborates with leading scientists around the world to build a critical mass around carbohydrate-based research. Global collaboration together with a mutil-disciplinary approach to research, are essential to achieving our vision to bring forward novel medicines and vaccines to the community.
 

 

Ground Zero Pharmaceuticals - Thursday, 5 May 2011

Organisation Name 
Ground Zero Pharmaceuticals

Organisation Category
Biotech Consultancy Organisation
GMP/Quality Management Consultancy
PK/PD Modelling Consultant
Regulatory Consultancy

Organisation Description
Ground Zero Pharmaceuticals (GZP) provides regulatory affairs, FDA representation, and product development consulting to firms developing drugs, biologics, vaccines, medical devices and combinations in areas such as strategic global planning, toxicology, pharmacology, PK/PD, manufacturing compliance, project management, medical writing, and clinical trials management. 

We provide objective, practical, targeted and quality services and believe that our first responsibility is to our clients. Our experience enables us to provide value-added strategic consulting with continuing innovation and consideration for the legal and regulatory framework of medical product development. Our services have proved beneficial to our clients from late discovery through marketing submission and post-submission activities and we are currently involved with more than 25 IND programs.

 

 

Institute of Health and Biomedical Innovation (IHBI), Queensland University of Technology - Thursday, 5 May 2011

Organisation Name 
Institute of Health and Biomedical Innovation (IHBI), Queensland University of Technology

Organisation Category
Research Organisation

Organisation Description
The Institute of Health and Biomedical Innovation(IHBI) is a collaborative institute based at QUT, devoted to improving the health of individuals through research innovation. We combine high quality health research with a commitment to social justice. This means that we do more than develop innovative solutions to health issues. We also apply our solutions to real world experiences to make sure that they are effective. Through our work, we seek to improve the health of individuals and of communities.

IHBI’s researchers focus on three broad health areas - prevention; mind and body health; and recovery. IHBI’s researchers are clustered into five flexible research domains that emphasise multidisciplinary collaboration:

Cells & Tissue
Human Health & Wellbeing
Injury Prevention & Rehabilitation
Medical Device
Vision Improvement.

 

IPG Print - Thursday, 28 April 2011

Organisation Name
IPG Print

Organisation Category
Print Solutions Company

Organisation Description
IPG Print is one of the leading providers of print solutions in Queensland. IPG was the first company in Queensland to embrace a true print management business model with online ordering and professional inventory management systems. We offer a broad range of in house printing equipment that includes traditional printing presses, state of the art digital presses and full colour
envelope machines.

The IPG Print plant is located at Brendale in Brisbane, approximately 16km north of the Brisbane GPO and convenient to all main arterial roads and the Brisbane airport. Employing 75 staff, IPG comprehensively covers all aspects of the commercial offset and digital printing field. Our qualified tradesmen operate a wide range of presses from single colour to 6 colour offset as well as the digital INDIGO presses.

IPG Print have the technology, expertise and above all enthusiasm to deliver to our customers a product with the quality an organization such as yours deserves and we look forward to the opportunity to work with you.

 

Griffith University, School of Pharmacy - Thursday, 28 April 2011

Organisation Name
Griffith University, School of Pharmacy

Organisation Category
Research Institution
School of Pharmacy

Organisation Description
Griffith’s Pharmacy School research spans a continuum from pharmacological and pharmaceutical sciences through to clinical and community care. The School has a strong tradition of research excellence, especially in inter-disciplinary and translational research. Staff comprises of clinical pharmacists, pharmacologists and pharmaceutical scientists with a multifaceted expertise in areas
such as complementary medicines, nutraceuticals, clinical pharmacy (esp. pain, osteoporosis, infectious diseases, cancer and geriatric medicine), pharmacology, bioassays and drug delivery. The School has established research links with various institutions nationally and internationally, as well as with pharmacies and hospitals on the Gold and Sunshine Coast and in Brisbane.

 

Griffith Health Institute - Thursday, 21 April 2011

Organisation Name
Griffith Health Institute

Organisation Category
Analytical/Pathology Laboratory
Clinical Research Organisation
Research Institution
Research Organisation
Griffith Institute for Health
& Medical Research

Organisation Description
The Griffith Health Institute conducts research to address health priorities of disease prevention and healthcare innovation utilising expertise in biomedical science,
immunology, molecular and microbial genomics, development and clinical psychology, dietetics, pharmacy, nursing, dentistry & oral health, epidemiology, cardiovascular science, neuroscience, public health, health economics and health policy.

Incorporated within GIHMR is the Genomics Research Centre (GRC: see separate listing) which investigates the genetic basis of disease and has a NATA accredited DNA testing laboratory to undertaking testing for 6 neurogenetic and stroke related disorders for Australia. The GRC also undertakes clinical trials primarily in neurological and cardiovascular areas including migraine and MS as well as nutraceutical trials for various conditions. Experts within the Behavioural Basis of Health program specialise in the delivery and evaluation of behavioural treatments and psychological interventions in various clinical groups including but not limited to brain injury and drug abuse.
Researchers within the Clinical and Community Practice Innovation and Population Health programs have conducted clinical trials within areas of expertise in acute and critical care, pain, ageing, disability and rehabilitation, women and families’ nutrition and dietetics.

 

James Cook University - Thursday, 21 April 2011

Organisation Name
James Cook University

Organisation Category
Clinical Research Organisation
Medical School
Research Institution
Research Organisation
Teaching Hospital

Organisation Description
James Cook University (JCU) is a comprehensive and multicampus university based in tropical North Queensland, ranked in the top 5% of the world’s tertiary institutions. It is Australia’s leading tropical research university and is amongst the top five tropical universities of the world for research in its major research fields.

In clinically-relevant areas, JCU produces graduates and undertakes research and research training in medicine, dentistry, allied health and rehabilitation (including physiotherapy, occupational therapy, speech pathology, and sports science) public health, nursing, midwifery, nutrition, veterinary science, psychology, and in the biomedical and biomolecular sciences. In the biomedical area, it has particular research strengths in immunology, genomics, cardiovascular biology and vascular disease, neuroscience, infectious diseases, parasitology, tropical medicine, tropical public health and epidemiology, colo-rectal and skin cancers, and in clinical program delivery to underserved populations. In most of these areas, JCU researchers are involved in both basic biological research and strongly clinical projects, including clinical trials.

 

Griffith Hack - Thursday, 14 April 2011

Organisation Name
Griffith Hack

Organisation Category
Legal & Patent Attorneys

Organisation Description
Griffith Hack is Australia’s largest IP firm for Australian applicants, comprising patent and trade marks attorneys, IP lawyers, information services and IP portfolio management. We provide a full range of comprehensive IP services to many of Australia’s leading companies.

With 30 Partners and over 230 staff Australia-wide, including more than 75 professionals and 150
support staff across our Sydney, Melbourne, Brisbane and Perth offices, Griffith Hack is a major IP
force in Australia. Through our involvement in IP worldwide for more than 100 years, Griffith Hack
enjoys a network of international associates unrivalled by even the largest law firms.

Griffith Hack Patent and Trade Marks Attorneys deals in all aspects of patents, trade marks and
registered designs, from registration through to prosecution and enforcement. Our firm has expertise in all types of technology.

Griffith Hack Lawyers is fully and seamlessly integrated with Griffith Hack Patent and Trade Mark
Attorneys and practises in a number of specialised areas to advise clients on all aspects of IP, including litigation. A fast-growing and competitive arm of Griffith Hack, the law firm was established in 1992 as an affiliate of the Patent & Trade Mark firm and shares its offices in Sydney and Melbourne.

One of the largest and longest standing IP firms in Australia, Griffith Hack has been leading the way in providing a complete range of IP services and strategic advice to our clients, for the past 110 years.

 

Logan Hospital - Thursday, 14 April 2011

Organisation Name
Logan Hospital

Organisation Category
Government – State Medical Department (clinic/ward part of a public hospital)

Organisation Description
Logan/Beaudesert Hospitals provides secondary medical, surgical, obstetric and gynaecology, mental health, paediatric, palliative care, renal dialysis, specialist outpatient and allied health services. Patients also flow into the PA Hospital for tertiary services and via the Mater, Children’s’, Adults’ and Women’s Hospitals. Logan/Beaudesert Hospital also provide mental health services with 40 Acute Adult Inpatient Beds, 10 Acute Adolescent Inpatient Beds, Adult community-based mental health services, with multiple teams working from a range of community facilities.

The District also provides a significant volume and variety of primary health services from a large number of community facilities, including oral health, mental health, child health, school health, aged care, rehabilitation, palliative care, chronic disease management, general primary medical care and alcohol, tobacco and other drug services. Outreach clinical services are also provided in non Queensland Health facilities e.g. high school and primary school nursing, oral health services, antenatal, child health and sexual health services.

 

Griffith Enterprise - Wednesday, 6 April 2011

Organisation Name
Griffith Enterprise

Organisation Category
Commercialisation Company
Griffith Enterprise

Organisation Description
To ensure that its teaching and research assets contribute effectively to society, Griffith University engages in a variety of commercial enterprises with industry, government and community organisations. Griffith Enterprise is the group within Griffith University with the mandate to capture these commercial enterprises. It does so via typical commercial mechanisms including research and development collaborations, fee-for-service consulting, the licensing of intellectual property, and new company formation.

 

Lumigenix Research Pty. Ltd. - Wednesday, 6 April 2011

Organisation Name
Lumigenix Research Pty. Ltd.

Organisation Category
Bioanalytical Facility
Biomarker Discovery
Biotech Consultancy Organisation
Clinical Research Organisation
IT Solutions Provider
Research Organisation

Organisation Description
We are a full service genomics contract research organisation (CRO), with global scope. Based in Australia, we make the rapidly advancing field of genomics and personalised medicine available to any company or researcher – from large pharmaceuticals to medium sized biotechnology companies and academic groups.
Our services cover the entire spectrum of genomic research including:
• Strategic Consultancy (including study planning and protocol development);
• Sample Collection and Logistics;
• Sample Processing and Genotyping;
• Statistical Analysis.

We are unique in the marketplace - as we provide both cutting edge bioinformatics and genetics statistics, with extensive knowledge of global genomics/genetics regulation and Good Clinical, Laboratory and Manufacturing Practice (GCP/GLP/GMP). We are able to leverage volume discounts and a sophisticated technical infrastructure to provide our customers with a cost effective and high quality service.

Lumigenix Research gives you access to genomic expertise and technologies that were previously only available to large pharmaceutical companies. Our full service solution allows you to add value to your early stage clinical studies through genotoxicity and genetic drug metabolism studies. With our drug metabolism services, you can increase the effectiveness and lower the risk of your pharmacokinetic and pharmacodynamic studies.

 

Gold Coast Health Services District - Cardiology Research Department - Thursday, 31 March 2011

Organisation Name
Gold Coast Health Services District - Cardiology Research Department

Organisation Category
Clinical Trials Unit
Dedicated Clinical Trials Centre (as part of a public or private hospital)
Government – State
Medical Department (clinic/ward part of a public hospital)
Research Institution
Tissue Bank

Organisation Description
The Cardiology Department of the Gold Coast District Health Service is currently part of a two campus hospital service, which also incorporates satellite clinics in a community setting – such as Cardiac Rehabilitation and Heart Failure Clinics.

As part of our growing commitment to continuing education and research the department has established itself as a research hub participating in clinical and non clinical trials that are specific to Cardiology. The department is also fortunate to have a Director who has affiliation with both Bond and Griffith University, and so the emphasis of the department is one of education through research and participation.

In 2012 the Gold Coast Hospital will become the ‘University Teaching Hospital’ when services are relocated to the new multi-million dollar facility at Parklands-Griffith University Campus. It is anticipated that by this time the Cardiology Department of the hospital will have established itself as a nationally recognised research centre.

 

Marsh (Qld) Pty Ltd - Thursday, 31 March 2011

Organisation Name
Marsh (Qld) Pty Ltd (Formerly RJ Neville & Associates)

Organisation Category
Insurance Company

Organisation Description
Marsh is a global insurance broking firm which provides insurance services to the Life Science industry in areas such as Pharmaceutical, drug development, biotechnology, medical devices and contract research organisations to name a few. We also provide insurance covers in other areas such as Directors’ and Officers’ Liability, Clinical Trials and Public and Products Liability.

 

The Genomics Research Centre - Thursday, 17 March 2011

Organisation Name
The Genomics Research Centre

Organisation Category
Analytical/Pathology Laboratory
Clinical Research Organisation
Dedicated Clinical Trials Centre (as part of a public or private hospital)
Research Organisation
Tissue Bank

Organisation Description
The Genomics Research Centre investigates the genetic basis of disease. Research is focused on common chronic human disorders that have a significant genetic component such as migraine, CVD and high blood pressure, various types of cancer, multiple sclerosis and osteoporosis. Scientists within the Centre have expertise in gene mapping and the characterisation of gene dysfunction and have the ability to translate this information to both diagnostic and therapeutic outcomes. In addition, the Centre
is aware of the important ethical and psychological issues associated with genetics and consequently is actively engaged in training Genetic Counsellors and Clinical Geneticists. The Centre has a NATA accredited DNA testing laboratory and undertakes testing for 6 neurogenetic and stroke related disorders for Australia. The Centre also undertakes clinical trials, recently completing a sponsored Phase 2 trial on migraine and another testing a potential new MS therapeutic.

The Centre has good industry links and has been involved in many industry funded R and D projects with for example GSK, Gemini Genomics, Sequenom, Corbett Research, CBio Ltd, Emerillon Ltd and Janssens.

 

Mater Medical Research Institute - Thursday, 17 March 2011

Organisation Name
Mater Medical Research Institute

Organisation Category
Biomarker Discovery
Medical Research Institute
Research Institution

Organisation Description
Based on a commitment to academic medicine, we are building a world-class medical research institute to discover, develop, translate, and commercialise medical research that integrates with relevant areas of excellence with Mater Health Services.

 

Gallipoli Medical Research Foundation - Thursday, 10 March 2011

Organisation Name
Gallipoli Medical Research Foundation

Organisation Category
Clinical Trials Unit
Dedicated Clinical Trials Centre (as part of a public or private hospital)

Organisation Description
The Gallipoli Medical Research Centre Clinical Trials Unit was established in 2007. It is located on the campus at Greenslopes Private Hospital, Australia’s largest private teaching hospital. Both investigator initiated and pharmaceutical company sponsored trials are conducted in the Unit. The Unit aims to promote and increase research activities on the Hospital campus and profits from clinical trials are channelled back into medical research in the Gallipoli Medical Research Centre.

 

Mater Pathology Services - Thursday, 10 March 2011

Organisation Name
Mater Pathology Services

Organisation Category
Analytical/Pathology Laboratory
Biomarker Discovery
Medical Department (clinic/ward part of a public hospital)

Organisation Description
Mater Pathology Services provides a comprehensive diagnostic service to the general practice and specialist medical community, and to the seven hospitals comprising the Mater network. Mater Pathology’s expertise ranges from prenatal medicine to the full spectrum of diseases of adulthood. There is a major interest in materno-fetal medicine, oncology, metabolic diseases and diabetes, as well as many other disorders. Mater Pathology is leading the way in the development of the latest genomic and proteomic-bases pathology testing.

 

Fusidium Pty Ltd - Thursday, 3 March 2011

Organisation Name
Fusidium Pty Ltd

Organisation Category
Biotech Consultancy Organisation
Business Consultancy Organisation
Commercialisation Company
List of Services
Biotech Consultancy Services Project Management Services
Business Consultancy Services Strategic Planning
Commercialisation Services Surveys
Distributor location and due diligence in Asia Pacific Technology assessment
Grant Application Preparation
Interim Management
Market Research

Organisation Description
Fusidium Pty Ltd is an independent consulting company servicing the Life Sciences industry in Australia. The company offers a range of services including:

• Business Development
• Strategic Planning Support
• Commercialisation Services
• Interim Management Services
• Market Research
• Grant Preparation
• Surveys
• Source Distributors in Asia Pacific

We can help with the development of your strategic plan with a focus on your Strategic Partners. We can work with you to develop your business through building contacts with potential partners, customers or licensees. We can provide support in governance at the level of Advisory or Corporate Board. We can assist business growth through the provision of management services. Fusidium has the experience and international contacts that may be necessary to the growth and development of your business.

 

McCullough Robertson - Thursday, 3 March 2011

Organisation Name
McCullough Robertson

Organisation Category
Legal & Patent Attorneys

Organisation Description
McCullough Robertson provides specialist legal services to all participants in the clinical trial industry. We are one of the largest groups of specialist life sciences lawyers of any Australian legal firm. With a significant depth of experience, several lawyers have science qualifications, relevant training in good clinical practice and experience in phase I, II and III single and multi-site clinical trials. Our lawyers act for listed and unlisted life science companies, local and international sponsors, CROs, investigators, together with a wide range of start-up companies, universities and research institutes. We advise on all aspects of bio-business, including intellectual property protection and commercialisation, venture capital, capital raising, contract negotiation and regulatory issues.

 

Medical Technology Association of Australia - Thursday, 24 February 2011

Organisation Name
Medical Technology Association of Australia

Organisation Category
Industry Association
Not-for-profit Institution/Organisation

Organisation Description
The Medical Technology Association of Australia (MTAA) is the national association representing companies in the medical technology industry. MTAA aims to ensure the benefits of modern, innovative and reliable medical technology are delivered effectively to provide better health outcomes to the Australian community.

MTAA represents manufacturers and suppliers of medical technology used in the diagnosis, prevention, treatment and management of disease and disability. The range of medical technology is diverse with products ranging from familiar items such as syringes and wound dressings, through to high-technology implanted devices such as pacemakers, defibrillators, hip and other orthopaedic implants. Products also include hospital equipment, diagnostic imaging equipment such as ultrasounds and magnetic resonance imaging machines, as well as diagnostic tests that detect disease.

MTAA members distribute approximately 70% of the non-pharmaceutical products used in the diagnosis and treatment of disease and disability in Australia. Our member companies also play a vital role in providing healthcare professionals with essential education and training to ensure safe and effective use of medical technology.

 

Fraunhofer Institute for Toxicology and Experimental Medicine - Thursday, 24 February 2011

Organisation Name
Fraunhofer Institute for Toxicology and Experimental Medicine

Organisation Category
Analytical/Pathology Laboratory
Bioanalytical Facility
Clinical Research Organisation
Clinical Trials Unit
Contract Research Organisation
GMP/Quality Management Consultancy
Government
Medical Research Institute
Not-for-profit Institution/Organisation
Preclinical Facility
Research Institution

Organisation Description
At the Fraunhofer ITEM, expertise in various disciplines such as toxicology, human and veterinary medicine, biology, chemistry and physics forms the basis for comprehensive contract research work and services. With regard to inflammatory and allergic diseases of the respiratory tract, the Institute offers research and development services from the molecular level, up to clinical trials.

Main areas of work
Human health is the focus of research at the Fraunhofer ITEM. IN the area of preventive medicine all relevant topics are covered. Research into cause and effect processes and development of methods and concepts for disease diagnosis and therapy play an important role. In in-vitro and in-vivo models, we study primarily substances that are taken up via the airways.
Methods of biochemistry, molecular biology, immunotoxicology and histopathology are used to elucidate mechanisms of action.

GXP – top-level quality
The acronym GXP collectively refers to quality assurance systems that are legally required and
implemented at the Institute: GLP (Good Laboratory Practice), GCP (Good Clinical Practice) and GMP (Good Manufacturing Practice).

Clinical studies for the indication airway diseases
For the registration of pharmaceuticals for the indications allergy, asthma and COPD, the Fraunhofer ITEM conducts clinical studies phases I-II.

 

MediQ - Thursday, 17 February 2011

Organisation Name
MediQ

Organisation Category
Industry Forum/Group

Organisation Description
MediQ (formerly known as Queensland Pharmaceuticals & Nutraceuticals Industry Forum - QPNIF) is an industry led action group that will champion strategy development, drive research, build networks
and support the future growth and success of Queensland therapeutic medicines.

Formed in 2006 with the support of Queensland Government, MediQ was initially formed to facilitate a skills formation strategy for the Queensland pharmaceutical and complementary medicines sector.
 

 

Griffith University Eskitis Institute - Thursday, 17 February 2011

Organisation Description
Griffith University Eskitis Institute

Organisation Category
Compound Library
Research Institution
Tissue Bank
University

Organisation Description
The Eskitis Institute for Cell and Molecular Therapies investigates novel therapies for human diseases in the thematic areas of cancer, neglected and infectious disease, neurodegenerative diseases and stem cell biology. Eskitis offers a range of unique opportunities.

Eskitis is home to Nature Bank, a unique library of over 200,000 optimized, prefractionated natural product extracts, available for external screening or screening on our fully-equipped high-throughput screening centre. Eskitis can provide fully characterised lead compounds active against a drug target.Commercial partners include Pfizer, Actelion and Creative Antibiotics.
 

 

Ernst and Young - Thursday, 10 February 2011

Organisation Name
Ernst & Young

Organisation Category
Professional Services

Organisation Description

How we make a difference
Ernst & Young is a global leader in assurance, tax, transaction and advisory services.

Working with our clients
It all starts with our own people - 135,000 talented individuals globally and 5,000 in Australia. We bring together the right people with the right skills, experience and insights to meet your needs. Working with you in a collaborative style, we gain a clear understanding of your organisation. We work to anticipate trends, identify implications and identify issues before they become problems. You get the
people you need, wherever in the world you need them, backed up by leading practices, world-class methodologies and tools.

Developing people
We attract talented people from diverse backgrounds. As business challenges become more complex, we need to call upon the widest spectrum of views and opinions to address them. We want our people to continue to succeed personally and professionally throughout  their careers so we offer great learning and development opportunities through formal classroom learning, coaching
and mentoring. And we believe you can’t beat real world experience - doing high quality work, which is both interesting and challenging, and brings out the best in people. It also means we make a real difference to our clients, our communities and our profession.

Strengthening communities
We help to improve regulatory regimes and company reporting models. We promote transparency in financial reporting and good corporate governance. We encourage and support entrepreneurship, which leads to growth, jobs and prosperous communities. Our people give their time and share their business skills and knowledge to help not-for-profit organisations address the issues and needs that confront our local communities and to create positive social change.
Our commitment to the Life Sciences Industry & experience for changing times
More than any other technology, life sciences has the potential to alter our lives in a positive way. And by achieving this potential, today’s life sciences companies are delivering new levels of health, prosperity and sustainability - across the world. But with increasing regulation, growing pricing and pressures and competition for acquisitions, you face unprecedented challenges. Ernst & Young has
been a pioneering presence in the life sciences industry. We were the first professional services firm to build a practice dedicated to serving your industry. We’ve stayed committed to your business with our leading reports and our knowledgeable professionals. So it’s not surprising that we serve more
life sciences companies than any other professional services firm - by a wide margin. The Ernst & Young Global Life Sciences Centre reflects our continuing commitment to life sciences. It develops our thought leadership and brings you clear insights to address your assurance, tax, transaction and advisory needs. And it networks and educates our life sciences professionals from around the world,
so they are informed about the emerging issues impacting your business.

The bottom line?
You receive a consistent, high-quality, seamless service - wherever you operate - and the help you need to meet your goals.

 

Mental Health Service, Metro South Health Service District - Thursday, 10 February 2011

Organisation Name
Mental Health Service, Metro South Health Service District

Organisation Category
Government - State

Organisation Description
The Mental Health Service, Metro South Health Service District is the largest mental health service in Queensland. It has Level 6 capability in relation to several areas including early psychosis, deafness and trans-cultural mental health services.

 

DLA Phillips Fox - Friday, 4 February 2011

Organisation Name
DLA Phillips Fox

Organisation Category
Legal & Patent Attorneys

Organisation Description
DLA Phillips Fox has a leading life sciences and health practice across Australia and New Zealand.
Our lawyers include those with medical degrees, scientific and technical training in molecular biology,
pharmacology, chemistry and medicine which enables us to better understand the technology and
developments within the sector. Our strength lies in our ability to add value at each stage of the
technology cycle by providing practical and solution driven legal advice. We are able to offer global
insights and service provision through our exclusive alliance with DLA Piper. DLA Piper is one of the
world’s largest law firms and has a leading life sciences group.

 

Emphron - Friday, 4 February 2011

Organisation Name
Emphron Informatics Pty Ltd

Organisation Category
Contract Research Organisation
IT Solutions Provider

Organisation Description
Clinical Trial Statistics
Emphron Informatics provide high level statistical consultancy to ensure that trial protocols satisfy the complex set of clinical, regulatory and commercial objectives which you face. We understand your
business problems, and we deliver effective solutions.

We also provide full service biostatistics analysis and clinical SAS programming for clinical trials,
covered by a comprehensive and established set of standard operating procedures.

We have experience across the spectrum of clinical research, from investigator-led clinical studies
through to phase III trials, and across many therapeutic areas.

Diagnostics
We have solid experience in the discovery and development of diagnostics. We operate across the
spectrum from discovery using modern genomic and proteomic platforms, through assay optimisation
to the design and analysis of diagnostic clinical trials. We have experience negotiating the design of
diagnostic trials with the FDA.

Genomics and Proteomics
We have substantial experience across the range of genomic platforms including: Illumina,
Combimatrix, Affymetrix and RTPCR based platforms. We cover the spectrum of activities through
study design, data management, quality assurance, differential expression, ontology analysis and
study reporting. We use state-of-the-art tools and techniques.

We also have experience in a range of proteomic technologies including mass spectroscopy, 2D
electrophoresis gels, FACS and antibody arrays.

Web Services
We have experience in developing and deploying GMP-compliant on-line diagnostic and analysis tools.

 

ERA Consulting - Friday, 4 February 2011

Organisation Name
ERA Consulting (Australia) Pty Ltd

Organisation Category
Biotech Consultancy Organisation
Regulatory Consultancy

Organisation Description
From its foundations in 1987, the ERA Consulting Group is now one of the longest established and most experienced global scientific/regulatory consulting groups for human medicines. Over the past 23 years ERA has consulted on over 400 drug and biotech/biological therapeutic products. With offices in Washington DC, London, Germany and Australia, our internationally experienced team can offer:
• Advice covering Australian, US and European regulatory expectations for drugs and biologics
• Advice on product development for high-tech biotech/biological and gene/cell therapy products
• Review of quality (manufacturing and control), non-clinical and clinical documentation for regulatory compliance
• Guidance and interaction with regulatory agencies worldwide
• Writing of clinical trial applications (IND, CTX and CTA), expert reports and registration dossiers for Australia Europe and the USA
• Biomarker validation and qualification with the FDA and EMEA
ERA’s mission is to add value to a client’s project and identify the most expeditious developmental and regulatory pathways.

We achieve this in a variety of ways. Our contribution may be in minimising the time to marketing authorisation of a product through adding resources to the client’s team and bringing creative ideas to the project. In other cases ERA’s input is to identifiy potential opportunitie in the preclinical development phase whilset ensuring that potential problems are avoided and costly delays are prevented.

 

Trialfacts - Friday, 4 February 2011

Organisation Name             
TrialFacts

Organisation Category
Patient Recruitment Organisation
 
Organisation Description
Trialfacts increases the competitiveness of local industry by partnering with research organisations to ensure trials are completed on or ahead of schedule, and rescue trials which have suffered delays. Trialfacts does this by combining our extensive marketing and advertising expertise with our in-depth clinical trial experience to create effective marketing solutions that adhere to GCP and HREC requirements.
 
Trialfacts provides a full range of marketing services as well as predefined solutions tailored to individual investigator sites or smaller studies. For CRO’s and sponsors Trialfacts provides an end to end recruitment solution with a continual focus on ROI to drive down cost per randomisation, which can include the following services:
 
•               Marketing strategy & campaign development
•               Advertisement creative and promotional material, including study specific websites
•               Online advertising
•               Database marketing
•               Traditional media buying (newspaper, other publications, radio, TV etc)agency
•               PR and media relations
•               Social media strategies
•               Online automated and offline call centre screening
•               Retention campaigns & study communications via email, SMS, phone, post and online questionnaires
 
A prime focus of Trialfacts’ since 2007 has been to build a database of qualified patients across Australia and New Zealand that would like to take part in clinical research. This database now exceeds 25,000 patients.
 

Microsoft - Friday, 4 February 2011

Organisation Name
Microsoft Pty Ltd

Organisation Category
IT Solutions Provider

Organisation Description
Microsoft is committed to improving health around the world through software innovation. Over the past twelve years Microsoft has steadily increased its investments in health, with a focus on addressing the challenges of health providers, health and social services organisations, payers, consumers and
life sciences companies, worldwide. Microsoft closely collaborates with a broad ecosystem of partners and develops its own powerful health solutions, such as Amalga and HealthVault. Together, Microsoft and its industry partners are working to advance a vision of unifying health information and making it more readily available, ensuring the best quality of life and affordable care for everyone.
At Microsoft, we envision a powerful future for healthcare – a dynamic health system that puts people in control of their own health data and gives clinicians the information they need to focus on prevention and personalised care. We believe healthcare can become a learning system of constant improvement. To make the future a reality today, healthcare organisations need to consolidate their data in one place
giving clinicians authorised access to all the information they need to make informed decisions.
At Microsoft, we can help you achieve this through our comprehensive set of solutions that help
connect consumers and healthcare organisations to the secure data they need.

 

Metro South Oral Health Service - Friday, 4 February 2011

Organisation Name
Metro South Oral Health Service

Organisation Category
Government - State

Organisation Description
The Metro South Oral Health Service is the largest oral health service in the State. The Service provides hospital/community based (adult) and school based (child/adolescent) primary oral health care services and a range of secondary and specialist care services at more than 80 different facilities across the Health Service District.

The Oral Health Service also provides, and or manages, services provided at oral health locations external to the Metro South District and at a range of other external locations including correctional centres, prison farms and various hospitals. While a limited number of oral health services are provided under general anaesthetic within a hospital, the majority of services are delivered by multi-disciplinary teams in a range of ambulatory settings. A range of occupational groups are employed as follows:

• clinicians: dentists, dental specialists, oral health therapists, dental therapists, dental prosthetists
• clinical support staff: dental assistants, nurses
• non-clinical support staff: dental technicians, operational officers, administrative officers.

 

DevDX Clinical - Thursday, 6 January 2011

 

 

Organisation Category
Biotech Consultancy Organisation
Clinical Research Organisation
Contract Research Organisation
Regulatory Consultancy
Research Organisation
Study Management Organisation

List of Services
Australian Clinical Trial Sponsorship
Bioinformatics
Biostatistical Analysis
Contract Research Services
Clinical Data Management
Clinical Monitoring
Clinical Project Management
Clinical Trial Administration
Clinical Trial Management & Logistics
Diagnostic Development & Delivery
Medical Writing
Product Development Strategy
Project Management Services
Protocol Review & Amendment Services
Regulatory Consultancy
Training


Organisation Description
DevDx Clinical is a full–service CRO dedicated to clinical diagnostics and medical devices. We
understand that device and IVD trials are markedly different from pharma trials, and call for very
different approaches. For most CROs these trials are a small part of the portfolio – for DevDx Clinical
they are our core business.


With decades of experience covering all phases of product development we understand the often
competing clinical, commercial and regulatory drivers. We will work collaboratively with your team to
ensure successful delivery of your project.
We are equally adept at managing a complete clinical trial program or a specific project and have
detailed knowledge of clinical evidence regulatory requirements for Australia, USA, Asia and Europe.
We are as skilled in modern biotechnology as we are in regulatory process.

Our Services include:
• Global Clinical Program Strategy
• Clinical Trial Design and Planning
• Ethics Submissions and Regulatory Affairs
• Monitoring and Project Management
• Biostatistical Analysis and Data Management
• Medical Writing and Reporting
• Software Development
• Training

Your product will face many regulatory hurdles and risks throughout its development cycle. Talk to
DevDx Clinical – the CRO with professionalism and specialist expertise that complements your own.

 

 

 

Neuromathix - Thursday, 6 January 2011

Organisation Category
Bioanalytical Facility
Clinical Research Software Company
Medical Device Company

List of Services
Bioinformatics
Computational Tools
Mathematics Modelling
Pharmacokinetic Analysis
Therapy Area Experience
CNS/Neurology
Endocrinology

Organisation Description
Neuromathix is a medical/IT company, designing software-based solutions to enhance drug
effectiveness across the entire lifecycle, from design and trialling to clinical deployment, with an
emphasis on chronic or degenerative diseases. Using patented technologies originally sourced from
advanced engineering applications, Neuromathix has developed software that enables reconstruction
of complex pharmacokinetic and pharmacodynamic systems, using appropriate fragments of timeseries
data. This is done using algorithms originally sourced from advanced robotics, running on
high-performance computers. The result is a patient-specific disease model, using patient-specific
parameters.

Using these parameter estimates, combined with algorithms originally sourced from aerospace
guidance and control, our software can generate appropriate, patient-specific medication programmes
to maintain drug concentrations within a specified therapeutic window.
As of October 2009 the company has been awarded Medical Devices Financial Incentive Program
(MDFIP) funding from Queensland Health, to enable development of prototype software that uses highperformance
computing to analyse patient data, to deliver improved personalised insulin medication
for “brittle” type-1 diabetics.

The company now has a dedicated supercomputer, built on the Nvidia Tesla GPU architecture, to
assist in development of its technologies.

 

Office of Health and Medical Research - Thursday, 23 December 2010

Office of Health and Medical Research

Organisation Category
Government - State

List of Services
Clinical Trial Administration
Commercialisation Services
Ethics Committee
IP Management

Organisation Description
The Office of Health and Medical Research (OHMR) was established in 2008 to support a skilled health research workforce, to improve the translation of research into practice, to provide clear leadership for health and medical R&D in Queensland, and to foster collaboration across the sector. Although it sits within Queensland Health, it has a broad focus on the health and medical research sector across Queensland including research institutes, universities and the health care system.
OHMR works closely with the Department of Employment, Economic Development and Innovation to ensure Queensland’s health and medical research sector delivers the dual outcomes of a healthy population and economic prosperity.

 

Davies Collison Cave - Thursday, 23 December 2010

Davies Collison Cave

Organisation Category
Legal & Patent Attorneys
Patent and Trade Mark Attorneys

List of Services
IP Management
Therapy Area Experience
Immunology

Organisation Description
Davies Collison Cave is the largest patent and trade mark attorney firm in Australia and the first patent and trade mark attorney firm to open an associated law firm. Davies Collison Cave provides an extensive range of strategically-focussed intellectual property services including expert advice in patents, trade marks, domain names, trade secrets, copyright and design protection, as well as licensing, litigation and related legal and commercial matters. The firm has more than 70 lawyers,
trade mark attorneys and patent attorneys engaged solely in intellectual property matters who are led by 37 partners throughout five Australian offices - Melbourne, Sydney, Brisbane, Canberra and Newcastle.

Davies Collison Cave Patent division has unrivalled experience in all technical areas including biotechnology, life sciences, medical devices, nanotechnology, chemistry, materials science and physics.

To ensure that we provide and maintain the highest level of service to our clients, many of our personnel hold doctoral degrees and have the ability to approach matters from both a technical and legal perspective. Our policy is to engage personnel who have superior standards of academic excellence and commercial acumen.

Davies Collison Cave continues to be Australia’s largest filer of Patents and Trade Marks and has been voted the No.1 patent and trade mark attorney firm in Australia by both Australasian Legal Business, Managing Intellectual Property and Worldleaders numerous times.

 

Cullens Patent and Trade Mark Attorneys - Thursday, 16 December 2010

Cullens Patent and Trade Mark Attorneys

Organisation Category
Legal & Patent & Trade Mark Attorneys

List of Services
IP Management
Freedom to operate and registrability searches
Legal Services

Organisation Description
With offices in Brisbane, the Gold Coast and Townsville, Cullens is Queensland’s longest established firm of patent and trade mark attorneys and a recognised leader in this field.

The firm represents a broad spectrum of clients, ranging from large multinational  corporations, universities and government departments to individual start-up entrepreneurs.
Cullens’ life sciences and applied chemistry & pharmaceuticals practice groups comprise attorneys with doctorates, and those attorneys are affiliated with a broad range of industry, government and educational groups.

The firm provides comprehensive specialist advisory and legal protection services in relation to intellectual property (IP), including:
• Patent literature and non-patent (eg. scientific) literature searches
• Freedom to operate searches and advice
• IP ownership advice
• Patentability and registrability searches and advice
• Preparing, filing and prosecuting patent, trade mark and design applications in Australia and
abroad
• Infringement and validity advice
• Industrial copyright and domain name advice
• Oppositions
• Litigation management
• Monitoring competitors’ IP
• IP audits
• Managing IP portfolios
• Licensing and other IP-based agreements


We take a practical objective-orientated approach with our clients, seeking to achieve their goals in a timely and cost-effective manner.

 

Perkins Resources Pty Ltd - Thursday, 16 December 2010

Organisation Category
Recruitment Company

List of Services
Human Resource Services/Recruitment

Organisation Description
Established in 2003, Perkins Resources aims to deliver high quality, value-added executive search & selection and scientific placement services to organisations and companies involved in science, technology and innovation. Based on an understanding of the complexities of the emerging sciences and the multiple talents that are required of the people employed in these areas, Perkins Resources brings together the expertise of the executive search and selection industry with a broad based knowledge of the science industry.

Perkins Resources can deliver search, selection & placement services for a variety of roles, such as:
• Board Level Positions – Chairman & Company Directors
• Executive Roles – Private & Public Companies, Research Institutes & Government funded entities
(e.g. CRC’s)
• Senior Academic Positions
• Business Development & Commercialisation Managers
• Senior Sales & Marketing Roles
• Senior Research Roles

In addition, Perkins Resources has advised various companies and organisations on relevant human resources issues such as the structure of their boards, defining the roles of Chairman, Directors and Executives and the reorganisation of senior management teams and relevant position descriptions.

With offices in Melbourne and Brisbane and a team of consultants working across a variety f industry sectors and at different management levels, Perkins Resources provides a service focused on the growth and needs of individual organisations and companies. The company has an established database of high quality candidates and significant national industry networks, as well as access to international networks where required. In addition to working on individual assignments, the company is able to redeploy a team of consultants for more complex assignments.

 

Core Research Group - Tuesday, 7 December 2010

Core Research Group
Organisation Category
Clinical Research Organisation
Study Management Organisation
 
 
List of Services
Biostatistical Analysis
Clinical Data Management
Clinical Monitoring
Clinical Project Management
Medical Writing
Treatment of Subjects (Context of Phase I/II Trials)
Treatment of Subjects (Context of Phase III/IV Trials)
 
 
Therapy Experience
Cardiovascular
Endocrinology
Women’s Health
 
 
 
Organisation Description
Core Research Group Pty Ltd is a clinical trial organization specializing in Cardiology, Endocrinology
and Women’s Health. We pride ourselves on patient recruitment and our wide network of specialists
and general practitioners which enable us to draw upon a larger pool of potential participants than
many of our competitors.
 
Our young, friendly and experienced staff have also been able to maintain very low rates of noncompliance and drop-out rates even over long term trials.
 
We have recently strengthened our internal auditing and data management procedures to ensure that
our data remains tight and protocol deviations are kept to an absolute minimum. We have two main
clinical trial teams who specialize in high intensity short-medium term trials and longer term, more
detailed studies respectively.
 
All our staff are trained in the latest ICH-GCP guidelines and the Helsinki statement on Clinical
Research involving Humans. All our senior study coordinators are members of ARCS and keep up to
date with the latest methodology in the field.
 
Our clinical team enjoy a challenge and are particularly excited to be involved in new and innovative
medical research in the broader community
 

 

Princess Alexandra Hospital Centres for Health Research - Tuesday, 7 December 2010

 
 
Princess Alexandra Hospital Centres for Health Research
 
Organisation Category
Government – State
Not-for-profit Institution/Organisation
Research Institution
Research Organisation
Tertiary Teaching Hospital (public sector) Research
 
 
List of Services
Biomarkers
Biomarkers Discovery
Biostatistical Analysis
Clinical Data Management
Clinical Monitoring
Clinical Research
Clinical Trial Administration
Drug Delivery
Drug Discovery
Ethics Committee
Medical Research
Pharmaceuticals & Toxicology
Pharmacogenetics
Pharmacogenomics
Pharmacokinetic Analysis
Preclinical Research
Protocol Review & Amendment Services
Quality Assurance
Tissue Banking
Translational Medicine
Treatment of Subjects (Context of Phase I/II Trials)
Treatment of Subjects (Context of Phase III/IV Trials)
 
 
Therapy Experience
Allergy
Anaesthesiology
Anti-infectious
Autoimmune Disease
Cardio-electrophysiology
Cardiology
Cardiovascular
Complementary Medicines
Dermatology
Devices
Endocrinology
Gastroenterology
General Medicine
Geriatric Medicine
Haematology
Hypertension
Immunology
Infectious Diseases
Intensive Care
Lymphoma
Men’s Health
Multiple Sclerosis
Neurogenetic Disorders
Oncology
Ophthalmology
Orthopaedics
Osteoporosis
Otolaryngology
Pathology
Physiotherapy
Psychiatry
Radiology
Renal Medicine
Respiratory/Pulmonary
Rheumatology
Stem Cell Research
Stroke
Surgery
Transplantation
Urology
Vaccines
Vision
 
 
Organisation Description
The Princess Alexandra Hospital is a pre-eminent research and teaching hospital and is a major contributor to national and international clinical research. A strong research culture with active programs prevails in basic science, clinical, and health services research. The theme of all research is translational, utilising research based understanding of disease processes and developing new treatments and therapies to improve the health of the community. Clinician researchers undertake an extensive range of investigator-initiated and collaborative research programs including Phase I / IV
sponsored clinical trials.
 
 

 

QCGC Research - Monday, 6 December 2010

 
QCGC Research
 
Organisation Category
Clinical Research Organisation
Clinical Trials Unit
Dedicated Clinical Trials Centre (as part of a public or private hospital)
Research Institution
Research Organisation
 
 
List of Services
Clinical Research
Medical Research
Treatment of Subjects (Context of Phase III/IV Trials)
 
 
Therapy Experience
Gynaecological Oncology
Oncology
Surgery
Women’s Health
 
 
 
Organisation Description
 
The Queensland Centre for Gynaecological Cancer (QCGC) is a state-wide service for the management of women with gynaecological cancer (cancer of the ovaries, the uterus, the cervix, the vulva and vagina).
 
QCGC works in partnership with Queensland Health for the State’s gynaecological cancer services. QCGC is lead by a Director and seven gynaecological oncologists providing services to major hospitals in Brisbane. The team also travels regularly to regional Queensland, particularly Gold Coast, Sunshine Coast, Toowoomba and Darling Downs, Far North Queensland and the Northern Territory.
 
QCGC Research is the research branch of QCGC and is an academic (non-profit) institution situated at the Royal Brisbane and Women’s Hospital (Herston, Brisbane). Its research funds are administered through The University of Queensland, School of Medicine.
 
QCGC Research’s mission is to develop the best standard of care for women experiencing gynaecological cancer. We focus on conducting surgical clinical trials in the field of gynaecological cancer but we also perform groundbreaking work outside the conventional clinical trials framework.
 
This may include finding causes for and preventing gynaecological cancer or finding better treatment options to cure women affected by gynaecological cancer.
 

 

Constellation BioConsulting - Monday, 6 December 2010

 
Constellation BioConsulting
Organisation Category
Biotech Consultancy Organisation
IT Solutions Provider
Regulatory Consultancy
 
 
List of Services
 
Investment and Strategy
Regulatory and Market Intelligence
Product Development Strategy
Technical and Regulatory Due Diligence
Investment Readiness
 
Product Development
Biologicals/Drugs/Devices/IVDs
Risk Management
Pharmacogenomics
Biomarker development and qualification
Diagnostic Development & Delivery
Master File/Technical Files
Labelling/IFU/advertising
Clinical Trials:
– IND, IDE, CTX etc.
Regulatory dossiers, submissions
and Agency Interactions:
– NDA, 510 (k), PMA, CE Marking and Medical and Scientific Writing product listings
 
Market Access
Reimbursement submissions
Market representative services including US agent
Quality Systems
Gap analyses
Implement and manage QMS
– (ISO 9001, ISO 13485 and FDA CFR
820, ICH, ISO 17025, EDQM)
Training and Education
Internal auditing
External Audit preparation
Vendor assessment and management
 
Compliance Management
Vigilance, Customer Feedback
Adverse events and reaction reporting
Recalls
 
Technical and Scientific Services
Biostatistical Analysis
Literature Reviews
Computational Tools
ISO 14971 risk assessment, biological safety,
standards compliance
Expert reports
IT Services
 
 
 
Therapy Experience
All areas
 
 
 
Organisation Description
 
Constellation BioConsulting is an alliance between the leading providers of strategic advice to
companies developing drug, biological and medical device products. Constellation Bioconsulting acts
as a local, accessible hub of expertise for groups that require advice and/or support with their product
development program.
 
Products include:
• Drugs and Biologics
• Medical Devices and Diagnostics
• Drug/Device Combination Products
 
With globally experienced consultants based in Australia, we are able to add value to a local company’s development plan by providing them with a considered international approach. Our alliance members work alongside virtual companies through to the most established pharma organisations inthe industry. So whether your projects are small or large, we have the required creative thinking and depth of practical knowledge to enhance and advance your development program.
 
 

 

Community and Primary Health Services, Metro South Health Service District - Monday, 29 November 2010

Community and Primary Health Services, Metro South Health Service District

Organisation Category
Community and Primary Health Division
Government - State

Services
Clinical Monitoring Medical Research
Clinical Project Management
Clinical Research
Drug Delivery
Medical Research
Paediatric Clinical Trials
Patient Screening
Training
 
 
 
Therapy Area Experience
Cardiology
Paediatrics
Cardiovascular
Pain
Drug and Alcohol
Physiotherapy
Endocrinology
Primary Health
General Medicine
Radiology
Geriatric Medicine
Refugee Health
Hypertension
Respiratory/Pulmonary
Indigenous Health
Stroke
Infectious Diseases
Vaccines
Men’s Health
Women’s Health
Multiple Areas
 
 
The District provides an extensive and comprehensive range of community and primary health services for a population base of over 1 million residents.
 
The Division of Community and Primary Health Services is the main provider of Queensland Health funded community and primary health services to the residents of Metro South Health Service District.
 
This includes the provision of services to patients of the Mater Hospital Group who are residents of Metro South Health Service District or require community-hospital interface services before being discharged to their district of residence across Queensland.
 
The division also manages a large, Queensland Health funded Residential Aged Care service. The Division has established strong partnerships with Griffith University, Queensland University and Queensland University of Technology in research activities.
 
Specific services that are provided include:
Residential Aged Care
Post-Acute and Palliative Care
Community: Hospital Interface Program
Hospital in the Home Program
Hospital in the Nursing Home Program
Home and Community Care
Aged Care Assessment Team
Aged Care-Dementia, Incontinence Coordination
Multicultural Services
Transition Care Program
Indigenous Health
Community interpreter services
Health Information Services
Community rehabilitation
Service Planning and Development
Breast Screen
Alcohol & Drug
Sexual Health
Child & Youth
Chronic Disease
Aboriginal & Torres Strait Island Health Worker
 
 

Q-Gen - Monday, 29 November 2010

 
Q-Gen Pty Ltd
 
Organisation Category
Manufacturing Facility
Contract Manufacturing Organisation
 
List of Services
Cellular Therapies
Production & Sterile Manufacture
Therapy Area Experience
Cellular vaccines
Haematology
Lymphoma
Multiple Areas
Oncology
Stem Cell Research
 
Q-Gen offers a suite of clean rooms and support services for the manufacture of cellular therapies for clinical studies. The company has conducted numerous Phase I-III clinical studies since 2002 utilising novel approaches to cell therapy research, pioneered through QIMR’s world class research. Q-Gen operates under a TGA licensed quality system that encompasses all facets of production, quality control and facility oversight.

 

Clinitec - Monday, 15 November 2010

Organisation Category
Clinical Research Software Company
IT Solutions Provider

Services
IT Services 

Therapy Area Experience
Clinitec’s systems are suitable for all therapeutic areas. Clinitec is an independent Australian provider of interactive voice response (IVRS) and web services (IWRS) for Clinical Trials.

Clinitec’s cost effective IVRS and IWRS solutions for clinical trial management and medication compliance including:

  • • Screening
  • • Randomisation
  • • Emergency unblinding
  • • Drug supply
  • • Site management
  • • Patient diaries

Clinitec is backed by more than 15 years experience in developing IVRS/IWRS and is able to extend the functionality and features of Clinitec in line with your needs. Provided as a hosted service, the system can be used for Phase I-IV trials across one or more countries in multiple languages. Other features include 24/7 support, easy to use interface, regulatory compliance and fast implementation time.
 

 

Q-Pharm Pty Ltd - Monday, 15 November 2010

Organisation Category
Clinical Research Organisation
Clinical Trials Unit
Contract Research Organisation
 

List of Services
Bioequivalence studies
Clinical Data Management
Clinical Project Management
Clinical Research
Clinical Trial Management & Logistics
Clinical Trial Site Services
Medical Writing
Pharmacokinetic Analysis
Treatment of Subjects (Context of Phase 0 Trials)
Treatment of Subjects (Context of Phase I/II Trials)
  
  
Therapy Area Experience
Anaesthesiology
Anti-infectious
Cardiovascular
CNS/Neurology
Complementary Medicines
Endocrinology
Gastroenterology
Immunology
Infectious Diseases  
Medical Imaging (monoclonal antibodies)
Oncology
Orthopaedics
Psychiatry
Respiratory/Pulmonary
Rheumatology
Vaccines
Volunteers
Women’s Health


Q-Pharm specialises in the conduct of early phase (Phases 1 and 2) clinical trials and bioequivalence & bioavailability studies. The company conducts trials on pharmaceutical, biotechnology and complementary medicine products spanning the areas of therapeutic, diagnostic and prophylactic agents. We provide a comprehensive, high quality service to our clients, and conduct clinical trials in accordance with all applicable national and international standards and guidelines. Q-Pharm’s clients include local and international companies from the pharmaceutical and biotechnology industries. Many of the clinical studies conducted at Q-Pharm have been accepted internationally for submissions to regulators in Australasia, Europe and the Americas.

Q-Pharm offers the best appointed early phase clinical trials facilities in Australasia. Our facilities include a dedicated outpatient and recruitment clinic, a specialized 18-bed clinic for the conduct of the most medically demanding trials and an open plan 24 bed facility for larger healthy volunteer trials. Q-Pharm also enjoys a strategic alliance with Tetra-Q, who offer a full range of bioanalytical services to complement our clinic-based services. Q-Pharm’s strength is its highly-qualified clinical trial team, whose leaders have a wealth of experience in clinical development including the management and conduct of over 250 bioequivalence and other pharmacokinetic studies at Q-Pharm. This experience enables Q-Pharm to understand the needs of our diverse range of clients and thereby deliver on time the highest quality clinical services.
 

 

Clinical Network Services (CNS) - Monday, 1 November 2010

Organisation Category
Clinical Research Organisation
Contract Research Organisation
Research Organisation

List of Services
Australian Clinical Trial Sponsorship Bioassays
Biostatistical Analysis
Clinical Data Management
Clinical Monitoring
Clinical Project Management
Clinical Trial Administration
Clinical Trial Management & Logistics
Contract Research Services  IP Management
Medical Writing
Nutraceutical
Product Development Strategy
Project Management Services
Protocol Review & Amendment Services Quality Assurance
Regulatory Consultancy
Training

Therapy Area Experience
CNS provides early phase clinical management services in drug, device and nutraceutical product development across all therapeutic areas.

CNS is an Australian Contract Research Organisation (CRO), focused on providing full service clinical management to the international healthcare community particularly during the early phase (Phase I and Phase II) clinical development of their products. Since 1998, CNS has established itself as Australia’s leading early phase Australian CRO working both nationally with dedicated phase I units and hospital groups as well as internationally with its strategic partners, in New Zealand, Europe, USA and Canada. In addition to its early phase expertise, CNS also supports its partners by acting as their Australasian partner where their clients require Australasia to support global phase III & IV studies.

Based in Brisbane, CNS has worked on over 100 projects for over 70 different clients, mainly from the US but increasing European and Australian. Also over this period CNS has expanded from providing study management and national clinical monitoring to a full range of services from protocol/IB development, through study start up, selection of sites with capacity to run early phase (0 – IIa) studies, monitoring and overall study management concluding with full Data Management/Biostatistics and Clinical Study Report writing. Furthermore, CNS now provides QA services and continues to support ACRP training and Accreditation.
 

Read more...

 

 

Quality Matters, Safety Matters - Monday, 1 November 2010


Organisation Category
Biotech Consultancy Organisation
Commercialisation company
Complementary/Nutraceutical Company
GMP/Quality Management Consultancy
Regulatory Consultancy
 

List of Services
Commercialisation Services
Contract Manufacturing/Scale-up
Product Development Strategy
Product Listing and Registration
Quality Assurance
Regulatory Consultancy
Training
  
Therapy Area Experience
Complementary Medicines
Dermatology
Devices Nutraceutical
Pain
20+ years Specialist Expertise in:
• Pharmaceutical / Biotechnology / Complementary Medicines / Personal Care /Analytical /Microbiology;
• Quality Product Development and Manufacture;
• Pharmaceutical Quality Assurance cGMP (Sterile manufacture through to topical and veterinary products);
• Dream fruition, facilitating the pathway from ideas to realisation, Product Innovation, Design and Manufacture;
• Quality Systems Design, Implementation and Management;
• GMP Training and Implementation;
• Process Validations;
• Regulatory Affairs, TGA, APVMA, NICNAS, WHSQ, DGM, etc;
• Safety Management, Industrial;
• Project Management and Trouble Shooting.

Read more...
 

 

Centre for Nutraceutical and Medical Research - Monday, 25 October 2010

Organisation Category

Clinical Research Organisation
Clinical Trials Unit
Complementary/Nutraceutical Company
Contract Research Organisation
Medical Cooperative Group
Medical Research Institute
Regulatory Consultancy
Research Institution
Research Organisation

Services

Biostatistical Analysis
Biotech Consultancy Services
Clinical Monitoring
Clinical Project Management
Clinical Research
Clinical Research Network
Clinical Trial Administration
Clinical Trial Management & Logistics
Clinical Trial Site Services
Contract Research Services
Literature Reviews
Medical Research
Nutraceutical
Patient Recruitment
Patient Screening
Product Development Strategy
Product Listing & Registration
Protocol Review & Amendment Services
Regulatory Consultancy
Training
Treatment of Subjects (Context of Phase I/II Trials)
Treatment of Subjects (Context of Phase III/IV Trials)

Therapy Area Experience

Complementary Medicines
General Medicine
 Multiple Areas
Nutraceutical

The Centre for Nutraceutical and Medical Research (CNMR) is the point of contact for any company looking to conduct medical research on a nutraceutical product.

CNMR is a collaboration of highly regarded specialist nutraceutical and medical researchers. The team comprises university researchers, physicians, specialists, contract research organisations, and regulatory consultants.

The strength of the centre is the ability to combine medical specialists with research at the forefront of Nutraceutical innovation. We recognise the value of nutraceuticals working in combination with pharmaceuticals to treat and prevent disease.

CNMR specifically works in the areas of clinical trials, consulting, expert product appraisals, and education.

read more...

 

Queen Elizabeth II Jubilee Hospital - Monday, 25 October 2010

Organisation Category

Government – State
Public Hospital which undertakes some research and engages in some clinical trials

List of Services

Clinical Data Management
Clinical Monitoring
Clinical Project Management
Clinical Research
Clinical Trial Site Services
Ethics Committee
Human Resource Services/Recruitment
Medical Research
Quality Assurance

Therapy Area Experience

Anaesthesiology
Cardiology
Gastroenterology
General Medicine
Genitourinary
Geriatric Medicine
Gynaecology
Intensive Care
Ophthalmology
Orthopaedics
Pain
Pathology
Physiotherapy
Radiology
Respiratory/Pulmonary
Stroke
Surgery
Urology
Women’s Health

The Queen Elizabeth II (QEII) Jubilee Hospital is a Level 3-4 acute hospital and is part of the Metro South Health Service District. QEII Hospital is the general hospital for its immediate geographic area. It has approximately 140 beds and provides specialist services in general surgery, orthopaedics, urology, gynaecology, ophthalmology, general medicine, intensive care, geriatric, rehabilitation medicine and emergency services. Emergency Department presentations are approximately 35,000 per year.

read more...

 

Cairns Base Hospital - Monday, 18 October 2010

Organisation Category
Clinical Trials Unit
Dedicated Clinical Trials Centre (as part of a public or private hospital)

Services
Clinical Research

Therapy Area Experience
Anti-infectious
Cardiology
Cardiovascular
CNS/Neurology
Endocrinology
Gastroenterology
General Medicine
Haematology
Infectious Diseases
Intensive Care
Lymphoma
Oncology
Renal Medicine
Respiratory/Pulmonary
Rheumatology
Surgery
Transplantation
Vaccines

Cairns Base Hospital is situated in the tropical climate of far north Queensland. The hospital has 285 beds and 12 Intensive Care beds. The hospital services the Cape York area including the Torres Strait.
The Infectious Diseases Department has consistently had the highest enrolment in Australia for anti-infective drug trials. The respiratory studies conducted at our centre have always met or exceeded recruitment targets.

read more...

 

Queensland Brain Institute - Monday, 18 October 2010

Organisation Category
Research Institution 

Therapy Area Experience
CNS/Neurology
Multiple Sclerosis
Neurogenetic Disorders
Oncology
Pain
Stroke
 
The Queensland Brain Institute’s fundamental research in neuroscience plays a vital role in the ongoing development of improved treatments for a diverse range of diseases and conditions. QBI’s main therapeutic areas of research include spinal cord injury, motor neuron disease, brain tumour, dementia, developmental disorders, schizophrenia and multiple sclerosis. QBI scientists collaborate with treating physicians in each of these therapeutic areas.
To support their research, QBI scientists have access to world-class technology, including a neuroscience dedicated Flow Cytometry Facility, 16.4T MRI for animal imaging and 4.0T fMRI human brain scanner and Zeiss microscopy suite.

read more...

 

BrizBrain & Spine Research Foundation - Tuesday, 28 September 2010

Organisation Category

Medical Research Institute
Not-for-profit Institution/Organisation
Research Organisation

Services

Clinical Research
Medical Research
Treatment of Subjects (Context of Phase 0 Trials)
Treatment of Subjects (Context of Phase I/II Trials)

Therapy Area Experience

CNS/Neurology
Oncology
Surgery
 

The BrizBrain & Spine Research Foundation is a not-for-profit organisation and registered charity dedicated to advancing the treatment of brain conditions.

The foundation is constantly seeking to push the boundaries of research within the fields of spinal surgery and neurosurgery and it is only with the support of the community that they are able to continue their work.

Through research, the goal is to improve the treatment and post-operative care of patients so they can return to a normal life as quickly as possible.

To do this we need to evaluate our current treatment methods scientifically and methodically. This often raises new questions about what we can do better, and these new methods must be trialled in a precise and scientific manner. We need to discover and initiate new ideas, techniques and approaches, which requires research and development in our specialty area.

Our mission is to monitor effectiveness of current neurosurgical treatment, develop and assess new treatments for brain and spinal conditions, provide advanced training in neurosurgical research and surgery and provide a private source of funding for research and training in neurosurgery.

 read more ...

Queensland Clinical Trials & Biostatistics Centre - Tuesday, 28 September 2010

Organisation Category

Clinical Trials Unit
Research Institution    

Services

Bioinformatics
Biomarkers
Biostatistical Analysis
Biotech Consultancy Services
Clinical Data Management
Clinical Project Management
Clinical Research
Computational Tools
Contract Research Services
eCRF Development Mathematics Modelling
Medical Research
Pharmacokinetic Analysis
Professional Statistical Analysis & Reporting
Protocol Review & Amendment Services
Randomisation
Statistical Analysis Plans
Study Design
Training


Therapy Area Experience

Cardiovascular
Complementary Medicines
Devices
Diabetes
Endocrinology
General Medicine
Geriatric Medicine
Hypertension
Intensive Care
Multiple Areas
Obstetrics
Oncology  Orthopaedics
Osteoporosis
Paediatrics
Physiotherapy
Psychiatry
Radiology
Renal Medicine
Rheumatology
Stroke
Surgery
Transplantation
Vaccines

The Queensland Clinical Trials & Biostatistics Centre (QCTBC) was established by the University of Queensland in recognition of the need for a specialised centre to promote clinical trials and biostatistical research and services. QCTBC provides expertise and infrastructure to design, conduct, and facilitate high quality clinical studies and biostatistical research with academic and industry collaborators to improve human health outcomes. Services and expertise include clinical trials, clinical studies, biostatistical research, and biostatistical consulting.

The Centre has a depth of experience in many therapeutic areas, and welcomes collaborations with academic and industry researchers in any area of clinical trials research.

 read more ...

Brisbane South Clinical Research Centre - Monday, 20 September 2010

Organisation Category

Private Dedicated Clinical Trials Centre

Services

Clinical Research
Patient Recruitment
Patient Screening
Treatment of Subjects (Context of Phase I/II Trials)
Treatment of Subjects (Context of Phase III/IV Trials)

Therapy Area Experience

Allergy
Anti-infectious
Autoimmune Disease
Cardiovascular
Endocrinology
Gastroenterology
General Medicine
Hypertension
Infectious Diseases
Migraine Multiple Areas
Paediatrics
Pain
Psychiatry
Respiratory/Pulmonary
Rheumatology
Smoking Cessation
Vaccines
Volunteers

Brisbane South Clinical Research Centre is a small dedicated private clinical research centre conducting Phase II to Phase IV clinical trials for the pharmaceutical industry. We have been established 11 years with a good track record of meeting and exceeding recruitment targets. We have had a number of sponsor audits with excellent reports.

read more...

 

Queensland Emergency Medicine Research Foundation - Monday, 20 September 2010

Organisation Category

Research Funding Body
Research Organisation

Services

Clinical Research Network
Medical Research
Funding for Emergency Medicine Research

Therapy Area Experience

Allergy
Anaesthesiology
Anti-infectious
Autoimmune Disease
Cardio-electrophysiology
Cardiology
Cardiovascular
CNS/Neurology Dermatology
Devices
Emergency Medicine Endocrinology
Gastroenterology
General Medicine Genitourinary
Geriatric Medicine  Haematology
Hypertension
Immunology
Infectious Diseases
Intensive Care
Lymphoma
Men’s Health
Migraine
Multiple Areas
Multiple Sclerosis
Neurogenetic Disorders
Obstetrics
Oncology
Ophthalmology
Orthopaedics
Osteoporosis Otolaryngology
Paediatrics
Pain
Pathology
Physiotherapy
Psychiatry
Radiology
Renal Medicine
Respiratory/Pulmonary
Rheumatology
Stroke
Urology
Vision
Volunteers
Women’s Health


ADVANCING EMERGENCY MEDICINE
The Queensland Emergency Medicine Research Foundation is a newly established organisation with a mission to conduct and facilitate research relating to the practice of Emergency Medicine in Queensland. The purpose of the Foundation is to support high quality research directed at improving the care of patients in Emergency Departments and to develop Emergency Medicine research capacity in Queensland. The Foundation has tax-deductible status and is a Registered Charity. Seed and ongoing funding for the Foundation has been received from the Queensland Government.

read more...

 

Brisbane Marketing - Monday, 13 September 2010

Organisation Category

Government – Local
Inward Investment Agency

Services

Business Consultancy Services
Investment Consultancy Services  


Brisbane Marketing’s Investment Attraction division is the city’s experienced and world class inward investment agency. Established 24 years ago as the Office of Economic Development by the Lord Mayor of Brisbane, we have a strong track record in bringing new business to Brisbane and connecting local partners with international networks. We focus our efforts to attract Foreign Direct Investment (FDI) in six key sectors for which Brisbane has a national or international competitive advantage:

  • Digital Industries (including ICT, mining technology & services, and electronic games)
  • Food and Beverage R&D and Manufacturing
  • Logistics and Distribution
  • Innovative Manufacturing
  • Clean Technologies and Renewable Energy
  • Infrastructure

Our dedicated and experienced team, work with investors to determine how Brisbane fits with their future growth strategy for the Asia Pacific region. We provide critical introductions to extensive networks in the private sector, all levels of government and academia, talent and labour analysis, property solutions and advice regarding grants and incentives.

Supporting our work in FDI, we play an influential role in shaping the business environment – ensuring Brisbane remains a competitive destination for business investment.

Brisbane Marketing’s Investment Attraction Agency was awarded the “World’s Best Performing Investment Promotion Agency and World’s Best City Agency” by London based consultancy GDP Global Development in 2007/08.

In a further acknowledgement of our success, the London Financial Times fDi Magazine ranked Brisbane in the top two cities in the Asia-Pacific region for foreign direct investment strategy. Brisbane was also recognised in the overall ‘Top 10 Asian Cities of the Future 2009/10’ making it the first time the city has been ranked in the study – outshining 133 cities across the Asia Pacific region.

read more...

 

Queensland Facility for Advanced Bioinformatics - Monday, 13 September 2010

Organisation Category

Bioanalytical Facility
Not-for-profit Institution/Organisation
Research Organisation   

Services

Bioinformatics
Biostatistical Analysis
 
QFAB provides the opportunity for researchers from a range of disciplines to capture the value in the overwhelming amounts of data being generated in the biotechnology and healthcare domains. Working with the researchers QFAB can help uncover the information in that data and ultimately derive greater knowledge about the system of interest.

Underpinning the discovery process, bioinformatics is the catalyst for interdisciplinary knowledge management. With the blending of fundamental DNA sequence data, expression profiling, through to protein folding prediction, metabolomic modelling and statistical inference, innovation is accelerated through the application of the skills of the bioinformatician.

QFAB offers a range of workflow solutions, customised web services and over 400 bioinformatic tools through a unique collaborative interface which allows dispersed research groups to work seamlessly together. It supports the bioinformatics requirements of research-intensive companies, institutions and
universities including secure access to very large databases, specialist software, high-performance computing, terabyte storage, data integration technologies and expert services beyond the capability of any single institution or company in Australia.

With its dedicated group of bioinformatics professionals QFAB helps deliver enhanced outcomes to health related research projects.

read more...

 

Brisbane Convention & Exhibition Centre - Monday, 6 September 2010

Organisation Category

Convention Centre

Services

Food and beverage services
International conference bidding
Venue hire  

Brisbane Convention & Exhibition Centre is ideally located in a unique riverside urban arts and lifestyle precinct, home to Australia’s newest and largest Gallery of Modern Art, opera companies, symphony orchestras, performing arts and more than 30 sidewalk cafes and restaurants and a wide selection of stylish shops.

The Centre is Australia’s most awarded convention centre and is officially ranked among the top three convention centres world-wide by the Association Internationale des Palais de Congres (AIPC).

A world-class venue, the Centre provides superb flexibility and versatility and offers a comprehensive range of fully integrated in-house services all under the one roof and delivered by our team of experienced professionals whose commitment to excellence extends across all events.

An impressive portfolio of meeting rooms and event spaces meets the challenge of all events of any complexity or size, accommodating plenary needs of 400 or 4,000, with the capacity to extend to 8,000.

read more...

 

Queensland Institute of Medical Research (QIMR) - Monday, 6 September 2010

Organisation Category

Biomarker Discovery
Contract Research Organisation
Medical Research Institute
Not-for-profit Institution/Organisation
Research Institution
Research Organisation
 
Services

Analytical/Pathology Laboratory Services
Bioinformatics
Biomarkers
Biomarkers Discovery
Biostatistical Analysis
Bone Marrow Transplant Laboratory Services
Clinical Research
Commercialisation Services
Contract Genomics Services
Contract Research Services
Drug Discovery
Epidemiology Research
Flow Cytometry Services
Genomics Research
Medical Research
Preclinical Research

Therapy Area Experience

Anti-infectious
Dermatology
Gastroenterology
Haematology
Immunology
Indigenous Health
Infectious Diseases
Oncology
Parasitology
Transplantation
Vaccines
Virology
Women’s Health

QIMR is a fully integrated biomedical research and development centre and one of the largest medical research institutes in Australia. QIMR has the capability to translate fundamental basic research from the discovery and development phase, through manufacture to Phase I and II clinical trials. The Institute incorporates Q-Gen Pty Ltd, a Therapeutic Goods Administration (TGA) approved, certified good manufacture process (cGMP) manufacturing facility and Q-Pharm Pty Ltd, a company specialising in Phase I and II clinical trials and bioequivalence studies.

QIMR has a long and prestigious history that spans nearly 60 years in medical research. Areas of research include the immunology and molecular basis of infectious diseases, cancers and immune disorders. The Institute is at the forefront in the discovery of genes, candidate vaccines and cancer therapeutics and the testing of vaccines and novel therapies at the cellular, animal model and clinical level.

QIMR has specialised facilities for genomics research, microarray and mass array analysis, transgenic and gene knockout mice, mouse models of tumour growth and infectious diseases, confocal and laser dissection microscopy, FACS and cell sorting facilities, PC2 animal facilities and Good Laboratory Practice (GLP) capabilities.

QIMR is the home of the Australian Centre for Vaccine Development and also houses a number of specialist laboratories including the drug discovery group and the protein discovery centre.

read more...

 

BMDIF - Wednesday, 1 September 2010

Organisation Category

Industry Forum
Not-for-profit Institution/Organisation

Therapy Area

Biotechnology
Devices

Services

Linking and Networking Opportunities  

The Biotechnology and Medical Devices Industry Forum (BMDIF) is an exciting opportunity for you to have a genuine role in the growth and success of the sector in Queensland.

For the first time we have key representatives from across the industry participating in an executive group that will help shape the strategic direction of the industry:

  • Medical Technology Association of Australia (MTAA)
  • AusBiotech QLD
  • AusMedtech QLD
  • Queensland Clinical Trials Network (QCTN)
  • Queensland Health
  • Industry representatives

A key goal of the BMDIF is to develop industry-led solutions to the following impediments to industry growth (as identified from industry surveys and analysis):

  1. Industry Financing
  2. Skills and Expertise
  3. Regulatory Compliance
  4. Product Development and Manufacturing
  5. Market Entry

BMDIF supports the Commercialisation Matrix: gateway to a wealth of resources for commercial success. The matrix is a tool to connect you to a wealth of government (state and federal), private sector, and tertiary sector resources to assist you with your commercialisation journey.

But we can’t do it without you!

You are the champions that can drive the strategic development of your industry.

read more...

 

 

Qpid - Wednesday, 1 September 2010

Organisation Category

Clinical Research Organisation Government – State
Clinical Trials Unit
Dedicated Clinical Trials Centre (as part of a public or private hospital) 
Medical Department (clinic/ward part of a public hospital)

Services

Clinical Project Management
Clinical Research
Clinical Trial Administration
Clinical Trial Management & Logistics
Clinical Trial Site Services
Medical Research
Paediatric Clinical Trials
Patient Recruitment
Patient Screening
Treatment of Subjects (Context of Phase I/II Trials)
Treatment of Subjects (Context of Phase III/IV Trials)
 
Therapy Area Experience

Anti-infectious  
Gastroenterology
Infectious Diseases  
Paediatrics
Respiratory/Pulmonary
Vaccines  

The Queensland Paediatric Infectious Diseases (Qpid) Laboratory Clinical Trials Group has been conducting research and clinical trials since 2004. We conduct research in a number of areas: infectious diseases, epidemiology and laboratory diagnostics and methods; vaccines and other preventative agents; antibiotics and other therapeutic agents; and other hospital based research unrelated to infectious diseases. Our studies have been hospital based and community based. We currently employ eight (FTE 7.2) nurse study coordinators, one dedicated study nurse, two laboratory technicians (FTE 1.0), three medical officers and the head of our group is an infectious diseases paediatrician and microbiologist.

read more...

 

biostate - Monday, 23 August 2010

Organisation Category
Business Consultancy Organisation

Services
Business Consultancy Services  

biostate provides consulting services to those individuals, institutions and commercial entities who require assistance to identify and realise the commercial potential of their research. With significant experience in the health sector, and as active participants in the biotech and pharmaceutical forums, we can provide:

  • advice in identifying the commercial potential of an idea or technology
  • assistance in the development of business and marketing plans
  • representation for our clients in relevant meetings, conferences or other forums
  • guidance in the identification and selection of strategic partners
  • support in negotiation of commercial and licensing agreements
  • introductions to industry contacts.

read more...

 

RBS Morgans - Monday, 23 August 2010

Organisation Category
Corporate Advisory 
Financial Planning
Stockbroking 

Services
Investment consultancy service
Research of listed life science companies

Therapy Area Experience
Devices  
Oncology  
Pain  

The trusted RBS Morgans team of corporate finance professionals are market leaders in all aspects of corporate finance solutions, with a demonstrated track record of delivering outcomes for Australian small and mid-cap companies. Housing a number of world class corporate finance advisers and analysts who specialise in the health care and biotech sector, RBS Morgans has the expertise to guide companies through the capital raising process.

We offer a full range of corporate finance, equity capital markets and advisory services including:

  • Initial public offers
  • Secondary raisings – placements, rights issues, share purchase plans
  • Hybrid and convertible offers
  • Share buy backs
  • Merger and acquisition advisory – relating to the assessment of acquisitions, mergers, joint ventures and divestment opportunities
  • Takeover defence
  • Asset / business sales
  • Private equity / venture capital

Since the early 1990’s our team at RBS Morgans has structured and raised more than $16.5 billion in new capital for clients in over 950 transactions. We provide our clients with direct access to retail equity markets (through a national stockbroking network), domestic institutional investors (through our dedicated small-mid cap institutional sales team) and international institutional clients (through the Royal Bank of Scotland international network).

read more...

 

BioPharmaceuticals Australia - Monday, 16 August 2010

Organisation Category
Manufacturing Facility/Contract Manufacturing Organisation

Services
Bioprocessing/Fermentation  
Contract Manufacturing/Scale-up 
Formulation & Fill 
Process Development 
Tissue Banking 

Therapy Area Experience
Manufacture of a range of therapeutics


BPA has been established with the support of the Queensland Government to achieve two broad objectives:

• To design, fund and implement construction of a biotherapeutic manufacturing facility to be operated in alliance with an experienced international partner
• To support and grow existing local Australian biotherapeutic manufacturing organisations, and to facilitate synergies between complementary providers of clinical development services.
• The new facility with provide a service solution for companies with biological drug candidate who seek to outsource their process development and manufacturing.  It will provide cutting-edge technical and economical methods for generating biopharmaceutical compounds expressed in mammalian cells.

The facility will enable early stage research to be converted into robust, production-ready processes, which can be tested at pilot scale before moving into the highly controlled GMP manufacturing environment required for human medicinal products. BPA will not only cater for pre-clinical development projects, but also for clients manufacturing for clinical trials and the marketplace.

Due to be opened in early 2013, the facility upstream suites will cater for mammalian cell culture up to 2000 litres, with the ability to accommodate future expansion.

 read more ...

Redland Hospital - Monday, 16 August 2010

Organisation Category
Government – State 
Public Hospital 

Services
Analytical/Pathology Laboratory Services
Clinical Data Management Patient Recruitment
Clinical Monitoring Patient Screening
Clinical Research Treatment of Subjects (Phase III/IV Trials)
Paediatric Clinical Trials 

Therapy Area Experience
Anaesthesilogy 
Cardiology 
Cardiovascular 
Endocrinology 
Gastroenterology 
General Medicine 
Geriatric Medicine  
Obstetrics 
Orthopaedics 
Paediatrics 
Physiotherapy 
Psychiatry 
Radiology
Renal Medicine
Respiratory/Pulmonary
Stroke
Surgery
Urology

General acute outer metropolitan hospital with a busy emergency department, obstetric service, paediatrics, medicine, cardiology, surgery and mental health departments. The Redland Hospital is collocated with a private hospital as well as a residential nursing facility.

 read more ...

BioAssayLINK - Monday, 9 August 2010

Organisation Category
On-line Matching Service

Services
Lab and Consultant Options 
On-line Matching Services

Therapy Area Experience
Allergy
Anti-infectious
Autoimmune Disease
Cardiology
Cardiovascular
CNS/Neurology
Complementary  Medicines
Dermatology
Devices
Endocrinology
Gastroenterology
Genitourinary
Geriatric Medicine
Haematology 
Hypertension
Immunology
Infectious Diseases
Lymphoma
Migraine
Multiple Areas
Multiple Sclerosis
Neurogenetic Disorders
Nutraceutical
Obstetrics
Oncology
Ophthalmology
Orthopaedics
Osteoporosis
Paediatrics
Pain
Pathology
Physiotherapy
Psychiatry
Radiology
Renal Medicine
Rheumatology
Stem Cell Research
Stroke
Surgery
Transplantation
Urology
Vaccines

BioAssayLINK is the ‘Wotif’ or ‘Expedia’ of global therapeutic R&D expertise and capabilities. Our online linking tool connects industry with the expertise and capabilities that they need to advance their new therapeutics. BioAssayLINK is the first convenient online marketplace of biomedical researchers, service providers and specialised consultants. The linking tool provides a rapid, cost effective and customer-specific way for seekers to connect with specialised providers. Seekers submit (and soon search) their laboratory and/or consultant options online. Providers are charged a nominal annual fee to list their specific capabilities and expertise. BioAssayLINK is headquartered in Brisbane, Australia, with distribution networks and affiliates in the United States of America and the United Kingdom and is constantly expanding.

 read more ...

RBWH Endocrinology Clinical Trials Unit - Monday, 9 August 2010

Organisation Category
Dedicated Clinical Trials Centre (as part of a public or private hospital)

Services
Clinical Research 
Medical Research 

Therapy Area Experience
Endocrinology 

The Endocrine Clinical Trials Network is based in one of the largest public hospitals in Australia and has been participating in clinical trials since 1986. It has a long history of successful recruitment into clinical trials due to the large patient population that it draws on. Its principal investigator, Dr Michael d’Emden has been on the management committee of several major international trials such as ASPEN, FIELD and TNT. It delivers high quality data and has received high commendations after many major audits. Its major clinical focus is any endocrine study, especially in diabetes and cardiovascular disease prevention trials.
 

 read more ...

AusTrials - Monday, 2 August 2010

Organisation Category
Analytical/Pathology Laboratory 
Central Laboratory 
Clinical Research Organisation 
Contract Research Organisation 
Dedicated Clinical Trials Centre (as part of a public or private hospital
Medical Department
Research Organisation

Services
Clinical Research 
Medical Research 
Pharmacokinetic Analysis 
Treatment of Subjects (Context of Phase I/II Trials)
Treatment of Subjects (Context of Phase III/IV Trials)

Therapy Area Experience
Allergy  
Anti-infectious  
Cardiovascular  
CNS/Neurology  
Dermatology  
Endocrinology  
Gastroenterology  
Genitourinary  
Haematology
Immunology
Men’s Health
Otolaryngology
Paediatrics
Pain
Psychiatry
Renal Medicine
Respiratory/Pulmonary
Rheumatology
Urology
Vaccines
Volunteers
Women’s Health

AusTrials, a wholly-owned subsidiary of Primary Health Care Ltd, is a leading provider of high-quality clinical research site services in Australia, conducting Phase II to IV studies in a wide range of therapeutic areas.
AusTrials builds on proficiency and expertise gained through the Australian Clinical Research Organisation (ACRO), with over 20 years of successfully conducted studies in over 50 therapeutic areas. The clinical research group has grown to seven cetnre in three states, with over 40 staff.  AusTrials is recognised for prompt study start-up and the highest standards in clinical research data.  AusTrials has also established GP Trial sites in a number of Primary medical centres, with new sites in development. Clinical trial coordinators are engaged on a permanent basis at GP Trials sites, improving recruitment across all Phase II-IV clinical trials.
AusTrials has working relationships with specialists in areas such as Neurology, Cardiology, Respiratory Medicine, Diabetes and Gastroenterology; and is able to communicate with over 1000 General Practitioners in large-scale, well-equipped medical centres throughout most states; with access to Pathology, Radiology, and Health Information technology.

 read more ...

Santo Santoro Consulting - Monday, 2 August 2010

Organisation Category
Biotech Consultancy Organisation 
Business Consultancy Oragnisation 
Government Liaison
Marketing & Communications Company

Services
Biotech Consultancy Services 
Business Consultancy Services 
Commercialisation Services 
Investment Consultancy Services 
Market Research
Marketing & Communications Services

Providing specialist services:
• Government Liaison
• Infrastructure Development Consultant
• Policy Development Advisor
• Networking and Connection Facilitator
• Board Representation
• Corporate Risk Consulting
• Aged Care Consulting Services
• Business Development
 

 read more ...

Australian Prostate Cancer Research Centre – Queensland - Monday, 26 July 2010

Organisation Category
Analytical/Pathology Laboratory 
Biomarker Discovery 
Dedicated Clinical Trials Centre (as part of a public or private hospital)
Medical Research Institute 
Not-for-profit Institution/Organisation 
Preclinical Facility
Research Institution
Research Organisation

Services
Analytical/Pathology Laboratory Services
Bioassays 
Bioinformatics 
Biomarkers Discovery 
Clinical Research 
Clinical Research Network 
Clinical Trial Administration 
Contract Research Services 
Genomics Research 
Medical Research 
Nutraceutical
Patient Recruitment
Pharmacogenomics
Preclinical Research
Tissue Banking
Translational Medicine
Treatment of Subjects (Phase 0 Trials)
Treatment of Subjects (Phase I/II Trials)
Treatment of Subjects (Phase III/IV Trials)

Therapy Area Experience
Endocrinology 
Men’s Health 
Nutraceutical 
Oncology  
Pathology 
Surgery 
Urology

The Australian Prostate Cancer Research Centre – Queensland is a transdisciplinary research centre focussed on the development of prostate cancer therapeutics and prognostic biomarkers. Hosted by the Queensland University of Technology at the Princess Alexandra Hospital, the APCRC-Q’s activities span from high throughput discovery, molecular pathology and functional characterisation of potential targets, through to preclinical therapeutic development and evaluation and clinical trials. The APCRC-Q is underpinning the establishment of a multi-disciplinary prostate cancer clinical trials unit at the Princess Alexandra Hospital for Phase I/II and III trials.

The prostate cancer clinical trials unit will work in close association with the Australia New Zealand Urogenital and Prostate Cancer Clinical trials consortium and the Trans-Tasman Radiation Oncology Group, as well as the international prostate cancer-focussed clinical trials consortia.  The APCRC-Q is the Australian hub of the Australian-Canadian Prostate Cancer Research Alliance Program.  This international network partners more than 250 scientists, clinicians, and other professionals working in prostate cancer, in order to facilitate access to unique resources, leading edge infrastructure, and clinical trials networks. The Australian Prostate Cancer Research Centre – Queensland is highly interested in working collaboratively or contracting with biotech, pharma and other industries in the development of new therapeutics, imaging and biomarkers.

 read more ...

St Andrew's Medical Institute - Monday, 26 July 2010

Organisation Category
Dedicated Clinical Trials Centre (as part of a public or private hospital) 
Medical Research Institute 
Not-for-profit Institution/Organisation
Research Institution

Services
Biostatistical Analysis 
Clinical Data Management 
Clinical Research 
Clinical Research Network 
Clinical Trial Administration
Clinical Trial Management & Logistics
Clinical Trial Site Services
Literature Reviews
Medical Research

Therapy Area Experience
Cardio-electrophysiology 
Cardiology 
Cardiovascular
CNS/Neurology
Orthopaedics

St Andrew’s Medical Institute (SAMI) supports clinical trial activities undertaken by the leading medical specialists at St Andrew’s War Memorial Hospital in Brisbane.  These specialists treat a procedural and medical casemix which is among the most acute in Australia, with substantial volume in specific therapeutic areas. SAMI’s collaborative arrangements with St Andrew’s Hospital enable direct access to the technology and facility infrastructure to support these activities.

 read more ...

The Australian Lung Foundation - Monday, 19 July 2010

Organisation Category
Medical Cooperative Group 
Not-for-Profit Public Benevolent Institution

Services
Clinical Trial Administration  
Ethics Committee 
Protocol Review & Amendment Service
Ethics Committee Expedited Access for Submissions

Therapy Area Experience
Oncology 
Radiology 
Respiratory/Pulmonary  
Transplantation 
Vaccines
Volunteers 

The Australian Lung Foundation’s Multi-Centre Clinical Trials Network (ALF MCTN) is an established service available to clinical trial sponsors and Clinical Research Organisations (CROs).  It provides access to a large-scale investigator and patient database.  The MCTN is supported by an efficient ethics submission process as well as an established network and recruitment management system.
The Network has been formed to support both local and international studies. It does not compete with the institutions that currently undertake clinical trials, but will enhance the recruitment base so that collectively, recruitment targets and tight study timelines can be met.  The ALF MCTN business returns any surplus earned to the ALF assisting the Foundation to fulfill their vision as a key agent of change in Australia, bringing about the understanding, management and relief of lung disease.

 read more ...

Sullivan Nicolaides Pathology - Monday, 19 July 2010

Organisation Category
Analytical/Pathology Laboratory 
Central Laboratory

Services
Analytical/Pathology Laboratory Services
Clinical Trial Management & Logistics 
Logistics 

Therapy Area Experience
All areas   

Sullivan Nicolaides Pathology has considerable experience in the provision of clinical trial services to the pharmaceutical industry and university research departments.
Logistics: Whilst utilising the extensive coverage of our own courier network, Sullivan Nicolaides Pathology also works in close co-operation with major courier companies to supply investigator sites with supplies, and rapid pick-up and return of samples for testing.
Rapid Result Turnaround: Sullivan Nicolaides Pathology provides services 24 hours a day, 7 days a week.  All samples are processed immediately on arrival with most reports being returned to the investigator site within 24 hours by transmission medium of your choice.
Supplies and Documentation: Collection supplies can be supplied as visit-specific kits or in ‘bulk.’ Request forms are study and site specific. Comprehensive, easy to use laboratory manuals are provided for each investigator site to ensure good site compliance.
Trials Management: Sullivan Nicolaides Pathology has dedicated in-house staff assigned to assist investigators in providing the samples required and to ensure that all requisitions are complete.
 

 read more ...

TetraQ - Monday, 12 July 2010

Organisation Category
Analytical/Pathology Laboratory 
Bioanalytical Facility 
Contract Research Organisation
Preclinical Facility

Services
Analytical/Pathology Laboratory Services 
Bioassays 
Efficacy- in-vitro and in-vivo models of efficacy 
Toxicology: in-vitro and in-vivo, genotoxicity assays, dose-range finding studies
Pharmaceutics: characterisation, stability, formulation development, dissolution
Pharmacokinetic Analysis
Pharmaceuticals & Toxicology
Translational Medicine

Therapy Area Experience
Allergy  
Anaesthesiology 
Autoimmune Disease 
Cardiovascular  
CNS/Neurology 
Complementary Medicines 
Dermatology
Endocrinology 
Gastroenterology 
Multiple Sclerosis
Nutraceutical 
Paediatrics 
Pain
Psychiatry
Respiratory/Pulmonary
Rheumatology
Vaccines


TetraQ is Australia’s leading, fully-integrated preclinical drug development contract research organisation (CRO) providing a range of high-quality, integrated and tailored preclinical services (ADME, Efficacy, Pharmaceutics, Toxicology) globally to pharmaceutical and biotechnology industries.  TetraQ has NATA ISO 17025 (R&D) accreditation and GLP recognition which allows bioanalytical and toxicology work to be accepted internationally for regulatory review and provides a high degree of assurance for TetraQ clients.
TetraQ work with companies developing new drugs, seeking assistance with selecting a drug candidate or requiring preclinical drug characterisation. TetraQ develop preclinical programs to ensure careful selection of studies which is critical to save on time and expenditure.
TetraQ aims to provide a ‘one-stop’ service and advice for clients. TetraQ has world-class facilities backed by a highly-skilled scientific team with a wealth of experience in all four core disciplines of preclinical development. The TetraQ team take the time to understand your business needs and provide comprehensive tailored solutions either in-house or through their extensive network. In addition to providing a range of contract services, TetraQ can also:
• Consult to your business by providing expert opinions, reviewing and interpreting data, reviewing and preparing product development plans and assisting in due diligence.
• Advise on early-stage drug development activities including regulatory strategy.
TetraQ currently provide services to clients base in the United States of America, Japan, Europe, the United Kingdom, SE Asia and New Zealand.

 read more ...

The Australian Institute for Commercialisation - Monday, 12 July 2010

Organisation Category
Commercialisation Company

Services
Commercialisation Project Management Services
Market Research and Opportunity Analysis
Professional Development Programs to increase Commercialisation skills and successes
Strategic Advice around Intellectual Property Management and Commercialisation
Technology Transfer Facilitation and brokerage of Intellectual Property (IP)

The Australian Institute for Commercialisation (AIC) is a leading service organisation helping innovators achieve commercial success. Around Australia, the AIC helps business, research organisations and governments conv